Daratumumab Clinical Trials (2026): 347 Studies for Multiple Myeloma & Plasma Cell Myeloma

Hipa.ai Research · Source: ClinicalTrials.gov / AACT

Synced daily from ClinicalTrials.gov via AACT. Last sync: .

347 Daratumumab clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 115 indications (including Multiple Myeloma & Plasma Cell Myeloma) and 54,064 total planned enrollment. 57 Phase 3 Daratumumab trials and 161 Phase 2, 7 Phase 4 are listed. 104 Daratumumab clinical trials are actively recruiting at 1,512 U.S. sites across 50 states. Most recent activity: NCT06358638 (Sep 2054).

Where to Participate: All Daratumumab Trial Sites in the U.S. (1,512 sites across 50 states)

Every actively recruiting Daratumumabtrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

StateFacilityCityTrialMap
ALUniversity of Alabama at BirminghamBirmingham35205NCT06615479Map
ALUniversity of Alabama at BirminghamBirmingham35294NCT06974786Map
ALUniversity of Alabama at Birmingham Cancer CenterBirmingham35233NCT03937635Map
ALUniversity of Alabama At Birmingham HospitalBirmingham35294-0004NCT04973605Map
ALGSK Investigational SiteMobile36607NCT06679101Map
AKAlaska Breast Care and Surgery LLCAnchorage99508NCT03937635Map
AKAlaska Breast Care and Surgery LLCAnchorage99508NCT05561387Map
AKAlaska Oncology and Hematology LLCAnchorage99508NCT03937635Map
AKAlaska Oncology and Hematology LLCAnchorage99508NCT05561387Map
AKAlaska Women's Cancer CareAnchorage99508NCT03937635Map
AKAlaska Women's Cancer CareAnchorage99508NCT05561387Map
AKAnchorage Associates in Radiation MedicineAnchorage98508NCT03937635Map
AKAnchorage Associates in Radiation MedicineAnchorage98508NCT05561387Map
AKAnchorage Oncology CentreAnchorage99508NCT05561387Map
AKAnchorage Radiation Therapy CenterAnchorage99504NCT05561387Map
AKKatmai Oncology GroupAnchorage99508NCT03937635Map
AKKatmai Oncology GroupAnchorage99508NCT05561387Map
AKProvidence Alaska Medical CenterAnchorage99508NCT03937635Map
AKProvidence Alaska Medical CenterAnchorage99508NCT05561387Map
AKFairbanks Memorial HospitalFairbanks99701NCT03937635Map
AZBanner MD Anderson Cancer CenterGilbert85234NCT05552222Map
AZCTCA at Western Regional Medical CenterGoodyear85338NCT03937635Map
AZCTCA at Western Regional Medical CenterGoodyear85338NCT06022939Map
AZKingman Regional Medical CenterKingman86401NCT03937635Map
AZCancer Center at Saint Joseph'sPhoenix85004NCT03937635Map
AZCancer Center at Saint Joseph'sPhoenix85004NCT04566328Map
AZCancer Center at Saint Joseph'sPhoenix85004NCT05561387Map
AZGSK Investigational SitePhoenix85054NCT06679101Map
AZMayo Clinic Hospital Scottsdale /ID# 278349Scottsdale85259NCT07095452Map
AZMayo Clinic in ArizonaScottsdale85259NCT05898646Map
AZBanner University Medical Center - TucsonTucson85719NCT06022939Map
AZUniversity of Arizona Cancer CenterTucson85719NCT05552222Map
AZUniversity of Arizona Cancer Center-North CampusTucson85719NCT06022939Map
ARMercy Hospital Fort SmithFort Smith72903NCT03937635Map
ARMercy Hospital Fort SmithFort Smith72903NCT04566328Map
ARMercy Hospital Fort SmithFort Smith72903NCT05561387Map
ARCARTI Cancer CenterLittle Rock72205NCT04566328Map
ARCARTI Cancer CenterLittle Rock72205NCT05561387Map
ARUniversity of Arkansas for Medical SciencesLittle Rock72205NCT05561387Map
CAMission Hope Medical Oncology - Arroyo GrandeArroyo Grande93420NCT03937635Map
CAMission Hope Medical Oncology - Arroyo GrandeArroyo Grande93420NCT04566328Map
CAMission Hope Medical Oncology - Arroyo GrandeArroyo Grande93420NCT05561387Map
CAPCR OncologyArroyo Grande93420NCT03937635Map
CAGSK Investigational SiteBeverly Hills90211NCT06679101Map
CAProvidence Saint Joseph Medical Center/Disney Family Cancer CenterBurbank91505NCT03937635Map
CAProvidence Saint Joseph Medical Center/Disney Family Cancer CenterBurbank91505NCT05561387Map
CAMarshall Cancer CenterCameron Park95682NCT05561387Map
CAMercy Cancer Center - CarmichaelCarmichael95608NCT03937635Map
CAMercy Cancer Center - CarmichaelCarmichael95608NCT04566328Map
CAMercy Cancer Center - CarmichaelCarmichael95608NCT05561387Map
CAMercy San Juan Medical CenterCarmichael95608NCT03937635Map
CAMercy San Juan Medical CenterCarmichael95608NCT04566328Map
CAMercy San Juan Medical CenterCarmichael95608NCT05561387Map
CAUCSF FresnoClovis93611NCT05552222Map
CACity of Hope Comprehensive Cancer CenterDuarte91010NCT06022939Map
CACity of Hope DuarteDuarte91010NCT05552222Map
CACity of Hope Medical CenterDuarte91010NCT05363111Map
CACity of Hope Medical CenterDuarte91010NCT06287944Map
CACity of Hope National Medical CenterDuarte91010-3012NCT04973605Map
CACity of Hope National Medical CenterDuarte91010-3012NCT07555938Map
CAMercy Cancer Center - Elk GroveElk Grove95758NCT03937635Map
CAMercy Cancer Center - Elk GroveElk Grove95758NCT04566328Map
CAMercy Cancer Center - Elk GroveElk Grove95758NCT05561387Map
CACity of Hope - Lennar Foundation Cancer CenterIrvine92618NCT07555938Map
CACity of Hope at Irvine LennarIrvine92618NCT06022939Map
CACity of Hope Irvine LennarIrvine92618-2377NCT04973605Map
CACity of Hope Orange County Lennar Foundation Cancer CenterIrvine92618NCT05552222Map
CAUCI Health - Chao Family Comprehensive Cancer Center and Ambulatory CareIrvine92612NCT06022939Map
CAScripps Clinic Torrey PinesLa Jolla92037NCT05137054Map
CALoma Linda University Children's HospitalLoma Linda92354NCT04972942Map
CACancer and Blood Specialty ClinicLos Alamitos90720NCT05552222Map
CACedars-Sinai Medical Center /ID# 278238Los Angeles90048NCT07095452Map
CAUCLA Hematology/Oncology - Santa MonicaLos Angeles90404NCT06615479Map
CAUniversity of Southern California /ID# 272414Los Angeles90033NCT06953960Map
CAValkyrie Clinical TrialsLos Angeles90067NCT05552222Map
CAValkyrie Clinical TrialsLos Angeles90670NCT06119685Map
CAContra Costa Regional Medical CenterMartinez94553-3156NCT03937635Map
CAFremont - Rideout Cancer CenterMarysville95901NCT05561387Map
CAMercy Cancer CenterMerced95340NCT04566328Map
CAMercy UC Davis Cancer CenterMerced95340NCT05561387Map
CAProvidence Queen of The ValleyNapa94558NCT05561387Map
CAUC Irvine Health/Chao Family Comprehensive Cancer CenterOrange92868NCT06022939Map
CAUniversity of California, Irvine (UCI) Health - UC Irvine Medical CenterOrange92868NCT06615479Map
CAGSK Investigational SitePasadena91105NCT06679101Map
CAMercy Cancer Center - RocklinRocklin95765NCT03937635Map
CAMercy Cancer Center - RocklinRocklin95765NCT04566328Map
CAMercy Cancer Center - RocklinRocklin95765NCT05561387Map
CAMercy Cancer Center - SacramentoSacramento95816NCT03937635Map
CAMercy Cancer Center - SacramentoSacramento95816NCT04566328Map
CAMercy Cancer Center - SacramentoSacramento95816NCT05561387Map
CAUniversity of California Davis Comprehensive Cancer CenterSacramento95817NCT05561387Map
CAUniversity of CaliforniaSan Francisco94143NCT04972942Map
CAPacific Central Coast Health Center-San Luis ObispoSan Luis Obispo93401NCT03937635Map
CAPacific Central Coast Health Center-San Luis ObispoSan Luis Obispo93401NCT04566328Map
CAPacific Central Coast Health Center-San Luis ObispoSan Luis Obispo93401NCT05561387Map
CAMission Hope Medical Oncology - Santa MariaSanta Maria93444NCT03937635Map
CAMission Hope Medical Oncology - Santa MariaSanta Maria93444NCT04566328Map
CAMission Hope Medical Oncology - Santa MariaSanta Maria93444NCT05561387Map
CAProvidence Medical Foundation - Santa RosaSanta Rosa95403NCT05561387Map
CAProvidence Santa Rosa Memorial HospitalSanta Rosa95405NCT05561387Map
CASaint Joseph's Medical CenterStockton95204NCT03937635Map
CASaint Joseph's Medical CenterStockton95204NCT04566328Map
CAGene Upshaw Memorial Tahoe Forest Cancer CenterTruckee96161NCT05561387Map
CABASS Medical Group - LennonWalnut Creek94598NCT03937635Map
CAWoodland Memorial HospitalWoodland95695NCT03937635Map
CAWoodland Memorial HospitalWoodland95695NCT04566328Map
CAWoodland Memorial HospitalWoodland95695NCT05561387Map
COGSK Investigational SiteAurora80012NCT06679101Map
CORocky Mountain Cancer Centers-AuroraAurora80012NCT03937635Map
CORocky Mountain Regional VA Medical CenterAurora80045NCT05561387Map
COBoulder Community Foothills HospitalBoulder80303NCT03937635Map
CORocky Mountain Cancer Centers-BoulderBoulder80304NCT03937635Map
COPenrose-Saint Francis HealthcareColorado Springs80907NCT03937635Map
COPenrose-Saint Francis HealthcareColorado Springs80907NCT04566328Map
COPenrose-Saint Francis HealthcareColorado Springs80907NCT05561387Map
CORocky Mountain Cancer Centers-PenroseColorado Springs80907NCT03937635Map
CORocky Mountain Cancer Centers-PenroseColorado Springs80907NCT04566328Map
CORocky Mountain Cancer Centers-PenroseColorado Springs80907NCT05561387Map
COSaint Francis Cancer CenterColorado Springs80923NCT03937635Map
COSaint Francis Cancer CenterColorado Springs80923NCT04566328Map
COSaint Francis Cancer CenterColorado Springs80923NCT05561387Map
COColorado Blood Cancer InstituteDenver80218NCT06974786Map
COColorado Blood Cancer Institute /ID# 273129Denver80218NCT06892522Map
COColorado Blood Cancer Institute /ID# 279080Denver80218NCT07095452Map
COPresbyterian - Saint Lukes Medical Center - Health OneDenver80218NCT03937635Map
COMercy Medical CenterDurango81301NCT05561387Map
COSouthwest Oncology PCDurango81301NCT05561387Map
COThe Melanoma and Skin Cancer InstituteEnglewood80113NCT03937635Map
COSaint Anthony HospitalLakewood80228NCT03937635Map
COSaint Anthony HospitalLakewood80228NCT04566328Map
COSaint Anthony HospitalLakewood80228NCT05561387Map
CORocky Mountain Cancer Centers-LittletonLittleton80120NCT03937635Map
COLongmont United HospitalLongmont80501NCT03937635Map
COLongmont United HospitalLongmont80501NCT05561387Map
COSaint Mary Corwin Medical CenterPueblo81004NCT03937635Map
COSaint Mary Corwin Medical CenterPueblo81004NCT04566328Map
COSaint Mary Corwin Medical CenterPueblo81004NCT05561387Map
CORocky Mountain Cancer Centers-ThorntonThornton80260NCT03937635Map
COSaint Anthony North HospitalWestminster80023NCT03937635Map
COSaint Anthony North HospitalWestminster80023NCT04566328Map
CTSmilow Cancer Hospital-Derby Care CenterDerby06418NCT03937635Map
CTSmilow Cancer Hospital-Derby Care CenterDerby06418NCT05561387Map
CTSmilow Cancer Hospital-Derby Care CenterDerby06418NCT06022939Map
CTSmilow Cancer Hospital Care Center-FairfieldFairfield06824NCT03937635Map
CTSmilow Cancer Hospital Care Center-FairfieldFairfield06824NCT05561387Map
CTUniversity of ConnecticutFarmington06030NCT05552222Map
CTSmilow Cancer Hospital Care Center at GlastonburyGlastonbury06033NCT03937635Map
CTSmilow Cancer Hospital Care Center at GlastonburyGlastonbury06033NCT05561387Map
CTSmilow Cancer Hospital Care Center at GreenwichGreenwich06830NCT03937635Map
CTSmilow Cancer Hospital Care Center at GreenwichGreenwich06830NCT05561387Map
CTSmilow Cancer Hospital Care Center at GreenwichGreenwich06830NCT06022939Map
CTSmilow Cancer Hospital Care Center - GuilfordGuilford06437NCT03937635Map
CTSmilow Cancer Hospital Care Center - GuilfordGuilford06437NCT05561387Map
CTSmilow Cancer Hospital Care Center - GuilfordGuilford06437NCT06022939Map
CTSmilow Cancer Hospital Care Center at Saint FrancisHartford06105NCT03937635Map
CTSmilow Cancer Hospital Care Center at Saint FrancisHartford06105NCT05561387Map
CTSmilow Cancer Hospital Care Center at Saint FrancisHartford06105NCT06022939Map
CTResearch SiteNew Haven06510NCT07391657Map
CTSmilow Cancer Center/Yale-New Haven HospitalNew Haven06510NCT03937635Map
CTSmilow Cancer Center/Yale-New Haven HospitalNew Haven06510NCT05561387Map
CTYale New Haven HospitalNew Haven06510NCT05552222Map
CTYale UniversityNew Haven06520NCT03937635Map
CTYale UniversityNew Haven06520NCT05561387Map
CTYale UniversityNew Haven06520NCT06022939Map
CTYale University School of Medicine /ID# 272447New Haven06510NCT06953960Map
CTYale-New Haven Hospital North Haven Medical CenterNorth Haven06473NCT03937635Map
CTYale-New Haven Hospital North Haven Medical CenterNorth Haven06473NCT05561387Map
CTYale-New Haven Hospital North Haven Medical CenterNorth Haven06473NCT06022939Map
CTSmilow Cancer Hospital-Orange Care CenterOrange06477NCT03937635Map
CTSmilow Cancer Hospital Care Center at Long RidgeStamford06902NCT03937635Map
CTSmilow Cancer Hospital Care Center at Long RidgeStamford06902NCT05561387Map
CTSmilow Cancer Hospital Care Center at Long RidgeStamford06902NCT06022939Map
CTSmilow Cancer Hospital-Torrington Care CenterTorrington06790NCT03937635Map
CTSmilow Cancer Hospital-Torrington Care CenterTorrington06790NCT05561387Map
CTSmilow Cancer Hospital Care Center-TrumbullTrumbull06611NCT03937635Map
CTSmilow Cancer Hospital Care Center-TrumbullTrumbull06611NCT05561387Map
CTSmilow Cancer Hospital Care Center-TrumbullTrumbull06611NCT06022939Map
CTSmilow Cancer Hospital-Waterbury Care CenterWaterbury06708NCT03937635Map
CTSmilow Cancer Hospital-Waterbury Care CenterWaterbury06708NCT05561387Map
CTSmilow Cancer Hospital Care Center - WaterfordWaterford06385NCT03937635Map
CTSmilow Cancer Hospital Care Center - WaterfordWaterford06385NCT05561387Map
DEChristianaCare Helen F Graham Cancer Center and Research InstituteNewark19713NCT05552222Map
DCChildren's National HospitalWashington D.C.20010NCT06358638Map
DCGeorgetown Lombardi Comprehensive Cancer CenterWashington D.C.20007NCT06015724Map
DCGSK Investigational SiteWashington D.C.20007NCT06679101Map
DCMedStar Georgetown University HospitalWashington D.C.20007NCT06022939Map
FLSylvester Comprehensive Cancer Center - AventuraAventura33180NCT05020236Map
FLUM Sylvester Comprehensive Cancer Center at AventuraAventura33180NCT06022939Map
FLUM Sylvester Comprehensive Cancer Center at Coral GablesCoral Gables33146NCT06022939Map
FLSylvester Comprehensive Cancer Center - Coral SpringsCoral Springs33065NCT05020236Map
FLUM Sylvester Comprehensive Cancer Center at Coral SpringsCoral Springs33065NCT06022939Map
FLUM Sylvester Comprehensive Cancer Center at Deerfield BeachDeerfield Beach33442NCT06022939Map
FLUniversity of Miami Hospital and Clinics - Deerfield BeachDeerfield Beach33442NCT05020236Map
FLGSK Investigational SiteEnglewood34223NCT06679101Map
FLHoly Cross HospitalFort Lauderdale33308NCT03937635Map
FLHoly Cross HospitalFort Lauderdale33308NCT04566328Map
FLHoly Cross HospitalFort Lauderdale33308NCT05561387Map
FLUniversity of FloridaGainsville32608NCT04972942
FLMemorial Healthcare SystemHollywood33021NCT05552222Map
FLSylvester Comprehensive Cancer Center - HollywoodHollywood33021NCT05020236Map
FLUM Sylvester Comprehensive Cancer Center at HollywoodHollywood33021NCT06022939Map
FLBaptist MD Anderson Cancer CenterJacksonville32207NCT06615479Map
FLMayo ClinicJacksonville32224NCT05654506Map
FLMayo Clinic in FloridaJacksonville32224-9980NCT05561387Map
FLJupiter Medical CenterJupiter33458NCT05561387Map
FLGSK Investigational SiteLady Lake32159NCT06679101Map
FLUM Sylvester Comprehensive Cancer Center at KendallMiami33176NCT06022939Map
FLUniversity of MiamiMiami33136-2107NCT04973605Map
FLUniversity of MiamiMiami33136NCT05896228Map
FLUniversity of MiamiMiami33136NCT06100237Map
FLUniversity of Miami Hospital and ClinicsMiami33136NCT05020236Map
FLUniversity of Miami Hospital and Clinics, Sylvester Cancer CenterMiami33136NCT06615479Map
FLUniversity of Miami Miller School of MedicineMiami33136NCT04139304Map
FLUniversity of Miami Miller School of Medicine-Sylvester Cancer CenterMiami33136NCT06022939Map
FLUniversity of Miami Sylvester Comprehensive Cancer Center at Sole MiaNorth Miami33181NCT06022939Map
FLAdventHealth Medical Group Blood & Marrow Transplant at OrlandoOrlando32804NCT05552222Map
FLGSK Investigational SitePembroke Pines33024NCT06679101Map
FLUM Sylvester Comprehensive Cancer Center at PlantationPlantation33324NCT06022939Map
FLGSK Investigational SiteSaint Augustine32256NCT06679101Map
FLMoffitt Cancer Center /ID# 272628Tampa33612NCT06892522Map
FLCleveland Clinic FloridaWeston33331NCT05552222Map
FLCleveland Clinic-WestonWeston33331NCT03937635Map
GAPhoebe Putney Memorial HospitalAlbany31701NCT03937635Map
GAEmory Saint Joseph's HospitalAtlanta30342NCT03937635Map
GAEmory University HospitalAtlanta30322NCT06119685Map
GAEmory University Hospital MidtownAtlanta30308NCT03937635Map
GAEmory University Hospital MidtownAtlanta30308NCT06022939Map
GAEmory University Hospital/Winship Cancer InstituteAtlanta30322NCT03937635Map
GAEmory University Hospital/Winship Cancer InstituteAtlanta30322NCT06022939Map
GAEmory University Winship Cancer CenterAtlanta30322-1013NCT04973605Map
GAEmory Winship Cancer InstituteAtlanta30322NCT04068597Map
GAGSK Investigational SiteAtlanta30322NCT06679101Map
GAWinship Cancer Institute of Emory UniversityAtlanta30004NCT05137054Map
GAWinship Cancer Institute of Emory UniversityAtlanta30329NCT07555938Map
GAWinship Cancer Institute of Emory University /ID# 274830Atlanta30322NCT06892522Map
GAWinship Cancer Institute of Emory University /ID# 277667Atlanta30322NCT07095452Map
GAWinship Cancer Institute, Emory UniversityAtlanta30322NCT06615479Map
GAGeorgia Cancer Center-Augusta UniversityAugusta30912NCT06142396Map
GAJohn B Amos Cancer CenterColumbus31904NCT03937635Map
GAEmory Johns Creek HospitalJohns Creek30097NCT03937635Map
GACity of Hope Cancer CenterNewnan30265NCT05552222Map
GALewis Hall Singletary Oncology CenterThomasville31792NCT03937635Map
IDSaint Alphonsus Cancer Care Center-BoiseBoise83706NCT03937635Map
IDSaint Alphonsus Cancer Care Center-BoiseBoise83706NCT04566328Map
IDSaint Luke's Cancer Institute - BoiseBoise83712NCT03937635Map
IDSaint Luke's Cancer Institute - BoiseBoise83712NCT05561387Map
IDSaint Alphonsus Cancer Care Center-CaldwellCaldwell83605NCT03937635Map
IDSaint Alphonsus Cancer Care Center-CaldwellCaldwell83605NCT04566328Map
IDKootenai Health - Coeur d'AleneCoeur d'Alene83814NCT03937635Map
IDSaint Luke's Cancer Institute - FruitlandFruitland83619NCT03937635Map
IDSaint Luke's Cancer Institute - FruitlandFruitland83619NCT05561387Map
IDIdaho Urologic Institute-MeridianMeridian83642NCT03937635Map
IDSaint Luke's Cancer Institute - MeridianMeridian83642NCT03937635Map
IDSaint Luke's Cancer Institute - MeridianMeridian83642NCT05561387Map
IDSaint Alphonsus Cancer Care Center-NampaNampa83687NCT03937635Map
IDSaint Alphonsus Cancer Care Center-NampaNampa83687NCT04566328Map
IDSaint Luke's Cancer Institute - NampaNampa83687NCT03937635Map
IDSaint Luke's Cancer Institute - NampaNampa83686NCT05561387Map
IDKootenai Clinic Cancer Services - Post FallsPost Falls83854NCT03937635Map
IDSaint Luke's Cancer Institute - Twin FallsTwin Falls83301NCT03937635Map
IDSaint Luke's Cancer Institute - Twin FallsTwin Falls83301NCT05561387Map
ILOSF Saint Anthony's Health CenterAlton62002NCT03937635Map
ILOSF Saint Anthony's Health CenterAlton62002NCT04566328Map
ILSaint Anthony's HealthAlton62002NCT05561387Map
ILAdvocate Outpatient Center - AuroraAurora60506NCT03937635Map
ILRush - Copley Medical CenterAurora60504NCT05561387Map
ILRush-Copley Medical CenterAurora60504NCT03937635Map
ILRush-Copley Medical CenterAurora60504NCT06022939Map
ILAdvocate Good Shepherd HospitalBarrington60010NCT03937635Map
ILIllinois CancerCare-BloomingtonBloomington61704NCT03937635Map
ILIllinois CancerCare-BloomingtonBloomington61704NCT04566328Map
ILIllinois CancerCare-BloomingtonBloomington61704NCT05561387Map
ILSaint Joseph Medical CenterBloomington61701NCT05561387Map
ILLoyola Center for Health at Burr RidgeBurr Ridge60527NCT05561387Map
ILIllinois CancerCare-CantonCanton61520NCT03937635Map
ILIllinois CancerCare-CantonCanton61520NCT04566328Map
ILIllinois CancerCare-CantonCanton61520NCT05561387Map
ILMemorial Hospital of CarbondaleCarbondale62902NCT03937635Map
ILMemorial Hospital of CarbondaleCarbondale62902NCT04566328Map
ILMemorial Hospital of CarbondaleCarbondale62902NCT05561387Map
ILSIH Cancer InstituteCarterville62918NCT03937635Map
ILSIH Cancer InstituteCarterville62918NCT04566328Map
ILSIH Cancer InstituteCarterville62918NCT05561387Map
ILIllinois CancerCare-CarthageCarthage62321NCT03937635Map
ILIllinois CancerCare-CarthageCarthage62321NCT04566328Map
ILIllinois CancerCare-CarthageCarthage62321NCT05561387Map
ILCentralia Oncology ClinicCentralia62801NCT03937635Map
ILCentralia Oncology ClinicCentralia62801NCT04566328Map
ILCentralia Oncology ClinicCentralia62801NCT05561387Map
ILSaint Mary's HospitalCentralia62801NCT05561387Map
ILAdvocate Illinois Masonic Medical CenterChicago60657NCT03937635Map
ILNorthwesternChicago60611NCT05289687Map
ILSwedish Covenant HospitalChicago60625NCT03937635Map
ILUniversity of Chicago Medical CenterChicago60637-1443NCT04973605Map
ILUniversity of IllinoisChicago60612NCT06022939Map
ILUniversity of Illinois at ChicagoChicago60612NCT04139304Map
ILUniversity Of Illinois Medical CenterChicago60612NCT05552222Map
ILAMG Crystal Lake - OncologyCrystal Lake60014NCT03937635Map
ILCarle at The RiverfrontDanville61832NCT03937635Map
ILCarle at The RiverfrontDanville61832NCT05561387Map
ILCarle at The RiverfrontDanville61832NCT06022939Map
ILCancer Care Specialists of Illinois - DecaturDecatur62526NCT03937635Map
ILCancer Care Specialists of Illinois - DecaturDecatur62526NCT04566328Map
ILCancer Care Specialists of Illinois - DecaturDecatur62526NCT05561387Map
ILDecatur Memorial HospitalDecatur62526NCT03937635Map
ILDecatur Memorial HospitalDecatur62526NCT04566328Map
ILDecatur Memorial HospitalDecatur62526NCT05561387Map
ILNorthwestern Medicine Cancer Center KishwaukeeDeKalb60115NCT04566328Map
ILIllinois CancerCare-DixonDixon61021NCT04566328Map
ILIllinois CancerCare-DixonDixon61021NCT05561387Map
ILAdvocate Good Samaritan HospitalDowners Grove60515NCT03937635Map
ILCarle Physician Group-EffinghamEffingham62401NCT03937635Map
ILCarle Physician Group-EffinghamEffingham62401NCT05561387Map
ILCarle Physician Group-EffinghamEffingham62401NCT06022939Map
ILCrossroads Cancer CenterEffingham62401NCT03937635Map
ILCrossroads Cancer CenterEffingham62401NCT04566328Map
ILCrossroads Cancer CenterEffingham62401NCT05561387Map
ILAdvocate Sherman HospitalElgin60123NCT03937635Map
ILIllinois CancerCare-EurekaEureka61530NCT03937635Map
ILIllinois CancerCare-EurekaEureka61530NCT04566328Map
ILIllinois CancerCare-EurekaEureka61530NCT05561387Map
ILNorthShore University HealthSystem-Evanston HospitalEvanston60201NCT03937635Map
ILIllinois CancerCare-GalesburgGalesburg61401NCT03937635Map
ILIllinois CancerCare-GalesburgGalesburg61401NCT04566328Map
ILIllinois CancerCare-GalesburgGalesburg61401NCT05561387Map
ILWestern Illinois Cancer Treatment CenterGalesburg61401NCT05561387Map
ILNorthwestern Medicine Cancer Center DelnorGeneva60134NCT04566328Map
ILNorthShore University HealthSystem-Glenbrook HospitalGlenview60026NCT03937635Map
ILAdvocate South Suburban HospitalHazel Crest60429NCT03937635Map
ILNorthShore University HealthSystem-Highland Park HospitalHighland Park60035NCT03937635Map
ILEdward Hines Jr VA HospitalHines60141NCT05561387Map
ILLoyola Medicine Homer GlenHomer Glen60491NCT05561387Map
ILIllinois CancerCare-Kewanee ClinicKewanee61443NCT03937635Map
ILIllinois CancerCare-Kewanee ClinicKewanee61443NCT04566328Map
ILIllinois CancerCare-Kewanee ClinicKewanee61443NCT05561387Map
ILAMG Libertyville - OncologyLibertyville60048NCT03937635Map
ILCondell Memorial HospitalLibertyville60048NCT03937635Map
ILIllinois CancerCare-MacombMacomb61455NCT03937635Map
ILIllinois CancerCare-MacombMacomb61455NCT04566328Map
ILIllinois CancerCare-MacombMacomb61455NCT05561387Map
ILCarle Physician Group-Mattoon/CharlestonMattoon61938NCT03937635Map
ILCarle Physician Group-Mattoon/CharlestonMattoon61938NCT05561387Map
ILCarle Physician Group-Mattoon/CharlestonMattoon61938NCT06022939Map
ILLoyola University Medical CenterMaywood60153NCT03937635Map
ILLoyola University Medical CenterMaywood60153NCT05552222Map
ILLoyola University Medical CenterMaywood60153NCT05561387Map
ILLoyola University Medical CenterMaywood60153NCT06022939Map
ILMarjorie Weinberg Cancer Center at Loyola-GottliebMelrose Park60160NCT05561387Map
ILGood Samaritan Regional Health CenterMount Vernon62864NCT05561387Map
ILSSM Health Good SamaritanMount Vernon62864NCT03937635Map
ILSSM Health Good SamaritanMount Vernon62864NCT04566328Map
ILCarle BroMenn Medical CenterNormal61761NCT03937635Map
ILCarle Cancer Institute NormalNormal61761NCT03937635Map
ILCancer Care Center of O'FallonO'Fallon62269NCT03937635Map
ILCancer Care Center of O'FallonO'Fallon62269NCT04566328Map
ILCancer Care Center of O'FallonO'Fallon62269NCT05561387Map
ILHSHS Saint Elizabeth's HospitalO'Fallon62269NCT03937635Map
ILHSHS Saint Elizabeth's HospitalO'Fallon62269NCT04566328Map
ILHSHS Saint Elizabeth's HospitalO'Fallon62269NCT05561387Map
ILAdvocate Christ Medical CenterOak Lawn60453-2699NCT03937635Map
ILIllinois CancerCare-Ottawa ClinicOttawa61350NCT03937635Map
ILIllinois CancerCare-Ottawa ClinicOttawa61350NCT04566328Map
ILIllinois CancerCare-Ottawa ClinicOttawa61350NCT05561387Map
ILAdvocate Lutheran General HospitalPark Ridge60068NCT03937635Map
ILIllinois CancerCare-PekinPekin61554NCT03937635Map
ILIllinois CancerCare-PekinPekin61554NCT04566328Map
ILIllinois CancerCare-PekinPekin61554NCT05561387Map
ILIllinois CancerCare-PeoriaPeoria61615NCT03937635Map
ILIllinois CancerCare-PeoriaPeoria61615NCT04566328Map
ILIllinois CancerCare-PeoriaPeoria61615NCT05561387Map
ILMethodist Medical Center of IllinoisPeoria61636NCT03937635Map
ILMethodist Medical Center of IllinoisPeoria61636NCT04566328Map
ILMethodist Medical Center of IllinoisPeoria61636NCT05561387Map
ILIllinois CancerCare-PeruPeru61354NCT03937635Map
ILIllinois CancerCare-PeruPeru61354NCT04566328Map
ILIllinois CancerCare-PeruPeru61354NCT05561387Map
ILValley Radiation OncologyPeru61354NCT04566328Map
ILValley Radiation OncologyPeru61354NCT05561387Map
ILIllinois CancerCare-PrincetonPrinceton61356NCT03937635Map
ILIllinois CancerCare-PrincetonPrinceton61356NCT04566328Map
ILIllinois CancerCare-PrincetonPrinceton61356NCT05561387Map
ILMemorial Medical CenterSpringfield62781NCT05561387Map
ILSouthern Illinois University School of MedicineSpringfield62702NCT03937635Map
ILSouthern Illinois University School of MedicineSpringfield62702NCT04566328Map
ILSouthern Illinois University School of MedicineSpringfield62702NCT05561387Map
ILSpringfield ClinicSpringfield62702NCT03937635Map
ILSpringfield ClinicSpringfield62702NCT04566328Map
ILSpringfield ClinicSpringfield62702NCT05561387Map
ILSpringfield Memorial HospitalSpringfield62781NCT03937635Map
ILSpringfield Memorial HospitalSpringfield62781NCT04566328Map
ILCarle Cancer CenterUrbana61801NCT03937635Map
ILCarle Cancer CenterUrbana61801NCT05561387Map
ILCarle Cancer CenterUrbana61801NCT06022939Map
ILThe Carle Foundation HospitalUrbana61801NCT03937635Map
ILThe Carle Foundation HospitalUrbana61801NCT05561387Map
ILNorthwestern Medicine Cancer Center WarrenvilleWarrenville60555NCT04566328Map
ILIllinois CancerCare - WashingtonWashington61571NCT03937635Map
ILIllinois CancerCare - WashingtonWashington61571NCT04566328Map
ILIllinois CancerCare - WashingtonWashington61571NCT05561387Map
ILRush-Copley Healthcare CenterYorkville60560NCT05561387Map
INIU Health North HospitalCarmel46032NCT05561387Map
INNorthwest Cancer Center - Main CampusCrown Point46307NCT05561387Map
INNorthwest Oncology LLCDyer46311NCT05561387Map
INFort Wayne Medical Oncology And Hematology /ID# 278141Fort Wayne46804NCT07095452Map
INNorthwest Cancer Center - HobartHobart46342NCT05561387Map
INSaint Mary Medical CenterHobart46342NCT05561387Map
INCommunity Health NetworkIndianapolis46227NCT04068597Map
INIndiana University Health Simon Cancer CenterIndianapolis46202NCT05137054Map
INIndiana University/Melvin and Bren Simon Cancer CenterIndianapolis46202NCT04566328Map
INIndiana University/Melvin and Bren Simon Cancer CenterIndianapolis46202NCT05561387Map
INRiley Children's HospitalIndianapolis46202NCT04972942Map
INSaint Catherine HospitalIndianapolis46312NCT05561387Map
INThe Community HospitalMunster46321NCT05561387Map
INWomen's Diagnostic Center - MunsterMunster46321NCT05561387Map
INReid HealthRichmond47374NCT03937635Map
INReid HealthRichmond47374NCT05561387Map
INNorthwest Cancer Center - ValparaisoValparaiso46383NCT05561387Map
IAMary Greeley Medical CenterAmes50010NCT04566328Map
IAMcFarland Clinic - AmesAmes50010NCT04566328Map
IAMission Cancer and Blood - AnkenyAnkeny50023NCT05561387Map
IAUI Health Care Mission Cancer and Blood - Ankeny ClinicAnkeny50023NCT03937635Map
IAUI Health Care Mission Cancer and Blood - Ankeny ClinicAnkeny50023NCT04566328Map
IAUI Health Care Mission Cancer and Blood - Ankeny ClinicAnkeny50023NCT06022939Map
IAUniversity of Iowa Healthcare Cancer Services Quad CitiesBettendorf52722NCT03937635Map
IAUniversity of Iowa Healthcare Cancer Services Quad CitiesBettendorf52722NCT05561387Map
IASaint Anthony Regional HospitalCarroll51401NCT03937635Map
IASaint Anthony Regional HospitalCarroll51401NCT04566328Map
IAMercy HospitalCedar Rapids52403NCT04566328Map
IAOncology Associates at Mercy Medical CenterCedar Rapids52403NCT04566328Map
IAPhysicians' Clinic of Iowa PCCedar Rapids52402NCT05561387Map
IAMedical Oncology and Hematology Associates-West Des MoinesClive50325NCT05561387Map
IAMercy Cancer Center-West LakesClive50325NCT03937635Map
IAMercy Cancer Center-West LakesClive50325NCT04566328Map
IAMercy Cancer Center-West LakesClive50325NCT05561387Map
IAUI Health Care Mission Cancer and Blood - West Des Moines ClinicClive50325NCT03937635Map
IAUI Health Care Mission Cancer and Blood - West Des Moines ClinicClive50325NCT04566328Map
IAUI Health Care Mission Cancer and Blood - West Des Moines ClinicClive50325NCT06022939Map
IAGreater Regional Medical CenterCreston50801NCT03937635Map
IAGreater Regional Medical CenterCreston50801NCT04566328Map
IAGreater Regional Medical CenterCreston50801NCT05561387Map
IABroadlawns Medical CenterDes Moines50314NCT03937635Map
IABroadlawns Medical CenterDes Moines50314NCT04566328Map
IAIowa Lutheran HospitalDes Moines50316NCT03937635Map
IAIowa Lutheran HospitalDes Moines50316NCT04566328Map
IAIowa Methodist Medical CenterDes Moines50309NCT03937635Map
IAIowa Methodist Medical CenterDes Moines50309NCT04566328Map
IAIowa Methodist Medical CenterDes Moines50309NCT06022939Map
IAMercy Medical Center - Des MoinesDes Moines50314NCT03937635Map
IAMercy Medical Center - Des MoinesDes Moines50314NCT04566328Map
IAMercy Medical Center - Des MoinesDes Moines50314NCT05561387Map
IAMission Cancer and Blood - LaurelDes Moines50314NCT05561387Map
IAUI Health Care Mission Cancer and Blood - Des Moines ClinicDes Moines50309NCT03937635Map
IAUI Health Care Mission Cancer and Blood - Des Moines ClinicDes Moines50309NCT04566328Map
IAUI Health Care Mission Cancer and Blood - Des Moines ClinicDes Moines50309NCT06022939Map
IAUI Health Care Mission Cancer and Blood - Laurel ClinicDes Moines50314NCT03937635Map
IAUI Health Care Mission Cancer and Blood - Laurel ClinicDes Moines50314NCT04566328Map
IAUI Health Care Mission Cancer and Blood - Laurel ClinicDes Moines50314NCT06022939Map
IAMcFarland Clinic - Trinity Cancer CenterFort Dodge50501NCT04566328Map
IAUI Healthcare Mission Cancer and Blood - Fort DodgeFort Dodge50501NCT04566328Map
IAUniversity of IowaIowa City52242NCT06974786Map
IAUniversity of Iowa/Holden Comprehensive Cancer CenterIowa City52242NCT03937635Map
IAUniversity of Iowa/Holden Comprehensive Cancer CenterIowa City52242NCT05561387Map
IAMcFarland Clinic - MarshalltownMarshalltown50158NCT04566328Map
IAUI Health Care Mission Cancer and Blood - Waukee ClinicWaukee50263NCT03937635Map
IAUI Health Care Mission Cancer and Blood - Waukee ClinicWaukee50263NCT04566328Map
IAUI Health Care Mission Cancer and Blood - Waukee ClinicWaukee50263NCT06022939Map
IAUniversity of Iowa Health CareWaukee50263NCT05552222Map
IAMercy Medical Center-West LakesWest Des Moines50266NCT03937635Map
IAMercy Medical Center-West LakesWest Des Moines50266NCT04566328Map
IAMercy Medical Center-West LakesWest Des Moines50266NCT05561387Map
IAMethodist West HospitalWest Des Moines50266-7700NCT03937635Map
IAMethodist West HospitalWest Des Moines50266-7700NCT04566328Map
KSCentral Care Cancer Center - Garden CityGarden City67846NCT03937635Map
KSCentral Care Cancer Center - Garden CityGarden City67846NCT04566328Map
KSCentral Care Cancer Center - Garden CityGarden City67846NCT05561387Map
KSCentral Care Cancer Center - Great BendGreat Bend67530NCT04566328Map
KSCentral Care Cancer Center - Great BendGreat Bend67530NCT05561387Map
KSUniversity of Kansas Cancer CenterKansas City66160NCT06022939Map
KSMercy Hospital PittsburgPittsburg66762NCT03937635Map
KSMercy Hospital PittsburgPittsburg66762NCT04566328Map
KSCotton O'Neil Cancer Center / Stormont Vail HealthTopeka66606NCT03937635Map
KSUniversity of Kansas Hospital-Westwood Cancer CenterWestwood66205NCT06022939Map
KYFlaget Memorial HospitalBardstown40004NCT04566328Map
KYFlaget Memorial HospitalBardstown40004NCT05561387Map
KYCommonwealth Cancer Center-CorbinCorbin40701NCT04566328Map
KYCommonwealth Cancer Center-CorbinCorbin40701NCT05561387Map
KYSaint Joseph HospitalLexington40504NCT03937635Map
KYSaint Joseph HospitalLexington40504NCT05561387Map
KYSaint Joseph Hospital EastLexington40509NCT03937635Map
KYSaint Joseph Hospital EastLexington40509NCT04566328Map
KYSaint Joseph Hospital EastLexington40509NCT05561387Map
KYSaint Joseph Radiation Oncology Resource CenterLexington40504NCT03937635Map
KYSaint Joseph Radiation Oncology Resource CenterLexington40504NCT04566328Map
KYSaint Joseph Radiation Oncology Resource CenterLexington40504NCT05561387Map
KYUniversity of Kentucky/Markey Cancer CenterLexington40536NCT03937635Map
KYSaint Joseph LondonLondon40741NCT04566328Map
KYSaint Joseph LondonLondon40741NCT05561387Map
KYNorton Cancer InstituteLouisville40207NCT05552222Map
KYThe James Graham Brown Cancer Center at University of LouisvilleLouisville40202NCT03937635Map
KYUniversity of Louisville-James Graham Brown Cancer CenterLouisville40202NCT03899155Map
KYUofL Health Medical Center NortheastLouisville40245NCT03937635Map
KYSaint Joseph Mount SterlingMount Sterling40353NCT04566328Map
KYSaint Joseph Mount SterlingMount Sterling40353NCT05561387Map
LALSU Health Baton Rouge-North ClinicBaton Rouge70805NCT03937635Map
LAOur Lady of The LakeBaton Rouge70808NCT03937635Map
LAOur Lady of the Lake Physician GroupBaton Rouge70808NCT03937635Map
LAOchsner Medical Center JeffersonNew Orleans70121NCT03937635Map
LATulane University School of MedicineNew Orleans70112NCT03937635Map
LALouisiana State University Health Sciences ShreveportShreveport71103NCT06615479Map
LALSU Health Sciences Center at ShreveportShreveport71103NCT03937635Map
LALSUHSC Shreveport Feist-Weiller Cancer CenterShreveport71103NCT05552222Map
MEGSK Investigational SitePortland04074NCT06679101Map
MEYork HospitalYork Village03909NCT03937635Map
MDGreater Baltimore Medical CenterBaltimore21204NCT05561387Map
MDJohns Hopkins UniversityBaltimore21205NCT05671757Map
MDJohns Hopkins University School of Medicine JHUSOMBaltimore21231NCT05552222Map
MDJohns Hopkins University/Sidney Kimmel Cancer CenterBaltimore21231NCT04139304Map
MDSaint Agnes HospitalBaltimore21229NCT03937635Map
MDSidney Kimmel Comprehensive Cancer Center at Johns HopkinsBaltimore21231NCT06398457Map
MDUniversity of Maryland Greenebaum Comprehensive Cancer CenterBaltimore21201NCT07075510Map
MDCenter for Cancer and Blood DisordersBethesda20817NCT05552222Map
MDNational Institutes of Health Clinical CenterBethesda20892NCT05907759Map
MDThe Center for Cancer and Blood Disorders (CCBD)Bethesda20817NCT04068597Map
MDWalter Reed National Military Medical CenterBethesda20889-5600NCT06022939Map
MABoston Children's HospitalBoston02115NCT04972942Map
MABoston Medical CenterBoston02118NCT05451771Map
MABoston Medical CenterBoston02118NCT06022939Map
MABoston Medical CenterBoston02118NCT06615479Map
MABrigham and Women's HospitalBoston02130NCT06483139Map
MADana Farber / Harvard Cancer CenterBoston02215NCT07393282Map
MADana Farber/Harvard Cancer CenterBoston02215NCT05137054Map
MADana_Farber Cancer Institute (DFCI)Boston02215NCT03899155Map
MADana-Farber Cancer Institute /ID# 271846Boston02215NCT06953960Map
MATufts Medical CenterBoston02111NCT03937635Map
MATufts Medical CenterBoston02111NCT04566328Map
MATufts Medical Center Cancer Center StonehamStoneham02180NCT04566328Map
MAGSK Investigational SiteWorcester01655NCT06679101Map
MIMyMichigan Medical Center GratiotAlma48801NCT03937635Map
MIMyMichigan Medical Center GratiotAlma48801NCT04566328Map
MIMyMichigan Medical Center AlpenaAlpena49707NCT04566328Map
MIGSK Investigational SiteAnn Arbor48103NCT06679101Map
MISaint Joseph Mercy HospitalAnn Arbor48106NCT05561387Map
MITrinity Health Saint Joseph Mercy Hospital Ann ArborAnn Arbor48106NCT03937635Map
MITrinity Health Saint Joseph Mercy Hospital Ann ArborAnn Arbor48106NCT04566328Map
MIUniversity of MichiganAnn Arbor48109NCT05552222Map
MIUniversity of MichiganAnn Arbor48109NCT05671757Map
MIUniversity of Michigan Health System - Ann Arbor /ID# 271536Ann Arbor48109NCT06953960Map
MIUniversity of Michigan Rogel Cancer CenterAnn Arbor48109NCT03937635Map
MIUniversity of Michigan Rogel Cancer CenterAnn Arbor48109NCT06022939Map
MIBronson Battle CreekBattle Creek49017NCT03937635Map
MIBronson Battle CreekBattle Creek49017NCT05561387Map
MISaint Joseph Mercy BrightonBrighton48114NCT05561387Map
MITrinity Health IHA Medical Group Hematology Oncology - BrightonBrighton48114NCT03937635Map
MITrinity Health IHA Medical Group Hematology Oncology - BrightonBrighton48114NCT04566328Map
MITrinity Health IHA Medical Group Hematology Oncology - BrightonBrighton48114NCT05561387Map
MITrinity Health Medical Center - BrightonBrighton48114NCT03937635Map
MITrinity Health Medical Center - BrightonBrighton48114NCT04566328Map
MIHenry Ford Cancer Institute-DownriverBrownstown48183NCT03937635
MIHenry Ford Cancer Institute-DownriverBrownstown48183NCT06022939
MISaint Joseph Mercy CantonCanton48188NCT05561387Map
MITrinity Health IHA Medical Group Hematology Oncology - CantonCanton48188NCT03937635Map
MITrinity Health IHA Medical Group Hematology Oncology - CantonCanton48188NCT04566328Map
MITrinity Health IHA Medical Group Hematology Oncology - CantonCanton48188NCT05561387Map
MITrinity Health Medical Center - CantonCanton48188NCT03937635Map
MITrinity Health Medical Center - CantonCanton48188NCT04566328Map
MICaro Cancer CenterCaro48723NCT05561387Map
MIChelsea HospitalChelsea48118NCT03937635Map
MIChelsea HospitalChelsea48118NCT04566328Map
MISaint Joseph Mercy ChelseaChelsea48118NCT05561387Map
MITrinity Health IHA Medical Group Hematology Oncology - Chelsea HospitalChelsea48118NCT03937635Map
MITrinity Health IHA Medical Group Hematology Oncology - Chelsea HospitalChelsea48118NCT04566328Map
MITrinity Health IHA Medical Group Hematology Oncology - Chelsea HospitalChelsea48118NCT05561387Map
MIHematology Oncology Consultants-ClarkstonClarkston48346NCT04566328Map
MIHematology Oncology Consultants-ClarkstonClarkston48346NCT05561387Map
MINewland Medical Associates-ClarkstonClarkston48346NCT04566328Map
MINewland Medical Associates-ClarkstonClarkston48346NCT05561387Map
MIHenry Ford Macomb Hospital-Clinton TownshipClinton Township48038NCT03937635Map
MIHenry Ford Macomb Hospital-Clinton TownshipClinton Township48038NCT06022939Map
MIHenry Ford Medical Center-FairlaneDearborn48126NCT03937635Map
MIHenry Ford Medical Center-FairlaneDearborn48126NCT06022939Map
MIAscension Saint John HospitalDetroit48236NCT05561387Map
MIGSK Investigational SiteDetroit48201NCT06679101Map
MIHenry Ford Cancer - Detroit Brigitte Harris Cancer PavilionDetroit48202NCT05552222Map
MIHenry Ford Health Saint John HospitalDetroit48236NCT03937635Map
MIHenry Ford Health Saint John HospitalDetroit48236NCT04566328Map
MIHenry Ford HospitalDetroit48202NCT03937635Map
MIHenry Ford HospitalDetroit48202NCT06022939Map
MIKarmanos Cancer InstituteDetroit48201NCT05137054Map
MIKarmanos Cancer InstituteDetroit48201NCT06107738Map
MIWayne State University/Karmanos Cancer InstituteDetroit48201NCT06022939Map
MIGreat Lakes Cancer Management Specialists-Doctors ParkEast China48054NCT05561387
MIHenry Ford River District HospitalEast China Township48054NCT04566328
MIOSF Saint Francis Hospital and Medical GroupEscanaba49829NCT04566328Map
MIWeisberg Cancer Treatment CenterFarmington Hills48334NCT06022939Map
MICancer Hematology Centers - FlintFlint48503NCT04566328Map
MIGenesee Cancer and Blood Disease Treatment CenterFlint48503NCT05561387Map
MIGenesee Hematology Oncology PCFlint48503NCT04566328Map
MIGenesee Hematology Oncology PCFlint48503NCT05561387Map
MIGenesys Hurley Cancer InstituteFlint48503NCT03937635Map
MIGenesys Hurley Cancer InstituteFlint48503NCT04566328Map
MIGenesys Hurley Cancer InstituteFlint48503NCT05561387Map
MIHurley Medical CenterFlint48503NCT03937635Map
MIHurley Medical CenterFlint48503NCT04566328Map
MIHurley Medical CenterFlint48503NCT05561387Map
MIMyMichigan Medical Center GladwinGladwin48624NCT04566328Map
MICancer And Hematology Centers of Western Michigan PCGrand Rapids49503NCT05552222Map
MICorewell Health Grand Rapids Hospitals - Butterworth HospitalGrand Rapids49503NCT03937635Map
MICorewell Health Grand Rapids Hospitals - Helen DeVos Children's HospitalGrand Rapids49503NCT03937635Map
MIHelen DeVos Children's HospitalGrand Rapids49503NCT04972942Map
MIHelen DeVos Children's Hospital at Spectrum HealthGrand Rapids49503NCT05561387Map
MISpectrum Health at Butterworth CampusGrand Rapids49503NCT05561387Map
MITrinity Health Grand Rapids HospitalGrand Rapids49503NCT03937635Map
MITrinity Health Grand Rapids HospitalGrand Rapids49503NCT05561387Map
MIAcademic Hematology Oncology SpecialistsGrosse Pointe Woods48236NCT05561387Map
MIGreat Lakes Cancer Management Specialists-Van Elslander Cancer CenterGrosse Pointe Woods48236NCT05561387Map
MIHenry Ford Saint John Hospital - AcademicGrosse Pointe Woods48236NCT04566328Map
MIHenry Ford Saint John Hospital - BreastGrosse Pointe Woods48236NCT04566328Map
MIHenry Ford Saint John Hospital - Van ElslanderGrosse Pointe Woods48236NCT03937635Map
MIHenry Ford Saint John Hospital - Van ElslanderGrosse Pointe Woods48236NCT04566328Map
MIAllegiance HealthJackson49201NCT03937635Map
MIAllegiance HealthJackson49201NCT06022939Map
MIAscension Borgess Cancer CenterKalamazoo49009NCT05561387Map
MIBeacon KalamazooKalamazoo49048NCT03937635Map
MIBorgess Medical CenterKalamazoo49048NCT05561387Map
MIBronson Methodist HospitalKalamazoo49007NCT03937635Map
MIBronson Methodist HospitalKalamazoo49007NCT05561387Map
MIWest Michigan Cancer CenterKalamazoo49007NCT03937635Map
MIWest Michigan Cancer CenterKalamazoo49007NCT05561387Map
MIKarmanos Cancer Institute at McLaren Greater LansingLansing48910NCT06022939Map
MIKCI at McLaren Greater LansingLansing48910NCT06107738Map
MIUniversity of Michigan Health - Sparrow LansingLansing48912NCT03937635Map
MIUniversity of Michigan Health - Sparrow LansingLansing48912NCT04566328Map
MIUniversity of Michigan Health - Sparrow LansingLansing48912NCT05561387Map
MITrinity Health Saint Mary Mercy Livonia HospitalLivonia48154NCT03937635Map
MITrinity Health Saint Mary Mercy Livonia HospitalLivonia48154NCT04566328Map
MITrinity Health Saint Mary Mercy Livonia HospitalLivonia48154NCT05561387Map
MIGreat Lakes Cancer Management Specialists-Macomb Medical CampusMacomb48044NCT05561387Map
MIHenry Ford Saint John Hospital - Macomb MedicalMacomb48044NCT03937635Map
MIHenry Ford Saint John Hospital - Macomb MedicalMacomb48044NCT04566328Map
MIHenry Ford Warren Hospital - Breast MacombMacomb48044NCT04566328Map
MISaint Mary's Oncology/Hematology Associates of MarletteMarlette48453NCT05561387Map
MIMyMichigan Medical Center MidlandMidland48670NCT03937635Map
MIMyMichigan Medical Center MidlandMidland48670NCT04566328Map
MIMyMichigan Medical Center Mount PleasantMount Pleasant48858NCT04566328Map
MITrinity Health Muskegon HospitalMuskegon49444NCT03937635Map
MITrinity Health Muskegon HospitalMuskegon49444NCT05561387Map
MICorewell Health Lakeland Hospitals - Niles HospitalNiles49120NCT03937635Map
MICorewell Health Lakeland Hospitals - Niles HospitalNiles49120NCT05561387Map
MICancer and Hematology Centers of Western Michigan - Norton ShoresNorton Shores49444NCT03937635Map
MICancer and Hematology Centers of Western Michigan - Norton ShoresNorton Shores49444NCT05561387Map
MIHenry Ford Health Providence Novi HospitalNovi48374NCT03937635Map
MIHenry Ford Medical Center-ColumbusNovi48377NCT03937635Map
MIHenry Ford Medical Center-ColumbusNovi48377NCT06022939Map
MIHenry Ford Providence Novi HospitalNovi48374NCT05552222Map
MI21st Century Oncology-PontiacPontiac48341NCT05561387Map
MIHope Cancer CenterPontiac48341NCT04566328Map
MIHope Cancer CenterPontiac48341NCT05561387Map
MIMichigan Healthcare Professionals PontiacPontiac48341NCT03937635Map
MIMichigan Healthcare Professionals PontiacPontiac48341NCT04566328Map
MINewland Medical Associates-PontiacPontiac48341NCT04566328Map
MINewland Medical Associates-PontiacPontiac48341NCT05561387Map
MISaint Joseph Mercy OaklandPontiac48341NCT05561387Map
MITrinity Health Saint Joseph Mercy Oakland HospitalPontiac48341NCT03937635Map
MITrinity Health Saint Joseph Mercy Oakland HospitalPontiac48341NCT04566328Map
MICorewell Health Reed City HospitalReed City49677NCT03937635Map
MICorewell Health Reed City HospitalReed City49677NCT05561387Map
MIAscension Saint Mary's HospitalSaginaw48601NCT05561387Map
MIMyMichigan Medical Center SaginawSaginaw48601NCT03937635Map
MIMyMichigan Medical Center SaginawSaginaw48601NCT04566328Map
MIOncology Hematology Associates of Saginaw Valley PCSaginaw48604NCT05561387Map
MICorewell Health Lakeland Hospitals - Marie Yeager Cancer CenterSaint Joseph49085NCT03937635Map
MICorewell Health Lakeland Hospitals - Marie Yeager Cancer CenterSaint Joseph49085NCT05561387Map
MICorewell Health Lakeland Hospitals - Saint Joseph HospitalSaint Joseph49085NCT03937635Map
MILakeland Medical Center Saint JosephSaint Joseph49085NCT05561387Map
MIHenry Ford Health Providence Southfield HospitalSouthfield48075NCT03937635Map
MIHenry Ford Providence Southfield CK Potluri Cancer CenterSouthfield48075NCT05552222Map
MIBhadresh Nayak MD PC-Sterling HeightsSterling Heights48312NCT05561387Map
MIAscension Saint Joseph HospitalTawas City48764NCT05561387Map
MIMyMichigan Medical Center TawasTawas City48764NCT03937635Map
MIMyMichigan Medical Center TawasTawas City48764NCT04566328Map
MIMunson Medical CenterTraverse City49684NCT03937635Map
MIMunson Medical CenterTraverse City49684NCT05561387Map
MIAdvanced Breast Care Center PLLCWarren48088NCT05561387Map
MIGreat Lakes Cancer Management Specialists-Macomb Professional BuildingWarren48093NCT05561387Map
MIHenry Ford Health Warren HospitalWarren48093NCT03937635Map
MIHenry Ford Health Warren HospitalWarren48093NCT04566328Map
MIHenry Ford Madison Heights Hospital - BreastWarren48093NCT04566328Map
MIHenry Ford Warren Hospital - GLCMSWarren48093NCT04566328Map
MIMacomb Hematology Oncology PCWarren48093NCT05561387Map
MIMichigan Breast Specialists-WarrenWarren48093NCT05561387Map
MISaint John Macomb-Oakland HospitalWarren48093NCT05561387Map
MIHenry Ford West Bloomfield HospitalWest Bloomfield48322NCT03937635Map
MIHenry Ford West Bloomfield HospitalWest Bloomfield48322NCT06022939Map
MISaint Mary's Oncology/Hematology Associates of West BranchWest Branch48661NCT05561387Map
MIHenry Ford Wyandotte HospitalWyandotte48192NCT03937635Map
MIHenry Ford Wyandotte HospitalWyandotte48192NCT06022939Map
MIUniversity of Michigan Health - WestWyoming49519NCT03937635Map
MIUniversity of Michigan Health - WestWyoming49519NCT05561387Map
MIHuron Gastroenterology PCYpsilanti48106NCT04566328Map
MIHuron Gastroenterology PCYpsilanti48106NCT05561387Map
MITrinity Health IHA Medical Group Hematology Oncology Ann Arbor CampusYpsilanti48197NCT03937635Map
MITrinity Health IHA Medical Group Hematology Oncology Ann Arbor CampusYpsilanti48197NCT04566328Map
MITrinity Health IHA Medical Group Hematology Oncology Ann Arbor CampusYpsilanti48197NCT05561387Map
MNRiverwood Healthcare CenterAitkin56431NCT05561387Map
MNEssentia Health - Baxter ClinicBaxter56425NCT05561387Map
MNSanford Joe Lueken Cancer CenterBemidji56601NCT05561387Map
MNEssentia Health Saint Joseph's Medical CenterBrainerd56401NCT03937635Map
MNEssentia Health Saint Joseph's Medical CenterBrainerd56401NCT05561387Map
MNMinnesota Oncology - BurnsvilleBurnsville55337NCT03937635Map
MNMinnesota Oncology - BurnsvilleBurnsville55337NCT04566328Map
MNMinnesota Oncology - BurnsvilleBurnsville55337NCT05561387Map
MNCambridge Medical CenterCambridge55008NCT04566328Map
MNCambridge Medical CenterCambridge55008NCT05561387Map
MNMinnesota Oncology Hematology PA-ChaskaChaska55318NCT03937635Map
MNMinnesota Oncology Hematology PA-ChaskaChaska55318NCT04566328Map
MNMercy HospitalCoon Rapids55433NCT03937635Map
MNMercy HospitalCoon Rapids55433NCT04566328Map
MNMercy HospitalCoon Rapids55433NCT05561387Map
MNMercy HospitalCoon Rapids55433NCT06022939Map
MNMinnesota Oncology - Coon RapidsCoon Rapids55433NCT03937635Map
MNMinnesota Oncology - Coon RapidsCoon Rapids55433NCT04566328Map
MNEssentia Health - Deer River ClinicDeer River56636NCT03937635Map
MNEssentia Health - Deer River ClinicDeer River56636NCT05561387Map
MNEssentia Health Saint Mary's - Detroit Lakes ClinicDetroit Lakes56501NCT03937635Map
MNEssentia Health Saint Mary's - Detroit Lakes ClinicDetroit Lakes56501NCT05561387Map
MNEssentia Health Cancer CenterDuluth55805NCT03937635Map
MNEssentia Health Cancer CenterDuluth55805NCT05561387Map
MNEssentia Health Saint Mary's Medical CenterDuluth55805NCT03937635Map
MNEssentia Health Saint Mary's Medical CenterDuluth55805NCT05561387Map
MNMiller-Dwan HospitalDuluth55805NCT03937635Map
MNMiller-Dwan HospitalDuluth55805NCT05561387Map
MNFairview Southdale HospitalEdina55435NCT03937635Map
MNFairview Southdale HospitalEdina55435NCT04566328Map
MNFairview Southdale HospitalEdina55435NCT05561387Map
MNFairview Southdale HospitalEdina55435NCT06022939Map
MNMinnesota Oncology - EdinaEdina55435NCT03937635Map
MNMinnesota Oncology - EdinaEdina55435NCT04566328Map
MNEssentia Health - Ely ClinicEly55731NCT05561387Map
MNEssentia Health - FosstonFosston56542NCT03937635Map
MNEssentia Health - FosstonFosston56542NCT05561387Map
MNEssentia Health Hibbing ClinicHibbing55746NCT03937635Map
MNEssentia Health Hibbing ClinicHibbing55746NCT05561387Map
MNEssentia Health - International Falls ClinicInternational Falls56649NCT05561387Map
MNFairview Clinics and Surgery Center Maple GroveMaple Grove55369NCT03937635Map
MNFairview Clinics and Surgery Center Maple GroveMaple Grove55369NCT04566328Map
MNFairview Clinics and Surgery Center Maple GroveMaple Grove55369NCT05561387Map
MNMinnesota Oncology - Maple GroveMaple Grove55369NCT03937635Map
MNMinnesota Oncology - Maple GroveMaple Grove55369NCT04566328Map
MNMinnesota Oncology Hematology PA-MaplewoodMaplewood55109NCT03937635Map
MNMinnesota Oncology Hematology PA-MaplewoodMaplewood55109NCT04566328Map
MNMinnesota Oncology Hematology PA-MaplewoodMaplewood55109NCT05561387Map
MNSaint John's Hospital - HealtheastMaplewood55109NCT03937635Map
MNSaint John's Hospital - HealtheastMaplewood55109NCT04566328Map
MNSaint John's Hospital - HealtheastMaplewood55109NCT05561387Map
MNAbbott-Northwestern HospitalMinneapolis55407NCT03937635Map
MNAbbott-Northwestern HospitalMinneapolis55407NCT04566328Map
MNAbbott-Northwestern HospitalMinneapolis55407NCT05561387Map
MNAbbott-Northwestern HospitalMinneapolis55407NCT06022939Map
MNHealth Partners IncMinneapolis55454NCT03937635Map
MNHealth Partners IncMinneapolis55454NCT05561387Map
MNHennepin County Medical CenterMinneapolis55415NCT03937635Map
MNHennepin County Medical CenterMinneapolis55415NCT04566328Map
MNHennepin County Medical CenterMinneapolis55415NCT05561387Map
MNMinnesota Oncology - Minneapolis Clinic /ID# 278720Minneapolis55404NCT07095452Map
MNUniversity of MinnesotaMinneapolis55455NCT06119685Map
MNMonticello Cancer CenterMonticello55362NCT03937635Map
MNMonticello Cancer CenterMonticello55362NCT04566328Map
MNMonticello Cancer CenterMonticello55362NCT05561387Map
MNEssentia Health - Moose Lake ClinicMoose Lake55767NCT05561387Map
MNNew Ulm Medical CenterNew Ulm56073NCT04566328Map
MNNew Ulm Medical CenterNew Ulm56073NCT05561387Map
MNEssentia Health - Park RapidsPark Rapids56470NCT03937635Map
MNEssentia Health - Park RapidsPark Rapids56470NCT05561387Map
MNFairview Northland Medical CenterPrinceton55371NCT04566328Map
MNFairview Northland Medical CenterPrinceton55371NCT05561387Map
MNNorth Memorial Medical Health CenterRobbinsdale55422NCT03937635Map
MNNorth Memorial Medical Health CenterRobbinsdale55422NCT04566328Map
MNNorth Memorial Medical Health CenterRobbinsdale55422NCT05561387Map
MNMayo ClinicRochester55905NCT05137054Map
MNMayo ClinicRochester55905NCT05654506Map
MNMayo Clinic Hospital Rochester /ID# 277886Rochester55905NCT07095452Map
MNMayo Clinic in RochesterRochester55905NCT04566328Map
MNMayo Clinic in RochesterRochester55905NCT05561387Map
MNMayo Clinic in RochesterRochester55905NCT05898646Map
MNMayo Clinic in RochesterRochester55905NCT06022939Map
MNMayo Clinic in RochesterRochester55905NCT06042725Map
MNMayo Clinic in RochesterRochester55905NCT06785415Map
MNMayo Clinic RochesterRochester55905NCT05451771Map
MNPark Nicollet Clinic - Saint Louis ParkSaint Louis Park55416NCT03937635Map
MNPark Nicollet Clinic - Saint Louis ParkSaint Louis Park55416NCT04566328Map
MNPark Nicollet Clinic - Saint Louis ParkSaint Louis Park55416NCT05561387Map
MNPark Nicollet Clinic - Saint Louis ParkSaint Louis Park55416NCT06022939Map
MNRegions HospitalSaint Paul55101NCT03937635Map
MNRegions HospitalSaint Paul55101NCT04566328Map
MNRegions HospitalSaint Paul55101NCT05561387Map
MNRegions HospitalSaint Paul55101NCT06022939Map
MNUnited HospitalSaint Paul55102NCT03937635Map
MNUnited HospitalSaint Paul55102NCT04566328Map
MNUnited HospitalSaint Paul55102NCT05561387Map
MNUnited HospitalSaint Paul55102NCT06022939Map
MNEssentia Health SandstoneSandstone55072NCT03937635Map
MNEssentia Health SandstoneSandstone55072NCT05561387Map
MNSaint Francis Regional Medical CenterShakopee55379NCT03937635Map
MNSaint Francis Regional Medical CenterShakopee55379NCT04566328Map
MNSaint Francis Regional Medical CenterShakopee55379NCT05561387Map
MNLakeview HospitalStillwater55082NCT03937635Map
MNLakeview HospitalStillwater55082NCT04566328Map
MNLakeview HospitalStillwater55082NCT05561387Map
MNSanford Thief River Falls Medical CenterThief River Falls56701NCT05561387Map
MNEssentia Health Virginia ClinicVirginia55792NCT03937635Map
MNEssentia Health Virginia ClinicVirginia55792NCT05561387Map
MNRidgeview Medical CenterWaconia55387NCT03937635Map
MNRidgeview Medical CenterWaconia55387NCT04566328Map
MNRidgeview Medical CenterWaconia55387NCT05561387Map
MNRice Memorial HospitalWillmar56201NCT03937635Map
MNRice Memorial HospitalWillmar56201NCT04566328Map
MNRice Memorial HospitalWillmar56201NCT05561387Map
MNMinnesota Oncology Hematology PA-WoodburyWoodbury55125NCT03937635Map
MNMinnesota Oncology Hematology PA-WoodburyWoodbury55125NCT04566328Map
MNMinnesota Oncology Hematology PA-WoodburyWoodbury55125NCT05561387Map
MNSanford Cancer Center WorthingtonWorthington56187NCT05561387Map
MNFairview Lakes Medical CenterWyoming55092NCT04566328Map
MNFairview Lakes Medical CenterWyoming55092NCT05561387Map
MSBaptist Memorial Hospital and Cancer Center-OxfordOxford38655NCT06022939Map
MSBaptist Memorial Hospital and Cancer Center-DesotoSouthhaven38671NCT06022939Map
MOMercy Oncology and Hematology - Clayton-ClarksonBallwin63011NCT04566328Map
MOSaint Louis Cancer and Breast Institute-BallwinBallwin63011NCT05561387Map
MOCentral Care Cancer Center - BolivarBolivar65613NCT03937635Map
MOCentral Care Cancer Center - BolivarBolivar65613NCT04566328Map
MOCentral Care Cancer Center - BolivarBolivar65613NCT05561387Map
MOCox Cancer Center BransonBranson65616NCT04566328Map
MOCox Cancer Center BransonBranson65616NCT05561387Map
MOMercy Cancer Center - Cape GirardeauCape Girardeau63703NCT03937635Map
MOMercy Cancer Center - Cape GirardeauCape Girardeau63703NCT04566328Map
MOSaint Francis Medical CenterCape Girardeau63703NCT03937635Map
MOSaint Francis Medical CenterCape Girardeau63703NCT04566328Map
MOSaint Francis Medical CenterCape Girardeau63703NCT05561387Map
MOSoutheast Cancer CenterCape Girardeau63703NCT05561387Map
MOSaint Luke's HospitalChesterfield63017NCT03937635Map
MOSiteman Cancer Center at Saint Peters HospitalCity of Saint Peters63376NCT03937635Map
MOSiteman Cancer Center at Saint Peters HospitalCity of Saint Peters63376NCT06022939Map
MOSiteman Cancer Center at West County HospitalCreve Coeur63141NCT03937635Map
MOSiteman Cancer Center at West County HospitalCreve Coeur63141NCT06022939Map
MOParkland Health Center - FarmingtonFarmington63640NCT03937635Map
MOParkland Health Center - FarmingtonFarmington63640NCT04566328Map
MOParkland Health Center - FarmingtonFarmington63640NCT05561387Map
MOCapital Region Southwest CampusJefferson City65109NCT05561387Map
MOFreeman Health SystemJoplin64804NCT03937635Map
MOFreeman Health SystemJoplin64804NCT04566328Map
MOFreeman Health SystemJoplin64804NCT05561387Map
MOMercy Hospital JoplinJoplin64804NCT03937635Map
MOMercy Hospital JoplinJoplin64804NCT04566328Map
MOMercy Hospital JoplinJoplin64804NCT05561387Map
MOMidAmerica Cancer CareKansas City64132NCT05552222Map
MOResearch Medical CenterKansas City64132NCT05561387Map
MOLake Regional HospitalOsage Beach65065NCT03937635Map
MOLake Regional HospitalOsage Beach65065NCT04566328Map
MOLake Regional HospitalOsage Beach65065NCT05561387Map
MODelbert Day Cancer Institute at PCRMCRolla65401NCT05561387Map
MOMercy Clinic-Rolla-Cancer and HematologyRolla65401NCT03937635Map
MOMercy Clinic-Rolla-Cancer and HematologyRolla65401NCT04566328Map
MOMercy Clinic-Rolla-Cancer and HematologyRolla65401NCT05561387Map
MOPhelps Health Delbert Day Cancer InstituteRolla65401NCT03937635Map
MOPhelps Health Delbert Day Cancer InstituteRolla65401NCT04566328Map
MOHeartland Regional Medical CenterSaint Joseph64506NCT03937635Map
MOHeartland Regional Medical CenterSaint Joseph64506NCT04566328Map
MOHeartland Regional Medical CenterSaint Joseph64506NCT05561387Map
MOSainte Genevieve County Memorial HospitalSainte Genevieve63670NCT03937635Map
MOSainte Genevieve County Memorial HospitalSainte Genevieve63670NCT04566328Map
MOSainte Genevieve County Memorial HospitalSainte Genevieve63670NCT05561387Map
MOCoxHealth South HospitalSpringfield65807NCT03937635Map
MOCoxHealth South HospitalSpringfield65807NCT04566328Map
MOCoxHealth South HospitalSpringfield65807NCT05561387Map
MOMercy Hospital SpringfieldSpringfield65804NCT03937635Map
MOMercy Hospital SpringfieldSpringfield65804NCT04566328Map
MOMercy Hospital SpringfieldSpringfield65804NCT05561387Map
MOMercy Hospital Saint LouisSt Louis63141NCT03937635Map
MOMercy Hospital Saint LouisSt Louis63141NCT04566328Map
MOMercy Hospital Saint LouisSt Louis63141NCT05561387Map
MOMercy Hospital SouthSt Louis63128NCT03937635Map
MOMercy Hospital SouthSt Louis63128NCT04566328Map
MOMercy Hospital SouthSt Louis63128NCT05561387Map
MOMercy Infusion Center - ChippewaSt Louis63109NCT04566328Map
MOMissouri Baptist Medical CenterSt Louis63131NCT03937635Map
MOMissouri Baptist Medical CenterSt Louis63131NCT04566328Map
MOMissouri Baptist Medical CenterSt Louis63131NCT05561387Map
MOSaint Louis Cancer and Breast Institute-South CitySt Louis63109NCT05561387Map
MOSiteman Cancer Center at Christian HospitalSt Louis63136NCT03937635Map
MOSiteman Cancer Center at Christian HospitalSt Louis63136NCT06022939Map
MOSiteman Cancer Center-South CountySt Louis63129NCT03937635Map
MOSiteman Cancer Center-South CountySt Louis63129NCT06022939Map
MOWashington University School of MedicineSt Louis63110NCT03937635Map
MOWashington University School of MedicineSt Louis63110-1010NCT04973605Map
MOWashington University School of MedicineSt Louis63110NCT06022939Map
MOMissouri Baptist Sullivan HospitalSullivan63080NCT03937635Map
MOMissouri Baptist Sullivan HospitalSullivan63080NCT04566328Map
MOMissouri Baptist Sullivan HospitalSullivan63080NCT05561387Map
MOBJC Outpatient Center at Sunset HillsSunset Hills63127NCT03937635Map
MOBJC Outpatient Center at Sunset HillsSunset Hills63127NCT04566328Map
MOBJC Outpatient Center at Sunset HillsSunset Hills63127NCT05561387Map
MOMercy Hospital WashingtonWashington63090NCT04566328Map
MOMercy Hospital WashingtonWashington63090NCT05561387Map
MTBillings Clinic Cancer CenterBillings59101NCT03937635Map
MTGSK Investigational SiteBillings59102NCT06679101Map
MTBozeman Health Deaconess HospitalBozeman59715NCT03937635Map
MTBenefis Sletten Cancer InstituteGreat Falls59405NCT03937635Map
MTGreat Falls ClinicGreat Falls59405NCT03937635Map
MTHi-Line Sletten Cancer CenterHavre59501NCT03937635Map
MTLogan Health Medical CenterKalispell59901NCT03937635Map
MTCommunity Medical CenterMissoula59804NCT03937635Map
MTSaint Patrick Hospital - Community HospitalMissoula59802NCT03937635Map
MTSaint Patrick Hospital - Community HospitalMissoula59802NCT05561387Map
NENebraska Medicine-BellevueBellevue68123NCT06022939Map
NECHI Health Saint FrancisGrand Island68803NCT04566328Map
NECHI Health Good SamaritanKearney68847NCT03937635Map
NECHI Health Good SamaritanKearney68847NCT04566328Map
NECHI Health Good SamaritanKearney68847NCT05561387Map
NEAlegent Health Bergan Mercy Medical CenterOmaha68124NCT03937635Map
NEAlegent Health Bergan Mercy Medical CenterOmaha68124NCT04566328Map
NEAlegent Health Bergan Mercy Medical CenterOmaha68124NCT05561387Map
NEAlegent Health Immanuel Medical CenterOmaha68122NCT04566328Map
NEAlegent Health Immanuel Medical CenterOmaha68122NCT05561387Map
NEAlegent Health Lakeside HospitalOmaha68130NCT04566328Map
NEAlegent Health Lakeside HospitalOmaha68130NCT05561387Map
NECreighton University Medical CenterOmaha68131NCT03937635Map
NECreighton University Medical CenterOmaha68131NCT05561387Map
NENebraska Cancer SpecialistsOmaha68130NCT04068597Map
NENebraska Cancer SpecialistsOmaha68130NCT05552222Map
NENebraska Medicine-Village PointeOmaha68118NCT06022939Map
NEUniversity of Nebraska Medical CenterOmaha68198NCT03937635Map
NEUniversity of Nebraska Medical CenterOmaha68198-6846NCT04068597Map
NEUniversity of Nebraska Medical CenterOmaha68198NCT05552222Map
NEUniversity of Nebraska Medical CenterOmaha68198NCT06022939Map
NVComprehensive Cancer Centers of Nevada - HendersonHenderson89052NCT03937635Map
NVAlliance for Childhood Diseases/Cure 4 the Kids FoundationLas Vegas89135NCT03937635Map
NVComprehensive Cancer Centers of NevadaLas Vegas89148NCT03937635Map
NVComprehensive Cancer Centers of Nevada - Central ValleyLas Vegas89169NCT03937635Map
NVComprehensive Cancer Centers of Nevada - NorthwestLas Vegas89128NCT03937635Map
NVComprehensive Cancer Centers of Nevada - Town CenterLas Vegas89144NCT03937635Map
NVComprehensive Cancer Centers of Nevada-SummerlinLas Vegas89144NCT03937635Map
NVOptumCare Cancer Care at CharlestonLas Vegas89102NCT03937635Map
NVOptumCare Cancer Care at Fort ApacheLas Vegas89183NCT03937635Map
NVOptumCare Cancer Care at MountainViewLas Vegas89128NCT03937635Map
NVRadiation Oncology Centers of Nevada CentralLas Vegas89106NCT03937635Map
NVRadiation Oncology Centers of Nevada SoutheastLas Vegas89119NCT03937635Map
NVSummerlin Hospital Medical CenterLas Vegas89144NCT03937635Map
NVRenown Regional Medical CenterReno89502NCT03937635Map
NHExeter HospitalExeter03833NCT05561387Map
NHDartmouth Hitchcock Medical CenterLebanon03756NCT05552222Map
NJMemorial Sloan Kettering Basking Ridge (Limited Protocol Activities)Basking Ridge07920NCT06083922Map
NJMSK Basking RidgeBasking Ridge07920NCT05623020Map
NJCooper Hospital University Medical CenterCamden08103NCT03937635Map
NJAstera Cancer CareEast Brunswick08816NCT05552222Map
NJGSK Investigational SiteHackensack07601NCT06679101Map
NJHackensack University Medical CenterHackensack07601-1915NCT04973605Map
NJJohn Theurer Cancer Center at Hackensack University Medical CenterHackensack07601NCT06015724Map
NJMemorial Sloan Kettering MonmouthMiddletown07748NCT06022939Map
NJMemorial Sloan Kettering Monmouth (Limited Protocol Activities)Middletown07748NCT06083922Map
NJMSK MonmouthMiddletown07748NCT05623020Map
NJMemorial Sloan Kettering BergenMontvale07645NCT06022939Map
NJMemorial Sloan Kettering Bergen (Limited Protocol Activities)Montvale07645NCT06083922Map
NJMSK BergenMontvale07645NCT05623020Map
NJMorristown Medical CenterMorristown07960NCT03937635Map
NJOverlook HospitalSummit07902NCT03937635Map
NJMD Anderson Cancer Center at Cooper-VoorheesVoorhees Township08043NCT03937635Map
NMLovelace Medical Center-Saint Joseph SquareAlbuquerque87102NCT05561387Map
NMPresbyterian Kaseman HospitalAlbuquerque87110NCT05561387Map
NMUniversity of New Mexico Cancer CenterAlbuquerque87102NCT05561387Map
NMPresbyterian Rust Medical Center/Jorgensen Cancer CenterRio Rancho87124NCT05561387Map
NMChristus St. Vincent Regional Cancer CenterSanta Fe87505NCT05552222Map
NYRoswell Park Cancer InstituteBuffalo14263NCT03899155Map
NYRoswell Park Comprehensive Cancer CenterBuffalo14263NCT06622005Map
NYHematology Oncology Associates of CNY at CamillusCamillus13031NCT03937635Map
NYMemorial Sloan Kettering Cancer Center Suffolk - Commack (Limited Protocol Activities)Commack11725NCT06083922Map
NYMemorial Sloan Kettering CommackCommack11725NCT06022939Map
NYMSK CommackCommack11725NCT05623020Map
NYHematology Oncology Associates of Central New York-East SyracuseEast Syracuse13057NCT03937635Map
NYHematology-Oncology Associates of CNYEast Syracuse13057NCT05552222Map
NYNorthwell HealthGreat Neck11021NCT05671757Map
NYMemorial Sloan Kettering WestchesterHarrison10604NCT06022939Map
NYMemorial Sloan Kettering Westchester (Limited Protocol Activities)Harrison10604NCT06083922Map
NYMSK WestchesterHarrison10604NCT05623020Map
NYNorthwell Health Cancer InstituteLake Success11042NCT05552222Map
NYNYU Langone Hematology Oncology Associates-MineolaMineola11501NCT03899155Map
NYNYU Langone Hospital Long IslandMineola11500NCT05552222Map
NYColumbia University Irving Medical CenterNew York10032NCT07110844Map
NYGSK Investigational SiteNew York10065NCT06679101Map
NYHospital for Special SurgeryNew York10021NCT05671757Map
NYIcahn School of Medicine at Mount SinaiNew York10029NCT06827860Map
NYIcahn School of Medicine at Mount Sinai /ID# 277844New York10029NCT07095452Map
NYMemorial Sloan Kettering Cancer CenterNew York10021NCT04139304Map
NYMemorial Sloan Kettering Cancer CenterNew York10065NCT05552222Map
NYMemorial Sloan Kettering Cancer CenterNew York10065NCT06022939Map
NYMemorial Sloan Kettering Cancer CenterNew York10021NCT07222761Map
NYMemorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street).New York10021NCT05020236Map
NYMemorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street).New York10021NCT05623020Map
NYMemorial Sloan Kettering Cancer Center - Main CampusNew York10065NCT05020236Map
NYMemorial Sloan Kettering Cancer Center - Main CampusNew York10065NCT05623020Map
NYMemorial Sloan Kettering Cancer Center - New York - York Avenue /ID# 271214New York10065NCT06953960Map
NYMemorial Sloan Kettering Cancer Center - New York - York Avenue /ID# 277946New York10065NCT07095452Map
NYMemorial Sloan Kettering Cancer Center (All Protocol Activities)New York10065NCT06083922Map
NYMemorial Sloan Kettering Cancer Center MskccNew York10065-6800NCT04973605Map
NYMemorial Sloan Kettering Cancer Center-Main CampusNew York10065NCT05623020Map
NYMount Sinai ChelseaNew York10011NCT03937635Map
NYMount Sinai HospitalNew York10029NCT03937635Map
NYNew York Presbyterian Hospital Columbia University Medical CenterNew York10032NCT05137054Map
NYNew York Presbyterian Hospital/Columbia University Irving Medical CenterNew York10032NCT05451771Map
NYNYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer CenterNew York10032NCT03937635Map
NYNYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer CenterNew York10032NCT05561387Map
NYNYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer CenterNew York10032NCT06022939Map
NYNYU LangoneNew York10016NCT05671757Map
NYPerlmutter Cancer Center at NYU Langone HealthNew York10016NCT05552222Map
NYWeill CornellNew York10021NCT05671757Map
NYWeill Cornell Medical CollegeNew York10065NCT05552222Map
NYWeill Cornell Medical CollegeNew York10065NCT06615479Map
NYWeill Cornell Medical College /ID# 272517New York10065NCT06892522Map
NYWeill Cornell Medical College Newyork Presbyterian HospitalNew York10065-4870NCT04973605Map
NYWeill Cornell Medicine Myeloma Center /ID# 278216New York10065NCT07095452Map
NYWeill Cornell Medicine/New York Presbyterian HospitalNew York10021NCT05137054Map
NYUniversity of RochesterRochester14642NCT04566328Map
NYUniversity of RochesterRochester14642NCT05561387Map
NYUniversity of RochesterRochester14642NCT06022939Map
NYGSK Investigational SiteStony Brook11790NCT06679101Map
NYMemorial Sloan Kettering Nassau (Limited Protocol Activities)Uniondale11553NCT06083922Map
NYMSK NassauUniondale11553NCT05623020Map
NYNew York Medical CollegeVallhala10595NCT04972942
NCUNC Lineberger Comprehensive Cancer CenterChapel Hill27599NCT03937635Map
NCUniversity North Carolina at Chapel HillChapel Hill27599NCT05654506Map
NCUniversity of North CarolinaChapel Hill27599NCT06974786Map
NCUniversity of North Carolina - Chapel HillChapel Hill27514NCT04139304Map
NCUniversity of North Carolina (Data Collection Only)Chapel Hill27514NCT06083922Map
NCUniversity of North Carolina at Chapel HillChapel Hill27599NCT05137054Map
NCUniversity of North Carolina at Chapel Hill /ID# 272454Chapel Hill27514NCT06953960Map
NCUniversity of North Carolina at Chapel Hill /ID# 274667Chapel Hill27514NCT06892522Map
NCUniversity of North Carolina at Chapel Hill /ID# 277708Chapel Hill27514NCT07095452Map
NCAtrium Health Levine Cancer Institute /ID# 271510Charlotte28204NCT06953960Map
NCAtrium Health Levine Cancer Institute /ID# 276193Charlotte28204-2990NCT06892522Map
NCGSK Investigational SiteCharlotte28204NCT06679101Map
NCLevine Cancer InstituteCharlotte28204NCT05552222Map
NCLevine Cancer InstituteCharlotte28204NCT06413498Map
NCLevine Cancer InstituteCharlotte28204NCT06615479Map
NCLevine Cancer InstituteCharlotte28204NCT06615479Map
NCNovant HealthCharlotte28204NCT05552222Map
NCNovant Health Presbyterian Medical CenterCharlotte28204NCT06022939Map
NCSoutheastern Medical Oncology Center-ClintonClinton28328NCT04566328Map
NCDuke UniversityDurham27710NCT05671757Map
NCDuke University Medical CenterDurham27710NCT06022939Map
NCDurham VAMCDurham27705NCT05552222Map
NCSoutheastern Medical Oncology Center-GoldsboroGoldsboro27534NCT04566328Map
NCEast Carolina UniversityGreenville27834NCT03937635Map
NCUniversity of North Carolina-Hillsborough CampusHillsborough27278NCT03937635Map
NCNovant Health Cancer Institute - HuntersvilleHuntersville28078NCT06022939Map
NCSoutheastern Medical Oncology Center-JacksonvilleJacksonville28546NCT04566328Map
NCECU Health Oncology KenansvilleKenansville28349NCT03937635Map
NCECU Health Oncology KinstonKinston28501NCT03937635Map
NCNovant Health Cancer Institute - MooresvilleMooresville28117NCT06022939Map
NCECU Health Oncology RichlandsRichlands28574NCT03937635Map
NCMarion L Shepard Cancer Center - ECU Health Beaufort HospitalWashington27889NCT03937635Map
NCNovant Health Zimmer Cancer InstituteWilmington28401NCT05552222Map
NCAtrium Health Wake Forest BaptistWinston-Salem27157NCT06119685Map
NCAtrium Health Wake Forest Baptist Comprehensive Cancer CenterWinston-Salem27157NCT05552222Map
NCAtrium Health Wake Forest Baptist Medical Center /ID# 274847Winston-Salem27157NCT06892522Map
NCGSK Investigational SiteWinston-Salem27103NCT06679101Map
NCNovant Health Forsyth Medical CenterWinston-Salem27103NCT05552222Map
NCNovant Health Forsyth Medical CenterWinston-Salem27103NCT06022939Map
NCWake Forest Baptist Health /ID# 271294Winston-Salem27103NCT06953960Map
NCWake Forest University Health SciencesWinston-Salem27157NCT05137054Map
NDSanford Bismarck Medical CenterBismarck58501NCT05561387Map
NDEssentia Health Cancer Center-South University ClinicFargo58103NCT03937635Map
NDEssentia Health Cancer Center-South University ClinicFargo58103NCT05561387Map
NDSanford Broadway Medical CenterFargo58122NCT05561387Map
NDSanford Medical Center FargoFargo58104NCT05561387Map
NDSanford Roger Maris Cancer CenterFargo58122NCT05561387Map
NDSanford South University Medical CenterFargo58103NCT05561387Map
NDSouthpointe-Sanford Medical Center FargoFargo58103NCT05561387Map
NDEssentia Health - Jamestown ClinicJamestown58401NCT03937635Map
NDEssentia Health - Jamestown ClinicJamestown58401NCT05561387Map
OHOhioHealth O'Bleness HospitalAthens45701NCT04566328Map
OHIndu and Raj Soin Medical CenterBeavercreek45431NCT03937635Map
OHIndu and Raj Soin Medical CenterBeavercreek45431NCT05561387Map
OHSaint Elizabeth Boardman HospitalBoardman44512NCT03937635Map
OHSaint Elizabeth Boardman HospitalBoardman44512NCT05561387Map
OHDayton Physicians LLC-Miami Valley SouthCenterville45459NCT05561387Map
OHMiami Valley Hospital SouthCenterville45459NCT03937635Map
OHGeauga HospitalChardon44024NCT03937635Map
OHAdena Regional Medical CenterChillicothe45601NCT03937635Map
OHBethesda North HospitalCincinnati45242NCT03937635Map
OHBethesda North HospitalCincinnati45242NCT04566328Map
OHBethesda North HospitalCincinnati45242NCT05561387Map
OHGood Samaritan Hospital - CincinnatiCincinnati45220NCT03937635Map
OHGood Samaritan Hospital - CincinnatiCincinnati45220NCT04566328Map
OHGood Samaritan Hospital - CincinnatiCincinnati45220NCT05561387Map
OHOncology Hematology CareCincinnati45242NCT03899155Map
OHOncology Hematology CareCincinnati45236NCT05552222Map
OHOncology Hematology Care - Kenwood /ID# 272918Cincinnati45236NCT06892522Map
OHOncology Hematology Care Inc-KenwoodCincinnati45236NCT05561387Map
OHThe Christ Hospital Cancer CenterCincinnati45219NCT05552222Map
OHTriHealth Cancer Institute-AndersonCincinnati45255NCT04566328Map
OHTriHealth Cancer Institute-AndersonCincinnati45255NCT05561387Map
OHTriHealth Cancer Institute-WestsideCincinnati45247NCT04566328Map
OHTriHealth Cancer Institute-WestsideCincinnati45247NCT05561387Map
OHUniversity of CincinnatiCincinnati45267NCT05552222Map
OHCase Western Reserve UniversityCleveland44106NCT03937635Map
OHCase Western Reserve UniversityCleveland44106NCT06022939Map
OHCleveland ClinicCleveland44195NCT06615479Map
OHCleveland Clinic FoundationCleveland44195NCT03937635Map
OHCleveland Clinic Main CampusCleveland44195NCT05552222Map
OHMetroHealth Medical CenterCleveland44109NCT03937635Map
OHMetroHealth Medical CenterCleveland44109NCT04566328Map
OHUniversity Hospitals ClevelandCleveland44106NCT06119685Map
OHUniversity Hospitals Cleveland Medical CenterCleveland44106NCT05552222Map
OHColumbus Oncology and Hematology Associates IncColumbus43214NCT04566328Map
OHDoctors HospitalColumbus43228NCT03937635Map
OHDoctors HospitalColumbus43228NCT04566328Map
OHGrant Medical CenterColumbus43215NCT03937635Map
OHGrant Medical CenterColumbus43215NCT04566328Map
OHGSK Investigational SiteColumbus43214NCT06679101Map
OHMount Carmel East HospitalColumbus43213NCT03937635Map
OHMount Carmel Health Center WestColumbus43222NCT03937635Map
OHOhioHealthColumbus43214NCT05552222Map
OHOhioHealthColumbus43214NCT07222761Map
OHRiverside Methodist HospitalColumbus43214NCT03937635Map
OHRiverside Methodist HospitalColumbus43214NCT04566328Map
OHRiverside Methodist HospitalColumbus43214NCT06022939Map
OHThe James Cancer Hospital and Solove Research Institute At Ohio State UniversityColumbus43210-1240NCT04973605Map
OHThe Mark H Zangmeister CenterColumbus43219NCT03937635Map
OHThe Ohio State UniversityColumbus43210NCT04139304Map
OHThe Ohio State University James Cancer HospitalColumbus43210NCT05137054Map
OHThe Ohio State University- James Cancer HospitalColumbus43210NCT05552222Map
OHThe Ohio State University- The James Cancer Hospital and Solove Research InstituteColumbus43210NCT06974786Map
OHThe Ohio UniversityColumbus43210NCT03899155Map
OHDayton Physician LLC - EnglewoodDayton45415NCT03937635Map
OHDayton Physician LLC-Miami Valley Hospital NorthDayton45415NCT05561387Map
OHMiami Valley HospitalDayton45409NCT03937635Map
OHMiami Valley Hospital NorthDayton45415NCT03937635Map
OHPremier Blood and Cancer CenterDayton45409NCT03937635Map
OHDelaware Health Center-Grady Cancer CenterDelaware43015NCT03937635Map
OHDelaware Health Center-Grady Cancer CenterDelaware43015NCT04566328Map
OHGrady Memorial HospitalDelaware43015NCT03937635Map
OHGrady Memorial HospitalDelaware43015NCT04566328Map
OHColumbus Oncology and Hematology AssociatesDublin43016NCT04566328Map
OHDublin Methodist HospitalDublin43016NCT03937635Map
OHDublin Methodist HospitalDublin43016NCT04566328Map
OHArmes Family Cancer CenterFindlay45840NCT03937635Map
OHArmes Family Cancer CenterFindlay45840NCT05561387Map
OHBlanchard Valley HospitalFindlay45840NCT03937635Map
OHBlanchard Valley HospitalFindlay45840NCT05561387Map
OHOrion Cancer CareFindlay45840NCT05561387Map
OHAtrium Medical Center-Middletown Regional HospitalFranklin45005-1066NCT03937635Map
OHDayton Physicians LLC-AtriumFranklin45005NCT03937635Map
OHDayton Physicians LLC-AtriumFranklin45005NCT05561387Map
OHDayton Physicians LLC-WayneGreenville45331NCT05561387Map
OHMiami Valley Cancer Care and InfusionGreenville45331NCT03937635Map
OHWayne HospitalGreenville45331NCT03937635Map
OHWayne HospitalGreenville45331NCT05561387Map
OHMount Carmel Grove City HospitalGrove City43123NCT03937635Map
OHGreater Dayton Cancer CenterKettering45409NCT03937635Map
OHGreater Dayton Cancer CenterKettering45409NCT05561387Map
OHKettering Medical CenterKettering45429NCT03937635Map
OHKettering Medical CenterKettering45429NCT05561387Map
OHSaint Rita's Medical CenterLima45801NCT03937635Map
OHOhioHealth Mansfield HospitalMansfield44903NCT03937635Map
OHOhioHealth Mansfield HospitalMansfield44903NCT04566328Map
OHMarietta Memorial HospitalMarietta45750NCT03937635Map
OHOhioHealth Marion General HospitalMarion43302NCT03937635Map
OHOhioHealth Marion General HospitalMarion43302NCT04566328Map
OHUH Seidman Cancer Center at Lake Health Mentor CampusMentor44060NCT03937635Map
OHUH Seidman Cancer Center at Southwest General HospitalMiddleburg Heights44130NCT03937635Map
OHMount Carmel New Albany Surgical HospitalNew Albany43054NCT03937635Map
OHLicking Memorial HospitalNewark43055NCT03937635Map
OHNewark Radiation OncologyNewark43055NCT03937635Map
OHMercy Health - Perrysburg HospitalPerrysburg43551NCT03937635Map
OHOhioHealth Pickerington Methodist HospitalPickerington43147NCT04566328Map
OHSouthern Ohio Medical CenterPortsmouth45662NCT03937635Map
OHUH Seidman Cancer Center at Firelands Regional Medical CenterSandusky44870NCT03937635Map
OHSpringfield Regional Cancer CenterSpringfield45504NCT03937635Map
OHSpringfield Regional Medical CenterSpringfield45504NCT03937635Map
OHDayton Physicians LLC - TroyTroy45373NCT05561387Map
OHUpper Valley Medical CenterTroy45373NCT03937635Map
OHSaint Joseph Warren HospitalWarren44484NCT03937635Map
OHSaint Joseph Warren HospitalWarren44484NCT05561387Map
OHOhioHealth Westerville Medical Campus/Westerville Cancer CenterWesterville43082NCT04566328Map
OHSaint Ann's HospitalWesterville43081NCT03937635Map
OHUH Seidman Cancer Center at Saint John Medical CenterWestlake44145NCT03937635Map
OHCleveland Clinic Wooster Family Health and Surgery CenterWooster44691NCT03937635Map
OHSaint Elizabeth Youngstown HospitalYoungstown44501NCT03937635Map
OHSaint Elizabeth Youngstown HospitalYoungstown44501NCT05561387Map
OHGenesis Healthcare System Cancer Care CenterZanesville43701NCT03937635Map
OKMercy Hospital Oklahoma CityOklahoma City73120NCT03937635Map
OKMercy Hospital Oklahoma CityOklahoma City73120NCT04566328Map
OKMercy Hospital Oklahoma CityOklahoma City73120NCT05561387Map
OKOklahoma Cancer Specialists and Research Institute-TulsaTulsa74146NCT03937635Map
ORSaint Alphonsus Cancer Care Center-Baker CityBaker City97814NCT04566328Map
ORSaint Charles Health SystemBend97701NCT03937635Map
ORSaint Charles Health SystemBend97701NCT05561387Map
ORClackamas Radiation Oncology CenterClackamas97015NCT03937635Map
ORClackamas Radiation Oncology CenterClackamas97015NCT05561387Map
ORProvidence Cancer Institute Clackamas ClinicClackamas97015NCT05561387Map
ORBay Area HospitalCoos Bay97420NCT03937635Map
ORBay Area HospitalCoos Bay97420NCT05561387Map
ORWillamette Valley Cancer Institute and Research Center /ID# 278721Eugene97401NCT07095452Map
ORRogue Valley Medical CenterMedford97504NCT05561387Map
ORProvidence Newberg Medical CenterNewberg97132NCT03937635Map
ORProvidence Newberg Medical CenterNewberg97132NCT05561387Map
ORProvidence Newberg Medical CenterNewberg97132NCT06022939Map
ORSaint Alphonsus Cancer Care Center-OntarioOntario97914NCT04566328Map
ORProvidence Willamette Falls Medical CenterOregon City97045NCT03937635Map
ORProvidence Willamette Falls Medical CenterOregon City97045NCT05561387Map
ORProvidence Willamette Falls Medical CenterOregon City97045NCT06022939Map
ORProvidence Portland Medical CenterPortland97213NCT03937635Map
ORProvidence Portland Medical CenterPortland97213NCT05561387Map
ORProvidence Portland Medical CenterPortland97213NCT06022939Map
ORProvidence Saint Vincent Medical CenterPortland97225NCT03937635Map
ORProvidence Saint Vincent Medical CenterPortland97225NCT05561387Map
ORProvidence Saint Vincent Medical CenterPortland97225NCT06022939Map
ORSaint Charles Health System-RedmondRedmond97756NCT05561387Map
PALehigh Valley Hospital-Cedar CrestAllentown18103NCT03937635Map
PALehigh Valley Hospital-Cedar CrestAllentown18103NCT04566328Map
PALehigh Valley Hospital-Cedar CrestAllentown18103NCT05561387Map
PALehigh Valley Hospital - MuhlenbergBethlehem18017NCT03937635Map
PALehigh Valley Hospital - MuhlenbergBethlehem18017NCT04566328Map
PALehigh Valley Hospital - MuhlenbergBethlehem18017NCT05561387Map
PAGeisinger Medical CenterDanville17822NCT03937635Map
PAGeisinger Medical CenterDanville17822NCT05561387Map
PAGeisinger Medical CenterDanville17822NCT06022939Map
PAPocono Medical CenterEast Stroudsburg18301NCT03937635Map
PAPocono Medical CenterEast Stroudsburg18301NCT04566328Map
PAPocono Medical CenterEast Stroudsburg18301NCT05561387Map
PAPenn State Health Medical Group - Andrews Patel Hematology/Oncology EastHarrisburg17111NCT04566328Map
PAGeisinger Medical Center-Cancer Center HazletonHazleton18201NCT03937635Map
PALehigh Valley Hospital-HazletonHazleton18201NCT04566328Map
PALehigh Valley Hospital-HazletonHazleton18201NCT05561387Map
PAPenn State Milton S Hershey Medical CenterHershey17033-0850NCT03937635Map
PAPenn State Milton S Hershey Medical CtrHershey17033NCT05552222Map
PALancaster General HealthLancaster17601NCT03899155Map
PAGeisinger Medical Oncology-LewisburgLewisburg17837NCT03937635Map
PAGeisinger Medical Oncology-LewisburgLewisburg17837NCT05561387Map
PALewistown HospitalLewistown17044NCT03937635Map
PAChildren's Hospital of PhiladelphiaPhiladelphia19104NCT04972942Map
PAFox Chase Cancer CenterPhiladelphia19111NCT06615479Map
PAPenn Medicine - Abramson Cancer Center PerelmanPhiladelphia19104NCT04068597Map
PAThomas Jefferson University HospitalPhiladelphia19107NCT06022939Map
PAUniversity of PennsylvaniaPhiladelphia19104NCT04139304Map
PAUniversity of Pennsylvania/Abramson Cancer CenterPhiladelphia19104NCT06022939Map
PAAllegheny General HospitalPittsburgh15212NCT03937635Map
PAAllegheny Health NetworkPittsburgh15224NCT05552222Map
PAWest Penn HospitalPittsburgh15224NCT03937635Map
PAGeisinger Cancer Services-PottsvillePottsville17901NCT03937635Map
PAPenn State Health Saint Joseph Medical CenterReading19605NCT04566328Map
PACommunity Medical CenterScranton18510NCT05561387Map
PAGeisinger Medical Oncology-SelinsgroveSelinsgrove17870NCT03937635Map
PAReading HospitalWest Reading19611NCT03937635Map
PAGeisinger Wyoming Valley/Henry Cancer CenterWilkes-Barre18711NCT03937635Map
PAGeisinger Wyoming Valley/Henry Cancer CenterWilkes-Barre18711NCT05561387Map
PAGeisinger Wyoming Valley/Henry Cancer CenterWilkes-Barre18711NCT06022939Map
RIGSK Investigational SiteProvidence02903NCT06679101Map
RIRhode Island HospitalProvidence02903NCT05552222Map
RIRhode Island HospitalProvidence02903NCT06119685Map
RISmilow Cancer Hospital Care Center - WesterlyWesterly02891NCT03937635Map
RISmilow Cancer Hospital Care Center - WesterlyWesterly02891NCT05561387Map
SCPrisma Health Cancer Institute - SpartanburgBoiling Springs29316NCT05561387Map
SCMedical University of South CarolinaCharleston29425NCT03937635Map
SCMUSC-Hollings Cancer CenterCharleston29425NCT05552222Map
SCRalph H Johnson VA Medical CenterCharleston29401NCT04566328Map
SCPrisma Health Cancer Institute - EasleyEasley29640NCT05561387Map
SCPrisma Health Cancer Institute - ButternutGreenville29605NCT05561387Map
SCPrisma Health Cancer Institute - EastsideGreenville29615NCT03937635Map
SCPrisma Health Cancer Institute - EastsideGreenville29615NCT05561387Map
SCPrisma Health Cancer Institute - FarisGreenville29605NCT03937635Map
SCPrisma Health Cancer Institute - FarisGreenville29605NCT05561387Map
SCPrisma Health Greenville Memorial HospitalGreenville29605NCT03937635Map
SCPrisma Health Cancer Institute - GreerGreer29650NCT03937635Map
SCPrisma Health Cancer Institute - GreerGreer29650NCT05561387Map
SCPrisma Health Cancer Institute - SenecaSeneca29672NCT03937635Map
SCPrisma Health Cancer Institute - SenecaSeneca29672NCT05561387Map
SDAvera Cancer Institute-AberdeenAberdeen57401NCT05561387Map
SDRapid City Regional HospitalRapid City57701NCT03937635Map
SDAvera Cancer InstituteSioux Falls57105NCT05561387Map
SDSanford Cancer Center Oncology ClinicSioux Falls57104NCT05561387Map
SDSanford USD Medical Center - Sioux FallsSioux Falls57117-5134NCT05561387Map
SDAvera Cancer Institute at YanktonYankton57078NCT05561387Map
TNBaptist Memorial Hospital and Cancer Center-ColliervilleCollierville38017NCT06022939Map
TNBaptist Memorial Hospital and Cancer Center-MemphisMemphis38120NCT06022939Map
TNHenry-Joyce Cancer ClinicNashville37232NCT05552222Map
TNSCRI Oncology PartnersNashville37203NCT06119685Map
TNSCRI Oncology PartnersNashville37203NCT06974786Map
TNSCRI Oncology Partners /ID# 278353Nashville37203NCT07095452Map
TNTennesse OncologyNashville37203NCT03899155Map
TNVanderbilt University/Ingram Cancer CenterNashville37232NCT03937635Map
TXGSK Investigational SiteAustin78705NCT06679101Map
TXGSK Investigational SiteAustin78712NCT06679101Map
TXHouston Methodist San Jacinto HospitalBaytown77521NCT03937635Map
TXHouston Methodist San Jacinto HospitalBaytown77521NCT06022939Map
TXMD Anderson in The WoodlandsConroe77384NCT03937635Map
TXMD Anderson in The WoodlandsConroe77384NCT05561387Map
TXHouston Methodist Cypress HospitalCypress77429NCT06022939Map
TXUniversity of Texas - Southwestern Medical Center /ID# 271914Dallas75235NCT06953960Map
TXUniversity of Texas SouthwesternDallas75390NCT05137054Map
TXUniversity of Texas SouthwesternDallas75390NCT06974786Map
TXUniversity of Texas Southwestern Medical CenterDallas75235NCT05552222Map
TXUT Southwestern Simmons Cancer Center - RedBirdDallas75237NCT03937635Map
TXUT Southwestern/Simmons Cancer Center-DallasDallas75390NCT03937635Map
TXUT Southwestern/Simmons Cancer Center-Fort WorthFort Worth76104NCT03937635Map
TXBaylor College of Medicine/Dan L Duncan Comprehensive Cancer CenterHouston77030NCT05561387Map
TXBen Taub General HospitalHouston77030NCT05561387Map
TXHouston Methodist HospitalHouston77030NCT03937635Map
TXHouston Methodist HospitalHouston77030NCT05552222Map
TXHouston Methodist HospitalHouston77030NCT06022939Map
TXHouston Methodist West HospitalHouston77094NCT03937635Map
TXHouston Methodist West HospitalHouston77094NCT06022939Map
TXM D Anderson Cancer CenterHouston77030NCT03937635Map
TXM D Anderson Cancer CenterHouston77030NCT05561387Map
TXM D Anderson Cancer CenterHouston77030NCT06022939Map
TXMD Anderson West HoustonHouston77079NCT03937635Map
TXMD Anderson West HoustonHouston77079NCT05561387Map
TXMethodist Willowbrook HospitalHouston77070NCT03937635Map
TXMethodist Willowbrook HospitalHouston77070NCT06022939Map
TXMichael E DeBakey VA Medical CenterHouston77030NCT05561387Map
TXThe University of Texas MD Anderson Cancer CenterHouston77030NCT04139304Map
TXUniversity of Texas MD Anderson Cancer CenterHouston77030NCT06119685Map
TXUniversity of Texas MD Anderson Cancer CenterHouston77030NCT06615479Map
TXUT MD AndersonHouston77030NCT07513129Map
TXGSK Investigational SiteKingwood77339NCT06679101Map
TXMD Anderson League CityLeague City77573NCT03937635Map
TXMD Anderson League CityLeague City77573NCT05561387Map
TXJoe Arrington Cancer Research Treatment CenterLubbock79410NCT05552222Map
TXHouston Methodist Saint John HospitalNassau Bay77058NCT03937635Map
TXHouston Methodist Saint John HospitalNassau Bay77058NCT06022939Map
TXUT Southwestern Clinical Center at Richardson/PlanoRichardson75080NCT03937635Map
TXGSK Investigational SiteSan Antonio78240NCT06679101Map
TXUniversity of Texas Health Science Center at San AntonioSan Antonio78229NCT05561387Map
TXHouston Methodist Sugar Land HospitalSugar Land77479NCT03937635Map
TXHouston Methodist Sugar Land HospitalSugar Land77479NCT06022939Map
TXMD Anderson in Sugar LandSugar Land77478NCT03937635Map
TXMD Anderson in Sugar LandSugar Land77478NCT05561387Map
TXHouston Methodist The Woodlands HospitalThe Woodlands77385NCT03937635Map
TXHouston Methodist The Woodlands HospitalThe Woodlands77385NCT06022939Map
TXTexas Oncology - The Woodlands /ID# 278726The Woodlands77380NCT07095452Map
TXGSK Investigational SiteTyler75702NCT06679101Map
TXTexas Oncology - Northeast Texas /ID# 278725Tyler75702NCT07095452Map
UTHuntsman Cancer InstituteSalt Lake City84112-5550NCT04973605Map
UTHuntsman Cancer InstituteSalt Lake City84112NCT05552222Map
UTHuntsman Cancer InstituteSalt Lake City84112NCT06615479Map
UTHuntsman Cancer Institute/University of UtahSalt Lake City84112NCT03937635Map
UTUtah Cancer SpecialistsSalt Lake City84106NCT05552222Map
VTWhite River Junction Veteran Administration Medical CenterWhite River Junction05009NCT04566328Map
VAUniversity of Virginia Cancer CenterCharlottesville22908NCT03937635Map
VAGSK Investigational SiteFairfax22031NCT06679101Map
VANEXT Oncology VirginiaFairfax22031NCT06119685Map
VAVirginia Cancer Specialists - Fairfax /ID# 278716Fairfax22031NCT07095452Map
VAAlexander T. Augusta Military Medical CenterFort Belvoir22060NCT05552222Map
VASovah Health MartinsvilleMartinsville24115NCT05561387Map
VAVirginia Oncology AssociatesNorfolk23502NCT06974786Map
VAVirginia Oncology Associates Brock Cancer CenterNorfolk23502NCT05552222Map
VARichmond VA Medical CenterRichmond23249NCT05552222Map
VAVCU Massey Cancer Center at Stony PointRichmond23235NCT05561387Map
VAVirginia Cancer InstituteRichmond23229NCT05561387Map
VAVirginia Commonwealth University Medical CenterRichmond23298NCT05552222Map
VAVirginia Commonwealth University/Massey Cancer CenterRichmond23298NCT05561387Map
VABlue Ridge Cancer Care - Roanoke /ID# 278722Roanoke24014NCT07095452Map
VAVCU Community Memorial Health CenterSouth Hill23970NCT05561387Map
WAProvidence Regional Cancer System-AberdeenAberdeen98520NCT03937635Map
WAProvidence Regional Cancer System-AberdeenAberdeen98520NCT05561387Map
WAPeaceHealth Saint Joseph Medical CenterBellingham98225NCT03937635Map
WAPeaceHealth Saint Joseph Medical CenterBellingham98225NCT05561387Map
WAHarrison Medical CenterBremerton98310NCT05561387Map
WAProvidence Regional Cancer System-CentraliaCentralia98531NCT03937635Map
WAProvidence Regional Cancer System-CentraliaCentralia98531NCT05561387Map
WASwedish Cancer Institute-EdmondsEdmonds98026NCT03937635Map
WASwedish Cancer Institute-EdmondsEdmonds98026NCT05561387Map
WAProvidence Regional Cancer PartnershipEverett98201NCT03937635Map
WAProvidence Regional Cancer PartnershipEverett98201NCT05561387Map
WASwedish Cancer Institute-IssaquahIssaquah98029NCT03937635Map
WASwedish Cancer Institute-IssaquahIssaquah98029NCT05561387Map
WAKadlec Clinic Hematology and OncologyKennewick99336NCT03937635Map
WAKadlec Clinic Hematology and OncologyKennewick99336NCT05561387Map
WAFHCC at EvergreenHealthKirkland98034NCT03937635Map
WAProvidence Regional Cancer System-LaceyLacey98503NCT03937635Map
WAProvidence Regional Cancer System-LaceyLacey98503NCT05561387Map
WAPeaceHealth Saint John Medical CenterLongview98632NCT03937635Map
WAPeaceHealth Saint John Medical CenterLongview98632NCT05561387Map
WASkagit Regional Health Cancer Care CenterMount Vernon98274NCT03937635Map
WAGSK Investigational SitePuyallup98373NCT06679101Map
WAValley Medical CenterRenton98055NCT03937635Map
WAFHCC at Northwest HospitalSeattle98133NCT03937635Map
WAFred Hutchinson Cancer CenterSeattle98109NCT03937635Map
WAResearch SiteSeattle98104NCT07391657Map
WASwedish Medical Center-Ballard CampusSeattle98107NCT03937635Map
WASwedish Medical Center-Ballard CampusSeattle98107NCT05561387Map
WASwedish Medical Center-Cherry HillSeattle98122-5711NCT03937635Map
WASwedish Medical Center-Cherry HillSeattle98122-5711NCT05561387Map
WASwedish Medical Center-First HillSeattle98122NCT03937635Map
WASwedish Medical Center-First HillSeattle98122NCT05561387Map
WAUniversity of WashingtonSeattle98195NCT04973605Map
WAUniversity of Washington Medical Center - MontlakeSeattle98195NCT03937635Map
WAVA Puget Sound Health Care SystemSeattle98108NCT05137054Map
WAPeaceHealth United General Medical CenterSedro-Woolley98284NCT03937635Map
WAPeaceHealth United General Medical CenterSedro-Woolley98284NCT05561387Map
WAProvidence Regional Cancer System-SheltonShelton98584NCT05561387Map
WASaint Michael Cancer CenterSilverdale98383NCT03937635Map
WASaint Michael Cancer CenterSilverdale98383NCT04566328Map
WACancer Care Northwest - Spokane SouthSpokane99202NCT03937635Map
WACancer Care Northwest-North SpokaneSpokane99218NCT03937635Map
WANorthwest Medical Specialties Tacoma /ID# 272506Tacoma98405NCT06953960Map
WANorthWest Medical Specialties, PLLCTacoma98405NCT05552222Map
WAPeaceHealth Southwest Medical CenterVancouver98664NCT03937635Map
WAPeaceHealth Southwest Medical CenterVancouver98664NCT05561387Map
WAProvidence Saint Mary Regional Cancer CenterWalla Walla99362NCT03937635Map
WAProvidence Saint Mary Regional Cancer CenterWalla Walla99362NCT05561387Map
WANorth Star Lodge Cancer Center at Yakima Valley Memorial HospitalYakima98902NCT03937635Map
WAProvidence Regional Cancer System-YelmYelm98597NCT05561387Map
WVUnited Hospital CenterBridgeport26330NCT03937635Map
WVWest Virginia University Charleston DivisionCharleston25304NCT03937635Map
WVWest Virginia University Charleston DivisionCharleston25304NCT05561387Map
WVWest Virginia University HealthcareMorgantown26506NCT03937635Map
WVCamden Clark Medical CenterParkersburg26101NCT03937635Map
WVWheeling Hospital/Schiffler Cancer CenterWheeling26003NCT03937635Map
WILanglade Hospital and Cancer CenterAntigo54409NCT05561387Map
WIThedaCare Regional Cancer CenterAppleton54911NCT03937635Map
WIThedaCare Regional Cancer CenterAppleton54911NCT04566328Map
WIThedaCare Regional Cancer CenterAppleton54911NCT05561387Map
WIDuluth Clinic AshlandAshland54806NCT03937635Map
WIDuluth Clinic AshlandAshland54806NCT05561387Map
WINorthwest Wisconsin Cancer CenterAshland54806NCT03937635Map
WINorthwest Wisconsin Cancer CenterAshland54806NCT05561387Map
WIAurora Cancer Care-Southern Lakes VLCCBurlington53105NCT03937635Map
WIMarshfield Clinic-Chippewa CenterChippewa Falls54729NCT05561387Map
WIMarshfield Medical Center-EC Cancer CenterEau Claire54701NCT03937635Map
WIMarshfield Medical Center-EC Cancer CenterEau Claire54701NCT05561387Map
WIAurora Health Center-Fond du LacFond du Lac54937NCT03937635Map
WIAurora Health Care Germantown Health CenterGermantown53022NCT03937635Map
WIAurora Cancer Care-GraftonGrafton53024NCT03937635Map
WIAurora BayCare Medical CenterGreen Bay54311NCT03937635Map
WISaint Vincent Hospital Cancer Center at Saint Mary'sGreen Bay54303NCT03937635Map
WISaint Vincent Hospital Cancer Center at Saint Mary'sGreen Bay54303NCT04566328Map
WISaint Vincent Hospital Cancer Center at Saint Mary'sGreen Bay54303NCT06022939Map
WISaint Vincent Hospital Cancer Center Green BayGreen Bay54301NCT03937635Map
WISaint Vincent Hospital Cancer Center Green BayGreen Bay54301NCT04566328Map
WISaint Vincent Hospital Cancer Center Green BayGreen Bay54301NCT06022939Map
WIEssentia Health-Hayward ClinicHayward54843NCT03937635Map
WIEssentia Health-Hayward ClinicHayward54843NCT05561387Map
WIMercyhealth Hospital and Cancer Center - JanesvilleJanesville53548NCT03937635Map
WIUniversity of Wisconsin Carbone Cancer Center - Johnson CreekJohnson Creek53038NCT03937635Map
WIAurora Cancer Care-Kenosha SouthKenosha53142NCT03937635Map
WIGundersen Lutheran Medical CenterLa Crosse54601NCT03937635Map
WIGundersen Lutheran Medical CenterLa Crosse54601NCT04566328Map
WIGundersen Lutheran Medical CenterLa Crosse54601NCT05561387Map
WIGundersen Lutheran Medical CenterLa Crosse54601NCT06022939Map
WIMarshfield Clinic - Ladysmith CenterLadysmith54848NCT05561387Map
WIUniversity of Wisconsin Carbone Cancer CenterMadison53792-0001NCT04973605Map
WIUniversity of Wisconsin Carbone Cancer Center - Eastpark Medical CenterMadison53718NCT03937635Map
WIUniversity of Wisconsin Carbone Cancer Center - Eastpark Medical CenterMadison53718NCT06022939Map
WIUniversity of Wisconsin Carbone Cancer Center - University HospitalMadison53792NCT03937635Map
WIUniversity of Wisconsin Carbone Cancer Center - University HospitalMadison53792NCT04566328Map
WIUniversity of Wisconsin Carbone Cancer Center - University HospitalMadison53792NCT06022939Map
WIUniversity of Wisconsin Clinical Science CenterMadison53792NCT06974786Map
WIWilliam S Middleton VA Medical CenterMadison53705NCT04566328Map
WIAurora Bay Area Medical Group-MarinetteMarinette54143NCT03937635Map
WIMarshfield Medical Center-MarshfieldMarshfield54449NCT03937635Map
WIMarshfield Medical Center-MarshfieldMarshfield54449NCT05561387Map
WIAspirus Medford HospitalMedford54451NCT05561387Map
WIAurora Cancer Care-MilwaukeeMilwaukee53209NCT03937635Map
WIAurora Saint Luke's Medical CenterMilwaukee53215NCT03937635Map
WIAurora Sinai Medical CenterMilwaukee53233NCT03937635Map
WIFroedtert Hospital & the Medical College of WisconsinMilwaukee53226NCT05451771Map
WIMedical College of WisconsinMilwaukee53226-1222NCT04973605Map
WIMedical College of WisconsinMilwaukee53226NCT06022939Map
WIMedical College of WisconsinMilwaukee53226NCT06615479Map
WIMedical College of WisconsinMilwaukee53226NCT06974786Map
WIMarshfield Clinic-Minocqua CenterMinocqua54548NCT05561387Map
WIMarshfield Medical Center - MinocquaMinocqua54548NCT03937635Map
WIProHealth D N Greenwald CenterMukwonago53149NCT03937635Map
WIThedaCare Regional Medical Center - NeenahNeenah54956NCT04566328Map
WIMarshfield Medical Center - NeillsvilleNeillsville54456NCT05561387Map
WICancer Center of Western WisconsinNew Richmond54017NCT03937635Map
WICancer Center of Western WisconsinNew Richmond54017NCT04566328Map
WICancer Center of Western WisconsinNew Richmond54017NCT05561387Map
WIProHealth Oconomowoc Memorial HospitalOconomowoc53066NCT03937635Map
WISaint Vincent Hospital Cancer Center at Oconto FallsOconto Falls54154NCT03937635Map
WISaint Vincent Hospital Cancer Center at Oconto FallsOconto Falls54154NCT04566328Map
WISaint Vincent Hospital Cancer Center at Oconto FallsOconto Falls54154NCT06022939Map
WIVince Lombardi Cancer Clinic - OshkoshOshkosh54904NCT03937635Map
WIAurora Cancer Care-RacineRacine53406NCT03937635Map
WIAscension Saint Mary's HospitalRhinelander54501NCT05561387Map
WIMarshfield Medical Center-Rice LakeRice Lake54868NCT03937635Map
WIMarshfield Medical Center-Rice LakeRice Lake54868NCT05561387Map
WIThedaCare Cancer Care - ShawanoShawano54166NCT03937635Map
WISaint Vincent Hospital Cancer Center at SheboyganSheboygan53081NCT06022939Map
WISheboygan Physicians GroupSheboygan53081NCT06022939Map
WIVince Lombardi Cancer Clinic-SheboyganSheboygan53081NCT03937635Map
WIEssentia Health-Spooner ClinicSpooner54801NCT03937635Map
WIEssentia Health-Spooner ClinicSpooner54801NCT05561387Map
WIAscension Saint Michael's HospitalStevens Point54481NCT05561387Map
WIMarshfield Medical Center-River Region at Stevens PointStevens Point54482NCT03937635Map
WIMarshfield Medical Center-River Region at Stevens PointStevens Point54482NCT05561387Map
WISaint Vincent Hospital Cancer Center at Sturgeon BaySturgeon Bay54235-1495NCT03937635Map
WISaint Vincent Hospital Cancer Center at Sturgeon BaySturgeon Bay54235-1495NCT04566328Map
WISaint Vincent Hospital Cancer Center at Sturgeon BaySturgeon Bay54235-1495NCT06022939Map
WIAurora Medical Center in SummitSummit53066NCT03937635
WIEssentia Health Saint Mary's Hospital - SuperiorSuperior54880NCT03937635Map
WIEssentia Health Saint Mary's Hospital - SuperiorSuperior54880NCT05561387Map
WIVince Lombardi Cancer Clinic-Two RiversTwo Rivers54241NCT03937635Map
WIUW Cancer Center at ProHealth CareWaukesha53188NCT03937635Map
WIAspirus Regional Cancer CenterWausau54401NCT05561387Map
WIMarshfield Clinic-Wausau CenterWausau54401NCT05561387Map
WIAurora Cancer Care-Milwaukee WestWauwatosa53226NCT03937635Map
WIAurora West Allis Medical CenterWest Allis53227NCT03937635Map
WIMarshfield Medical Center - WestonWeston54476NCT03937635Map
WIMarshfield Medical Center - WestonWeston54476NCT05561387Map
WIAspirus Cancer Care - Wisconsin RapidsWisconsin Rapids54494NCT05561387Map
WIMarshfield Clinic - Wisconsin Rapids CenterWisconsin Rapids54494NCT05561387Map
WYMemorial Hospital of Laramie CountyCheyenne82001NCT03937635Map

Daratumumab clinical trials at a glance: phase × recruitment status

Phaserecruitingactive not recruitingenrolling by invitationcompletedterminatedwithdrawnsuspendednot yet recruitingunknownapproved for marketingTotal
Early P13115
P18921832152
P1/P29711643242
P2324413316111815161
P2/P321227
P3231512221257
P43227
N/A5315216

Recruiting Daratumumab clinical trials (104)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

NCT IDTitlePhaseIndicationEnrollmentStarted
NCT06358638SUN-RAYSickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell AntibodyP2Sickle Cell Disease12Apr 2024
NCT07095452A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for TransplantP2/P3Multiple Myeloma660Jan 2026
NCT07428369LINKER-MM8A Study of Linvo-VR vs DVRd in Transplant-Eligible Adult Participants With Newly Diagnosed Multiple Myeloma (NDMM)P2/P3Multiple Myeloma (MM)1,570Jun 2026
NCT06187441HOVON174MMFeAsiBility of a Treatment Free Interval in Newly Diagnosed MM Patients Treated With Daratumumab-lenalidomide-dexamethasone (HOVON174MM)P3Multiple Myeloma599May 2024
NCT06932562A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for TransplantP3Multiple Myeloma1,000Dec 2025
NCT06918002ElLenElranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in Transplant-eligible NDMM PatientsP3Multiple Myeloma, Newly Diagnosed824Jul 2025
NCT06892522AEA Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion Alone or in Combination With Oral, IV, Subcutaneous Daratumumab; Lenalidomide; Dexamethasone; CarfilzomibP1/P2Multiple Myeloma440Jun 2025
NCT07247097ELDORADOELDORADO: Elranatamab Versus Daratumumab in Combination With RVd Lite for Newly Diagnosed Transplant Ineligible/Deferred Multiple MyelomaP2Multiple Myeloma160Apr 2026
NCT05907759Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman DiseaseP2Lymphoma, Primary Effusion28Jul 2024
NCT07072585T-ALLTesting the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)P2/P3Stage II T Lymphoblastic Leukemia/Lymphoma1,708Aug 2026
NCT05137054A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care TreatmentsP1Multiple Myeloma317Aug 2022
NCT07222761LINKER-MM5A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)P3Relapsed and/or Refractory Multiple Myeloma (RRMM)915Jan 2026
NCT07285239PrE1005Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple MyelomaP3Multiple Myeloma500Jul 2026
NCT07107529Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.P2Multiple Myeloma (MM)150Dec 2025
NCT07110844Teclistamab-Daratumumab in AL AmyloidosisP2Amyloid Light-chain Amyloidosis25Nov 2025
NCT05552222MajesTEC-7A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple MyelomaP3Multiple Myeloma1,590Oct 2022
NCT05623020MagnetisMM-6A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for TransplantP3Multiple Myeloma1,116Nov 2022
NCT07393282LINKER-SMM2A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)P3High Risk Smoldering Multiple Myeloma (HR-SMM)270May 2026
NCT06974786FASTERFrontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple MyelomaP2Multiple Myeloma, Newly Diagnosed100Aug 2025
NCT07555938CEVOLUTIONCevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple MyelomaP3Multiple Myeloma380Jun 2026
NCT07605416Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM TrialP2Plasma Cell Leukemia74Jul 2026
NCT07075510Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell DisordersP1/P2Plasma Cell Disorder30Oct 2025
NCT06182774Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Multiple MyelomaP3Multiple Myeloma570Apr 2024
NCT06615479QUINTESSENTIAL-2A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)P3Relapsed or Refractory Multiple Myeloma (RRMM)440Mar 2025
NCT04513639REMNANTThe Relapse from MRD Negativity As Indication for Treatment (REMNANT) StudyP2/P3Multiple Myeloma176Aug 2020
NCT07029776MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple MyelomaP2Multiple Myeloma (MM)50Jul 2026
NCT07513129Venetoclax, Dexamethasone, Bortezomib, and Daratumumab For The Treatment Of Adolescent And Young Adults With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And T-cell Acute Lymphoblastic LymphomaP1T-cell Acute Lymphoblastic Leukemia18Jun 2026
NCT06931704IFM 2024_06Comparison of Elranatamab and Lenalidomide Versus Daratumumab and Lenalidomide as Post-transplant Maintenance Therapy in Patients With Newly Diagnosed Myeloma (ElMMA)P2Multiple Myeloma176May 2025
NCT06413498iMMagine-3A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple MyelomaP3Multiple Myeloma450Aug 2024
NCT05561387NDMMComparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable TreatmentP3Plasma Cell Myeloma510Oct 2023
NCT06679101DREAMM-10A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)P3Multiple Myeloma520Dec 2024
NCT06785415Elotuzumab, Daratumumab, Iberdomide, and Dexamethasone for the Treatment of Relapsed Multiple MyelomaP1/P2Recurrent Multiple Myeloma37Mar 2025
NCT05896228Iber-KDdIberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple MyelomaP2Refractory Multiple Myeloma30Feb 2024
NCT06953960MMA Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)P1/P2Multiple Myeloma199Jul 2025
NCT06464991FUMANBA-03A Phase III Study of Eque-cel in Subjects With Len-refractory RRMM (FUMANBA-03)P3Multiple Myeloma240Mar 2024
NCT06022939Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL AmyloidosisP3AL Amyloidosis338Jul 2024
NCT05572229IFM2021-01Study of Teclistamab in Combination in Elderly Patients With Multiple MyelomaP2Multiple Myeloma74Dec 2023
NCT04139304A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic LymphomaEarly P1Plasmablastic Lymphoma15May 2021
NCT07391657DURGA-4A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)P3Relapsed Refractory Multiple Myeloma508Feb 2026
NCT06622005SX-682 in Combination With Carfilzomib, Daratumumab-Hyaluronidase, and Dexamethasone in Patients With Relapsed or Refractory Multiple MyelomaP1Recurrent Multiple Myeloma15Apr 2025
NCT07221032FT836 CAR T-cell Therapy in Combination With Daratumumab in Patients With Relapsed and/or Refractory Multiple MyelomaP1Relapse Multiple Myeloma12Jul 2026
NCT07452198A Study of GR1803 Injection Versus Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Participants With Relapsed or Refractory Multiple MyelomaP3Multiple Myeloma358Mar 2026
NCT07045909GEM-AnitoFIRSTEfficacy and Safety of Anitocabtagene Autoleucel in Participants With Newly Diagnosed Multiple Myeloma (GEM-AnitoFIRST)P2De Novo Multiple Myeloma30Jun 2025
NCT06100237REVIVETeclistamab in Combination With Daratumumab for High-Risk Smoldering Myeloma: A Clinical and Correlative Phase 2 Immuno-Oncology Study (the REVIVE Study)P2Multiple Myeloma50Dec 2023
NCT06119685IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic CancersP1/P2NHL128Oct 2023
NCT05438043A Study of DaratumumabP3Multiple Myeloma500Dec 2022
NCT03937635Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering MyelomaP3Smoldering Plasma Cell Myeloma288Sep 2019
NCT05695508HD10/DSMMXXGMMG-HD10 / DSMM-XX / 64007957MMY2003, MajesTEC-5P2Multiple Myeloma160Dec 2022
NCT03899155Pan Tumor Rollover StudyP2Cancer1,500Aug 2019
NCT06952478A Study to Compare Pharmacokinetics, Efficacy and Safety of Subcutaneous CT-P44 and Darzalex Faspro in Combination With Lenalidomide and Dexamethasone in Patients With Refractory or Relapsed Multiple MyelomaP3Refractory or Relapsed Multiple Myeloma486Aug 2025
NCT07485647Identifying Effective and Cost-Conscious Maintenance Daratumumab DosingP2Multiple Myeloma50May 2026
NCT07110662NET-CD38New Therapeutic Target for Toxic Epidermal Necrolysis (TEN) Using Anti-CD38+ Monoclonal Antibodies.P1/P2Toxic Epidermal Necrolysis9Oct 2025
NCT07341867Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null PhenotypeP1Multiple Myeloma90Jun 2026
NCT07335887Sonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With t(11;14) Primary AL AmyloidosisP2AL Amyloidosis (AL)39Jan 2026
NCT06636552EUMELEIAAn Investigator-Initiated, Phase II, Multicenter, Open-Label, Single-Arm, Prospective Clinical Trial to Evaluate the Efficacy and Safety of Alternating Bortezomib-Based Regimens in Combination With DaratUMumab Followed by Maintenance With Daratumumab in the Frontline Setting of Primary Plasma CEll LP2Primary Plasma Cell Leukemia43Nov 2021
NCT07287228DARA-AA-001The Safety and Efficacy of Daratumumab in Patients With Refractory Aplastic AnemiaP1/P2Aplastic Anemia37Dec 2025
NCT06042725MC210808 Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven-Rd), Daratumumab and Dexamethasone (Ven-Dd), or Daratumumab-Lenalidomide-Dexamethasone (Ven-DRd) for the Treatment of Multiple MyelomaP1Multiple Myeloma100Mar 2024
NCT07234019ITPRituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)P2Immune Thrombocytopenia160Jan 2026
NCT06768489A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide or in Combination With Pomalidomide for Multiple MyelomaP1Multiple Myeloma140Dec 2024
NCT06505369TALTECBispecific T-cell Redirectors as Part of First Line Treatment in Transplant Eligible Multiple Myeloma PatientsP2Multiple Myeloma50Jun 2024
NCT04972942ALLO-T-DARTTargeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & LymphomaP1T-cell Acute Lymphoblastic Leukemia30May 2023
NCT07018050Phase II Study of QLS32015 Combination Therapy in the Treatment of Multiple MyelomaP2Relapsed or Refractory Multiple Myeloma160Sep 2025
NCT06287944225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic SyndromeP1Acute Lymphoblastic Leukemia15Jul 2025
NCT07362238ITPDaratumumab Versus Rituximab in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)P2Immune Thrombocytopenia122Mar 2026
NCT05054478PCL-2Primary Plasma Cell Leukemia: a Prospective Phase 2 Study Incorporating Daratumumab to Chemotherapy and Stem Cell TransplantationP2Plasma Cell Leukemia29Oct 2021
NCT06948084Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First RelapseP2Recurrent Multiple Myeloma80Aug 2026
NCT06827860Subcutaneous Talquetamab in Elderly Patients With Multiple Myeloma in Early RelapseP2Multiple Myeloma in Relapse23Nov 2025
NCT06697483Risk Stratification and MRD-driven Maintenance for MM After ASCTN/AMultiple Myeloma100Dec 2024
NCT06409702Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease DetectionP4Newly Diagnosed59Jun 2024
NCT04566328Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE TrialP3Plasma Cell Myeloma1,450Feb 2021
NCT07297563ITPAnti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)P2Immune Thrombocytopenia160Jan 2026
NCT06867991RADIASafety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune EncephalitisP3Anti-N-Methyl-D-Aspartate Receptor Encephalitis200Nov 2024
NCT06142396Pilot Study Dara-CyBorD in Newly Diagnosed Multiple Myeloma Patients With Renal FailureEarly P1Multiple Myeloma30Nov 2024
NCT05849740AHA2023An Exploratory Study of Cluster of Differentiation 38 (CD38) Monoclonal Antibody Combined Corticosteroid in Acquired Hemophilia AP4Acquired Hemophilia25May 2023
NCT06140966Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, Ultra High-risk, Newly Diagnosed Multiple MyelomaP2Multiple Myeloma54Oct 2023
NCT04915248FIL_DALYAStudy to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients.P2Plasmablastic Lymphoma28Jul 2022
NCT06015724DARANIVOVAXAnti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung CancerP2Pancreatic Ductal Adenocarcinoma54Jan 2024
NCT06889948DAMOCLESThe Effect of Daratumumab in Patients with Monoclonal Gammopathy of Renal Significance (MGRS) in FinlandP2Kidney Failure30Jan 2024
NCT05289687Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALLP2T-cell Acute Lymphoblastic Leukemia20May 2023
NCT05020236MAGNETISMM-5A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other TreatmentsP3Multiple Myeloma944Oct 2021
NCT07362199ITPAnti-CD38 Monoclonal Antibody Combined With Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)P2Immune Thrombocytopenia20Mar 2026
NCT06398457Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific AntibodiesEarly P1Hematologic Malignancy8Sep 2024
NCT06192979Optimize First-line Treatment for AL Amyloidosis With t (11; 14)N/AAmyloidosis; Systemic41Jan 2024
NCT05671757DARE-APSDaratumumab in Primary Antiphospholipid SyndromeP1/P2Autoimmune Disorders22May 2023
NCT04068597Study to Evaluate CCS1477 (Inobrodib) in Haematological MalignanciesP1/P2Haematological Malignancy250Aug 2019
NCT05363111Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multiple MyelomaP1Recurrent Plasma Cell Myeloma15Nov 2022
NCT07081126DARTABMRDaratumumab for Late Antibody-Mediated RejectionN/AKidney Tansplant20Jul 2025
NCT06107738IBEXIberdomide and Daratumumab As Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple MyelomaP2Multiple Myeloma60Dec 2023
NCT05888870ITI Using SCT800 Alone or Combining Daratumumab in Hemophilia A Adolescents and Adults With High Titer InhibitorP4Hemophilia A With Inhibitor50Nov 2023
NCT05898646Daratumumab Maintenance Therapy for Improving Survival in Patients With Light Chain Amyloidosis, EMILIA TrialP2AL Amyloidosis96Jul 2023
NCT04973605BGB-11417A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple MyelomaP1/P2Relapsed/Refractory Multiple Myeloma246Sep 2021
NCT07026604CCM-DS01Daratumumab for Familial Cerebral Cavernous Malformations: A Single-Arm Safety and Efficacy StudyEarly P1Cavernous Malformation, Cerebral10Jul 2025
NCT06083922MGRSA Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)P2Multiple Myeloma20Oct 2023
NCT05581875A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Pomalidomide and Dexamethasone in Patients With Relapsed/ Refractory Multiple Myeloma Previously Treated With One Line Therapy Who Are Lenalidomide RefractoryP1/P2Multiple Myeloma48Oct 2022
NCT06629818Daratumumab Combined With Venetoclax and Dexamethasone for Newly Diagnosed Light-Chain Amyloidosis With Translocation (11;14)P2Light Chain (AL) Amyloidosis36Oct 2024
NCT07015021DKPDThe Efficacy and Safety of the Combination Therapy of Daratumumab, Cabozantinib, Pomalidomide, and Dexamethasone (D-KPd) in the Treatment of High-risk First-time Relapsed or Primary Refractory MM PatientsN/AMultiple Myeloma72Jun 2025
NCT05451771Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) AmyloidosisP1/P2AL Amyloidosis53Oct 2022
NCT07063199ITPAnti-CD38 Antibody Treating Elderly Patients With Primary Immune Thrombocytopenia (ITP)P2Immune Thrombocytopenia30Aug 2025
NCT06838962ITPAnti-CD38 Antibody Treating Children With Primary Immune Thrombocytopenia (ITP)P2Immune Thrombocytopenia30Aug 2024
NCT05654506Daratumumab for Treatment of Proliferative Glomerulonephritis With Monoclonal Immune DepositsP2Proliferative Glomerulonephritis With Monoclonal IgG Deposits40Aug 2023
NCT05300451Daratumumab in HLA Desensitization Prior to TransplantationP2Cardiac Transplant10Mar 2022
NCT07021677DARA_T_ALLUse of a New Medicine "Daratumumab" to Treat Left-over Cancer in a Blood Cancer Called "T Acute Lymphoblastic Leukemia"P2T Acute Lymphoblastic Leukemia18Aug 2023
NCT06483139Novel Treatments in Improving Renal Outcomes in Light Chain Cast NephropathyMultiple Myeloma450Jun 2024
NCT06455748Daratumumab/Daratumumab and Hyaluronidase-fihj in Combination With Pomalidomide and Dexamethasone for the Treatment of Patients With Newly Diagnosed AL Amyloidosis: a Prospective, Multicenter, Single-arm StudyN/AAmyloid Light-chain Amyloidosis20Mar 2024

Daratumumab clinical trials by indication

Multiple Myeloma (157)

NCTAcronymPhaseStatusTitle
NCT07095452P2/P3recruitingA Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
NCT05257083CARTITUDE-6P3active not recruitingA Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma
NCT04071457DRAMMATICP3active not recruitingS1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration
NCT06187441HOVON174MMP3recruitingFeAsiBility of a Treatment Free Interval in Newly Diagnosed MM Patients Treated With Daratumumab-lenalidomide-dexamethasone (HOVON174MM)
NCT06932562P3recruitingA Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant
NCT06892522AEP1/P2recruitingA Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion Alone or in Combination With Oral, IV, Subcutaneous Daratumumab; Lenalidomide; Dexamethasone; Carfilzomib
NCT07247097ELDORADOP2not yet recruitingELDORADO: Elranatamab Versus Daratumumab in Combination With RVd Lite for Newly Diagnosed Transplant Ineligible/Deferred Multiple Myeloma
NCT05137054P1recruitingA Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
+ 149 more, see All trials below.

Plasma Cell Myeloma (11)

NCTAcronymPhaseStatusTitle
NCT05561387NDMMP3recruitingComparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
NCT05392946P1/P2active not recruitingIberdomide, Daratumumab, Bortezomib, and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma, IDEAL Study
NCT04566328P3recruitingTesting the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
NCT03942224DeRIVEP2active not recruitingDaratumumab, Ixazomib, & Dexamethasone or Daratumumab, Bortezomib, & Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
NCT03346135P2active not recruitingDaratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma
NCT03477539P2completedDaratumumab in Treating Transplant-Eligible Patients With Multiple Myeloma
NCT05511428P4completedHome Based Daratumumab Administration for Patients With Multiple Myeloma
NCT04892264P1terminatedBelantamab Mafodotin, Lenalidomide, and Daratumumab for the Treatment of Relapsed, Refractory, or Previously Untreated Multiple Myeloma
+ 3 more, see All trials below.

Recurrent Plasma Cell Myeloma (11)

NCTAcronymPhaseStatusTitle
NCT04756401P2active not recruitingSelinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma
NCT03763162P2active not recruitingDaratumumab, Bortezomib, and Dexamethasone Followed by Daratumumab, Ixazomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
NCT05363111P1recruitingRadioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multiple Myeloma
NCT03622775P2terminatedDaratumumab in Treating Participants With Relapsed Multiple Myeloma After Stem Cell Transplant
NCT01415882P2completedIxazomib Citrate in Treating Patients With Relapsed Multiple Myeloma That Is Not Refractory to Bortezomib
NCT03311828P1completedCopper 64Cu-DOTA-Daratumumab Positron Emission Tomography in Diagnosing Patients With Relapsed Multiple Myeloma
NCT04407442P2terminatedDaratumumab, Azacitidine, and Dexamethasone for Treatment of Patients With Recurrent or Refractory Multiple Myeloma Previously Treated With Daratumumab
NCT04956302P1terminatedPanobinostat in Combination With Daratumumab, Bortezomib and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma
+ 3 more, see All trials below.

Immune Thrombocytopenia (7)

NCTAcronymPhaseStatusTitle
NCT07234019ITPP2recruitingRituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)
NCT07362238ITPP2recruitingDaratumumab Versus Rituximab in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)
NCT07297563ITPP2recruitingAnti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)
NCT07362199ITPP2recruitingAnti-CD38 Monoclonal Antibody Combined With Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)
NCT07063199ITPP2recruitingAnti-CD38 Antibody Treating Elderly Patients With Primary Immune Thrombocytopenia (ITP)
NCT06838962ITPP2recruitingAnti-CD38 Antibody Treating Children With Primary Immune Thrombocytopenia (ITP)
NCT05562882P2unknownA Clinical Trial to Assess Safety and Efficacy of Daratumumab in the Treatment of Primary Immune Thrombocytopenia

AL Amyloidosis (7)

NCTAcronymPhaseStatusTitle
NCT06022939P3recruitingComparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
NCT05486481ALTITUDEP1/P2withdrawnVenetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocation (11;14) (ALTITUDE)
NCT05898646P2recruitingDaratumumab Maintenance Therapy for Improving Survival in Patients With Light Chain Amyloidosis, EMILIA Trial
NCT05451771P1/P2recruitingVenetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis
NCT04895917DarPALP2terminatedDaratumumab and Pomalidomide in Previously Treated Patients With AL Amyloidosis
NCT04304144P2completedA Study to Evaluate the Safety and Tolerability of CAEL-101 in Patients With AL Amyloidosis
NCT02841033P1/P2completedDaratumumab for the Treatment of Patients With AL Amyloidosis

Relapsed/Refractory Multiple Myeloma (6)

NCTAcronymPhaseStatusTitle
NCT05259839IVP1active not recruitingA Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused Etentamig (ABBV-383) in Combination With Anti-Cancer Regimens for the Treatment of Adult Participants With Relapsed/Refractory Multiple Myeloma
NCT04973605BGB-11417P1/P2recruitingA Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
NCT05857982P1/P2unknownMitoxantrone Hydrochloride Liposome Injection in the Treatment of Relapsed/Refractory Multiple Myeloma
NCT05308654P1active not recruitingA Study to Assess the Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma Receiving Oral ABBV-453 Tablets
NCT03590652P2terminatedDaratumumab, Ixazomib, Pomalidomide, and Dexamethasone as Salvage Therapy in Relapsed/Refractory Multiple Myeloma
NCT03450057DAREP2completedEfficacy of Daratumumab in Patients With Relapsed/Refractory Myeloma With Renal Impairment

Newly Diagnosed Multiple Myeloma (5)

NCTAcronymPhaseStatusTitle
NCT03742297P3active not recruitingTreatment for Elderly Fit Newly Diagnosed Multiple Myeloma Patients Aged Between 65 and 80 Years
NCT06348147P2withdrawnDara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell Transplantation
NCT04052880P2active not recruitingStudy of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly NDMM
NCT05561049N/AunknownEfficacy and Safety of Daratumumab in Combination With Bortezomib, Thalidomide, and Dexamethasone Regimens in Newly Diagnosed Multiple Myeloma
NCT05088330N/AunknownA Study to Access of Daratumumab Combined With VRD in the Treatment of Patients With Standard-risk Newly Diagnosed MM

Recurrent Multiple Myeloma (4)

NCTAcronymPhaseStatusTitle
NCT06785415P1/P2recruitingElotuzumab, Daratumumab, Iberdomide, and Dexamethasone for the Treatment of Relapsed Multiple Myeloma
NCT06622005P1recruitingSX-682 in Combination With Carfilzomib, Daratumumab-Hyaluronidase, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
NCT06948084P2not yet recruitingTesting the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse
NCT07082270P1withdrawnSelvigaltin With Standard of Care Treatment for the Treatment of Relapsed/Refractory Multiple Myeloma

Multiple Myeloma in Relapse (4)

NCTAcronymPhaseStatusTitle
NCT06827860P2recruitingSubcutaneous Talquetamab in Elderly Patients With Multiple Myeloma in Early Relapse
NCT04925193P2active not recruitingPersonalized Selinexor-based Therapy for Relapsed/Refractory Multiple Myeloma
NCT03836014CONFIRMP3active not recruitingStudy Comparing Continuous Versus Fixed Duration Therapy With Daratumumab, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
NCT03697629P2completedA Study of an Accelerated Infusion Rate of Daratumumab in Patients With Relapsed and Refractory Multiple Myeloma

Relapsed or Refractory Multiple Myeloma (4)

NCTAcronymPhaseStatusTitle
NCT07018050P2recruitingPhase II Study of QLS32015 Combination Therapy in the Treatment of Multiple Myeloma
NCT05408026PVD-DARAP1/P2withdrawnStudy of Combination POM, BTZ, Low-Dose DEX, and DARA (PVD-DARA) in Patients With RRMM
NCT06055075P1/P2completedA Study Evaluating Safety, Tolerability, and Clinical Activity of Forimtamig-Based Treatment Combinations in Participants With Relapsed or Refractory Multiple Myeloma
NCT03837509SCP1/P2terminatedINCB001158 Combined With Subcutaneous (SC) Daratumumab, Compared to Daratumumab SC, in Relapsed or Refractory Multiple Myeloma

T-cell Acute Lymphoblastic Leukemia (3)

NCTAcronymPhaseStatusTitle
NCT07513129P1recruitingVenetoclax, Dexamethasone, Bortezomib, and Daratumumab For The Treatment Of Adolescent And Young Adults With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And T-cell Acute Lymphoblastic Lymphoma
NCT04972942ALLO-T-DARTP1recruitingTargeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma
NCT05289687P2recruitingDaratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALL

Multiple Myeloma (MM) (3)

NCTAcronymPhaseStatusTitle
NCT07428369LINKER-MM8P2/P3not yet recruitingA Study of Linvo-VR vs DVRd in Transplant-Eligible Adult Participants With Newly Diagnosed Multiple Myeloma (NDMM)
NCT07107529P2recruitingStudy for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.
NCT07029776P2not yet recruitingMMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma

Plasma Cell Leukemia (3)

NCTAcronymPhaseStatusTitle
NCT07605416P2not yet recruitingTesting an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial
NCT05054478PCL-2P2not yet recruitingPrimary Plasma Cell Leukemia: a Prospective Phase 2 Study Incorporating Daratumumab to Chemotherapy and Stem Cell Transplantation
NCT03591744P1withdrawnDaratumumab, Bortezomib, Dexamethasone, Pegylated Liposomal Doxorubicin Hydrochloride, and Lenalidomide in Treating Participants With Plasma Cell Leukemia

Myeloma Multiple (3)

NCTAcronymPhaseStatusTitle
NCT07085728P2active not recruitingTesting the Investigational Agent Combination of Daratumumab, Bortezomib, and Dexamethasone Compared to the Usual Treatment of Cyclophosphamide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients With Kidney Failure
NCT03992170DART4MMP2unknownStudy of Daratumumab in Multiple Myeloma (MM) Patients in >VGPR/MRD-positive
NCT04065789KyDaRP2completedCarfilzomib in Combination With Daratumumab, Lenalidomide and Dexamethasone in Transplant-ineligible NDMM Patients

Amyloidosis (3)

NCTAcronymPhaseStatusTitle
NCT05250973AQUARIUSP2active not recruitingA Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis
NCT03201965ALP3completedA Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis
NCT02816476AMYDARAP2completedDaratumumab Therapy for Patients With Refractory or Relapsed AL Amyloidosis

Acute Myeloid Leukemia (3)

NCTAcronymPhaseStatusTitle
NCT04714372P1completedFT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia
NCT04614636P1terminatedFT538 in Subjects With Advanced Hematologic Malignancies
NCT02807558SY-1425P2completedA Biomarker-Directed Phase 2 Trial of Tamibarotene (SY-1425) in Participants With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Allosensitization (3)

NCTAcronymPhaseStatusTitle
NCT04610320P1completedDaratumumab-SC for Highly Sensitized Patients Awaiting Heart Transplantation
NCT04204980DARDARP1/P2completedDesensitization in Kidney Allograft Using Daratumumab
NCT04088903P1withdrawnStudy of Daratumumab for Decreasing Circulating Antibodies in Sensitized Patients Awaiting Heart Transplantation

Relapsed Refractory Multiple Myeloma (2)

NCTAcronymPhaseStatusTitle
NCT07391657DURGA-4P3recruitingA Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
NCT03732703MyDRUGP1/P2completedMyeloma-Developing Regimens Using Genomics (MyDRUG)

Relapsed and/or Refractory Multiple Myeloma (RRMM) (2)

NCTAcronymPhaseStatusTitle
NCT07222761LINKER-MM5P3recruitingA Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
NCT04776018RRMMP1/P2terminatedA Study Of TAK-981 Given With Monoclonal Antibodies (mAbs) In Adults With Relapsed or Refractory Multiple Myeloma (RRMM)

Aplastic Anemia (2)

NCTAcronymPhaseStatusTitle
NCT07287228DARA-AA-001P1/P2not yet recruitingThe Safety and Efficacy of Daratumumab in Patients With Refractory Aplastic Anemia
NCT05832216P1completedEfficacy of Daratumumab to Overcome Platelet Transfusion Refractoriness in Patients with Aplastic Anemia

Amyloid Light-chain Amyloidosis (2)

NCTAcronymPhaseStatusTitle
NCT07110844P2recruitingTeclistamab-Daratumumab in AL Amyloidosis
NCT06455748N/ArecruitingDaratumumab/Daratumumab and Hyaluronidase-fihj in Combination With Pomalidomide and Dexamethasone for the Treatment of Patients With Newly Diagnosed AL Amyloidosis: a Prospective, Multicenter, Single-arm Study

Multiple Myeloma, Newly Diagnosed (2)

NCTAcronymPhaseStatusTitle
NCT06918002ElLenP3recruitingElranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in Transplant-eligible NDMM Patients
NCT06974786FASTERP2recruitingFrontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma

Relapsed or Refractory Multiple Myeloma (RRMM) (2)

NCTAcronymPhaseStatusTitle
NCT06615479QUINTESSENTIAL-2P3recruitingA Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
NCT04824794P1/P2terminatedGEN3014 Trial in Relapsed or Refractory Hematologic Malignancies

Refractory Multiple Myeloma (2)

NCTAcronymPhaseStatusTitle
NCT05896228Iber-KDdP2recruitingIberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma
NCT03589222SELIBORDARAP2active not recruitingSELIBORDARA: Selinexor, Bortezomib and Daratumumab in Multiple Myeloma

Amyloidosis; Systemic (2)

NCTAcronymPhaseStatusTitle
NCT06192979N/ArecruitingOptimize First-line Treatment for AL Amyloidosis With t (11; 14)
NCT04474938P2unknownDaratumumab Combined With Bortezomib and Dexamethasone in Mayo 04 Stage III Light Chain Amyloidosis

Plasmablastic Lymphoma (2)

NCTAcronymPhaseStatusTitle
NCT04139304Early P1recruitingA Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
NCT04915248FIL_DALYAP2recruitingStudy to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients.

Relapsed Multiple Myeloma (2)

NCTAcronymPhaseStatusTitle
NCT03158688CANDORP3completedStudy of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma.
NCT04649060LIGHTHOUSEP3terminatedStudy of Melflufen (Melphalan Flufenamide) in Combination With Daratumumab in Relapsed-Refractory Multiple Myeloma

Myeloma (2)

NCTAcronymPhaseStatusTitle
NCT03500445P2active not recruitingDaratumumab, Carfilzomib, Lenalidomide and Low Dose Dexamethasone (DKRd) in Newly Diagnosed, Multiple Myeloma
NCT03184194P2completedNivolumab Combined With Daratumumab With or Without Low-dose Cyclophosphamide

Smoldering Multiple Myeloma (2)

NCTAcronymPhaseStatusTitle
NCT03289299ASCENTP2active not recruitingAggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant
NCT03301220P3completedA Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma

Relapse Multiple Myeloma (1)

NCTAcronymPhaseStatusTitle
NCT07221032P1not yet recruitingFT836 CAR T-cell Therapy in Combination With Daratumumab in Patients With Relapsed and/or Refractory Multiple Myeloma

Stage II T Lymphoblastic Leukemia/Lymphoma (1)

NCTAcronymPhaseStatusTitle
NCT07072585T-ALLP2/P3not yet recruitingTesting the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)

High Risk Smoldering Multiple Myeloma (HR-SMM) (1)

NCTAcronymPhaseStatusTitle
NCT07393282LINKER-SMM2P3recruitingA Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)

AL Amyloidosis (AL) (1)

NCTAcronymPhaseStatusTitle
NCT07335887P2not yet recruitingSonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With t(11;14) Primary AL Amyloidosis

ALL, Adult (1)

NCTAcronymPhaseStatusTitle
NCT06570915T-ALL-2024P2withdrawnDaratumumab for T Cell ALL With MRD-positive After Standard Chemotherapy

Microvascular Inflammation - MVI in Kindey Transplant Recipients (1)

NCTAcronymPhaseStatusTitle
NCT07274462DARA-MVIP4active not recruitingDARA-MVI Study (Daratumumab for Microvascular Inflammation in Kidney Transplantation)

Toxic Epidermal Necrolysis (1)

NCTAcronymPhaseStatusTitle
NCT07110662NET-CD38P1/P2not yet recruitingNew Therapeutic Target for Toxic Epidermal Necrolysis (TEN) Using Anti-CD38+ Monoclonal Antibodies.

Plasma Cell Disorder (1)

NCTAcronymPhaseStatusTitle
NCT07075510P1/P2recruitingSubcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders

Peripheral Neuropathy (1)

NCTAcronymPhaseStatusTitle
NCT06046287Dara-MGUSP2withdrawnDaratumumab for Polyneuropathy Associated With MGUS

Refractory or Relapsed Multiple Myeloma (1)

NCTAcronymPhaseStatusTitle
NCT06952478P3recruitingA Study to Compare Pharmacokinetics, Efficacy and Safety of Subcutaneous CT-P44 and Darzalex Faspro in Combination With Lenalidomide and Dexamethasone in Patients With Refractory or Relapsed Multiple Myeloma

Cavernous Malformation, Cerebral (1)

NCTAcronymPhaseStatusTitle
NCT07026604CCM-DS01Early P1not yet recruitingDaratumumab for Familial Cerebral Cavernous Malformations: A Single-Arm Safety and Efficacy Study

Kidney Tansplant (1)

NCTAcronymPhaseStatusTitle
NCT07081126DARTABMRN/ArecruitingDaratumumab for Late Antibody-Mediated Rejection

Acute Lymphoblastic Leukemia (1)

NCTAcronymPhaseStatusTitle
NCT06287944P1recruiting225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome

De Novo Multiple Myeloma (1)

NCTAcronymPhaseStatusTitle
NCT07045909GEM-AnitoFIRSTP2recruitingEfficacy and Safety of Anitocabtagene Autoleucel in Participants With Newly Diagnosed Multiple Myeloma (GEM-AnitoFIRST)

Anti-N-Methyl-D-Aspartate Receptor Encephalitis (1)

NCTAcronymPhaseStatusTitle
NCT06867991RADIAP3recruitingSafety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis

T-Lymphocytic Leukemia, Acute (1)

NCTAcronymPhaseStatusTitle
NCT06253637DARATALL-VHRP2active not recruitingDaratumumab in VHR T-ALL Treated According to the ALL National Treatment Program

Light Chain (AL) Amyloidosis (1)

NCTAcronymPhaseStatusTitle
NCT06629818P2recruitingDaratumumab Combined With Venetoclax and Dexamethasone for Newly Diagnosed Light-Chain Amyloidosis With Translocation (11;14)

Hematologic Malignancy (1)

NCTAcronymPhaseStatusTitle
NCT06398457Early P1recruitingDarzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

Acute Kidney Injury (1)

NCTAcronymPhaseStatusTitle
NCT06549634N/AcompletedBiomarkers of AKI in Patients Receiving Daratumumab

Lymphoma, Primary Effusion (1)

NCTAcronymPhaseStatusTitle
NCT05907759P2recruitingDaratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease

Newly Diagnosed (1)

NCTAcronymPhaseStatusTitle
NCT06409702P4recruitingTreatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease Detection

Sickle Cell Disease (1)

NCTAcronymPhaseStatusTitle
NCT06358638SUN-RAYP2recruitingSickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody

M-protein Related Cardiac Disease (1)

NCTAcronymPhaseStatusTitle
NCT06297681N/AunknownCombination of Daratumumab and BD Regimen and Dapagliflozin in the Treatment of M-protein Related Cardiac Disease

Pancreatic Ductal Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT06015724DARANIVOVAXP2recruitingAnti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer

Kidney Failure (1)

NCTAcronymPhaseStatusTitle
NCT06889948DAMOCLESP2recruitingThe Effect of Daratumumab in Patients with Monoclonal Gammopathy of Renal Significance (MGRS) in Finland

Hemophilia A With Inhibitor (1)

NCTAcronymPhaseStatusTitle
NCT05888870P4recruitingITI Using SCT800 Alone or Combining Daratumumab in Hemophilia A Adolescents and Adults With High Titer Inhibitor

NHL (1)

NCTAcronymPhaseStatusTitle
NCT06119685P1/P2recruitingIDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

High-Risk de Novo Multiple Myeloma (1)

NCTAcronymPhaseStatusTitle
NCT05849610GEM-TECTALP2active not recruitingTeclistamab-Daratumumab and Talquestamab-Daratumumab in Newly Diagnosed High-risk Multiple Myeloma

T Acute Lymphoblastic Leukemia (1)

NCTAcronymPhaseStatusTitle
NCT07021677DARA_T_ALLP2recruitingUse of a New Medicine "Daratumumab" to Treat Left-over Cancer in a Blood Cancer Called "T Acute Lymphoblastic Leukemia"

Proliferative Glomerulonephritis With Monoclonal IgG Deposits (1)

NCTAcronymPhaseStatusTitle
NCT05654506P2recruitingDaratumumab for Treatment of Proliferative Glomerulonephritis With Monoclonal Immune Deposits

Non-small Cell Lung Cancer With STK11/LKB1 Mutation (1)

NCTAcronymPhaseStatusTitle
NCT05807048P2completedDaratumumab in STK11 Mutated NSCLC

Autoimmune Disorders (1)

NCTAcronymPhaseStatusTitle
NCT05671757DARE-APSP1/P2recruitingDaratumumab in Primary Antiphospholipid Syndrome

Antibody-mediated Rejection (1)

NCTAcronymPhaseStatusTitle
NCT05913596N/AunknownThe Safety and Efficacy of CD38 Monoclonal Antibody Monotherapy for CaAMR in Renal Transplantation

Acquired Hemophilia (1)

NCTAcronymPhaseStatusTitle
NCT05849740AHA2023P4recruitingAn Exploratory Study of Cluster of Differentiation 38 (CD38) Monoclonal Antibody Combined Corticosteroid in Acquired Hemophilia A

Immunoglobulin Light-chain Amyloidosis (1)

NCTAcronymPhaseStatusTitle
NCT05776940P3unknownProbiotic Supplementation Reduces Gastrointestinal Symptoms During the Therapy and Improves Therapeutic Response in AL Amyloidosis

Nephrotic Syndrome (1)

NCTAcronymPhaseStatusTitle
NCT05704400P2unknownEfficacy of Anti-CD20 Ab Associated With Anti-CD38 in the Childhood Multidrug Dependent and Resistant Nephrotic Syndrome

Neuromyelitis Optica (1)

NCTAcronymPhaseStatusTitle
NCT05403138DAWNP2/P3active not recruitingSafety and Efficacy of Daratumumab in Patients With Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorders

Glioblastoma (1)

NCTAcronymPhaseStatusTitle
NCT04922723PRIDEP1/P2active not recruitingRadiation/Temozolomide and Immunotherapy With Daratumumab to Improve Antitumor Efficacy in Glioblastoma

ISS Stage III Plasma Cell Myeloma (1)

NCTAcronymPhaseStatusTitle
NCT05497804P2active not recruitingCombination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial

Cardiac Transplant (1)

NCTAcronymPhaseStatusTitle
NCT05300451P2enrolling by invitationDaratumumab in HLA Desensitization Prior to Transplantation

Hemolytic Anemia (1)

NCTAcronymPhaseStatusTitle
NCT05004259DARA-AIHAP1completedThe Safety of Repurposing Daratumumab for Relapsed or Refractory Autoimmune Antibody Mediated Hemolytic Anemia

Sensitisation (1)

NCTAcronymPhaseStatusTitle
NCT05145296COMBATP2terminatedThe Safety/Efficacy Of Daratumumab With Belatacept In Highly HLA-Sensitized Patients Awaiting Kidney Transplantation

Relapsed Hematologic Malignancy (1)

NCTAcronymPhaseStatusTitle
NCT05205252ARIAP1/P2withdrawnA Study of Tazemetostat in Combination With Various Treatments in Participants With Blood Cancer.

Primary Plasma Cell Leukemia (1)

NCTAcronymPhaseStatusTitle
NCT06636552EUMELEIAP2recruitingAn Investigator-Initiated, Phase II, Multicenter, Open-Label, Single-Arm, Prospective Clinical Trial to Evaluate the Efficacy and Safety of Alternating Bortezomib-Based Regimens in Combination With DaratUMumab Followed by Maintenance With Daratumumab in the Frontline Setting of Primary Plasma CEll L

Highly Sensitized Prospective Kidney Transplant Recipients (1)

NCTAcronymPhaseStatusTitle
NCT04827979ATTAINP1/P2active not recruitingDaratumumab and Belatacept for Desensitization

Systemic Lupus Erythematosus (1)

NCTAcronymPhaseStatusTitle
NCT04810754DARALUPP2unknownAn Open Label Study to Evaluate Daratumumab in Participants With Moderate to Severe Systemic Lupus Erythematosus

Lupus Nephritis (1)

NCTAcronymPhaseStatusTitle
NCT04868838P2active not recruitingDaratumumab to Treat Active Lupus Nephritis

Amyloid (1)

NCTAcronymPhaseStatusTitle
NCT04270175P2active not recruitingDaratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab

High-risk Smoldering Multiple Myeloma (1)

NCTAcronymPhaseStatusTitle
NCT04775550PRISMP2active not recruitingDARA RVD For High Risk SMM

ITP (1)

NCTAcronymPhaseStatusTitle
NCT04703621P2unknownThe DART Study- Daratumumab Treatment in ITP

Recurrent Chronic Lymphocytic Leukemia (1)

NCTAcronymPhaseStatusTitle
NCT04230304P2terminatedDaratumumab and Ibrutinib for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia, DIRECT Study

Myeloma, Multiple (1)

NCTAcronymPhaseStatusTitle
NCT04009109P2active not recruitingStudy of Lenalidomide/Ixazomib/Dexamethasone/Daratumumab in Transplant-Ineligible Patients With Newly Diagnosed MM

POEMS Syndrome (1)

NCTAcronymPhaseStatusTitle
NCT04396496P2completedTreatment of POEMS Syndrome With Daratumumab

Refractory T-Cell Lymphoma (1)

NCTAcronymPhaseStatusTitle
NCT04251065P2terminatedDaratumumab Plus Gemcitabine, Dexamethasone, Cisplatin in pt R/R CD38+ PTCL-NOS, AITL and TFH

Waldenstrom Macroglobulinemia (1)

NCTAcronymPhaseStatusTitle
NCT03679624P2terminatedDaratumumab Plus Ibrutinib in Patients With Waldenstrӧm's Macroglobulinemia

Minimal Residual Disease (1)

NCTAcronymPhaseStatusTitle
NCT03537599P1/P2terminatedDaratumumab and Donor Lymphocyte Infusion in Treating Participants With Relapsed Acute Myeloid Leukemia After Stem Cell Transplant

Alzheimer Disease (1)

NCTAcronymPhaseStatusTitle
NCT04070378DARZADP2completedStudy of Daratumumab in Patients With Mild to Moderate Alzheimer's Disease

Light Chain (AL) Amyloidosis, Stage 3B (1)

NCTAcronymPhaseStatusTitle
NCT04131309ALP2completedA Study of Daratumumab Monotherapy in Previously Untreated Patients With Stage 3B Light Chain (AL) Amyloidosis

Smoldering Plasma Cell Myeloma (1)

NCTAcronymPhaseStatusTitle
NCT03937635P3recruitingLenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Haematological Malignancy (1)

NCTAcronymPhaseStatusTitle
NCT04068597P1/P2recruitingStudy to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Cancer (1)

NCTAcronymPhaseStatusTitle
NCT03899155P2recruitingPan Tumor Rollover Study

Relapsed or Refractory Chronic Lymphocytic Leukemia (1)

NCTAcronymPhaseStatusTitle
NCT03734198IDA53P2active not recruitingEvaluation of the Safety and Efficacy of the Association of Ibrutinib and Daratumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia With p53 Dysfunction

Multiple Myeloma Stage I (1)

NCTAcronymPhaseStatusTitle
NCT03792620MAXDARAP3unknownDaratumumab Intensified Treatment to Eligible MM New Patients CTD-Dara Induction, Follow by Dara Consolidation

Chronic Lymphocytic Leukemia (1)

NCTAcronymPhaseStatusTitle
NCT03447808P1completedDaratumumab and Ibrutinib in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia

Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic (1)

NCTAcronymPhaseStatusTitle
NCT03207542ALLP2withdrawnTrial Evaluating the Efficacy and Safety of Daratumumab in Subjects With Relapsed/Refractory B-cell or T-cell Precursor Acute Lymphoblastic Leukemia (ALL)

Bladder Urothelial Carcinoma (1)

NCTAcronymPhaseStatusTitle
NCT03473730Early P1completedDaratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer

Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

NCTAcronymPhaseStatusTitle
NCT03384654P2completedA Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Relapse and / or Refractory Myeloma (1)

NCTAcronymPhaseStatusTitle
NCT03143036P2unknownDaratumumab, Thalidomide and Dexamethasone in Relapse and/or Refractory Myeloma

Breast Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT03432741P1terminatedDirect Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer

Newly Diagnosed Primary Amyloidosis (1)

NCTAcronymPhaseStatusTitle
NCT03283917P1active not recruitingDaratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis

Waldenström Macroglobulinemia (1)

NCTAcronymPhaseStatusTitle
NCT03187262P2completedA Study of Daratumumab in Patients With Relapsed or Refractory Waldenström Macroglobulinemia

Monoclonal Gammopathy (1)

NCTAcronymPhaseStatusTitle
NCT03236428P2active not recruitingPhase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma

High Risk Myelodysplastic Syndrome (1)

NCTAcronymPhaseStatusTitle
NCT03067571P2terminatedDaratumumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Healthy (1)

NCTAcronymPhaseStatusTitle
NCT03320707P1completedA Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-54767414 (Daratumumab) in Healthy Participants

Membranoproliferative Glomerulonephritis (1)

NCTAcronymPhaseStatusTitle
NCT03095118P2completedDaratumumab in Treatment of PGNMID and C3 GN

Advanced Cancer (1)

NCTAcronymPhaseStatusTitle
NCT03098550P1/P2completedA Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread

Prostate Adenocarcinoma (1)

NCTAcronymPhaseStatusTitle
NCT03177460P1completedDaratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Localized or Locally Advanced Prostate Cancer

Malignant Neoplasms of Male Genital Organs (1)

NCTAcronymPhaseStatusTitle
NCT03035357P2withdrawnNeoadjuvant Listeria or Daratumumab in Prostate Cancer

Myelodysplastic Syndromes (1)

NCTAcronymPhaseStatusTitle
NCT03011034JNJ-56022473P2completedStudy to Separately Evaluate the Activity of Talacotuzumab (JNJ-56022473) or Daratumumab in Transfusion-Dependent Participants With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) Who Are Relapsed or Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment

Lymphoma (1)

NCTAcronymPhaseStatusTitle
NCT02927925NKTCLP2completedA Study to Assess the Clinical Efficacy and Safety of Daratumumab in Participants With Relapsed or Refractory Natural Killer/T-Cell Lymphoma (NKTCL), Nasal Type

Carcinoma, Non-Small-Cell Lung (1)

NCTAcronymPhaseStatusTitle
NCT03023423DARZALEXP1/P2completedA Study of Daratumumab in Combination With Atezolizumab Compared With Atezolizumab Alone in Participants With Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer

Various Advanced Cancer (1)

NCTAcronymPhaseStatusTitle
NCT02488759CheckMate358P1/P2completedAn Investigational Immuno-therapy Study to Investigate the Safety and Effectiveness of Nivolumab, and Nivolumab Combination Therapy in Virus-associated Tumors

Lymphoma, Mantle-Cell (1)

NCTAcronymPhaseStatusTitle
NCT02413489P2terminatedAn Efficacy and Safety Proof of Concept Study of Daratumumab in Relapsed/Refractory Mantle Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular Lymphoma

Microsatellite Unstable Colorectal Cancer (1)

NCTAcronymPhaseStatusTitle
NCT02060188CheckMate142P2completedA Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has Spread

Non-Hodgkin's Lymphoma (1)

NCTAcronymPhaseStatusTitle
NCT01592370P1/P2completedAn Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma

Other (1)

NCTAcronymPhaseStatusTitle
NCT04264884SCN/Aapproved for marketingPre-Approval Access for Administration of Daratumumab Subcutaneously (SC) in Participants Who Are Unable to Receive Intravenous (IV) Daratumumab

Daratumumab pivotal trial highlights (Phase 2/3/4)

Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.

AcronymNCTPhaseStatusIndicationEnrollmentPubMed
AHA2023NCT05849740P4recruitingAcquired Hemophilia25
DARA-MVINCT07274462P4active not recruitingMicrovascular Inflammation - MVI in Kindey Transplant Recipients20
CARTITUDE-6NCT05257083P3active not recruitingMultiple Myeloma759
DRAMMATICNCT04071457P3active not recruitingMultiple Myeloma1,100
HOVON174MMNCT06187441P3recruitingMultiple Myeloma599
ElLenNCT06918002P3recruitingMultiple Myeloma, Newly Diagnosed824
LINKER-MM5NCT07222761P3recruitingRelapsed and/or Refractory Multiple Myeloma (RRMM)915
PrE1005NCT07285239P3not yet recruitingMultiple Myeloma500
MajesTEC-7NCT05552222P3recruitingMultiple Myeloma1,590
MagnetisMM-6NCT05623020P3recruitingMultiple Myeloma1,116
LINKER-SMM2NCT07393282P3recruitingHigh Risk Smoldering Multiple Myeloma (HR-SMM)270
CEVOLUTIONNCT07555938P3recruitingMultiple Myeloma380
EXCALIBER-RRMMNCT04975997P3active not recruitingMultiple Myeloma939PMID 40346992
QUINTESSENTIAL-2NCT06615479P3recruitingRelapsed or Refractory Multiple Myeloma (RRMM)440
iMMagine-3NCT06413498P3recruitingMultiple Myeloma450
NDMMNCT05561387P3recruitingPlasma Cell Myeloma510
DREAMM-10NCT06679101P3recruitingMultiple Myeloma520
FUMANBA-03NCT06464991P3recruitingMultiple Myeloma240
ALUMMINATENCT06232707P3withdrawnMultiple Myeloma0
DURGA-4NCT07391657P3recruitingRelapsed Refractory Multiple Myeloma508
PerseusNCT03710603P3active not recruitingMultiple Myeloma709PMID 38084760
CARTITUDE-4NCT04181827P3active not recruitingMultiple Myeloma419PMID 40768190
MajesTEC-3NCT05083169P3active not recruitingMultiple Myeloma587PMID 41363801
DREAMM 7NCT06868667P3active not recruitingMultiple Myeloma24
DREAMM 7NCT06868654P3active not recruitingMultiple Myeloma72
DREAMM 7NCT04246047P3active not recruitingMultiple Myeloma494PMID 40763276
MonumenTAL-3NCT05455320P3active not recruitingMultiple Myeloma864
RADIANCT06867991P3recruitingAnti-N-Methyl-D-Aspartate Receptor Encephalitis200
MAGNETISMM-5NCT05020236P3recruitingMultiple Myeloma944
KarMMa-3NCT03651128P3active not recruitingMultiple Myeloma381PMID 38651976
IFM2017_03NCT03993912P3active not recruitingMultiple Myeloma294PMID 41038184
CONFIRMNCT03836014P3active not recruitingMultiple Myeloma in Relapse436
AURIGANCT03901963P3active not recruitingMultiple Myeloma200PMID 35985959
AlloRelapseMMNCT05675319P3terminatedMultiple Myeloma28PMID 39865222
EMN14NCT03180736P3completedMultiple Myeloma304PMID 37793772
ALNCT03201965P3completedAmyloidosis416PMID 36862168
DVMPNCT02195479P3completedMultiple Myeloma706PMID 40220771
VMPNCT03217812P3completedMultiple Myeloma220PMID 37024420
CassiopeiaNCT02541383P3completedMultiple Myeloma1,085PMID 38889735
MAXDARANCT03792620P3unknownMultiple Myeloma Stage I20PMID 7520771
CANDORNCT03158688P3completedRelapsed Multiple Myeloma466PMID 40087058
LIGHTHOUSENCT04649060P3terminatedRelapsed Multiple Myeloma54PMID 37646660
SUN-RAYNCT06358638P2recruitingSickle Cell Disease12
ELDORADONCT07247097P2not yet recruitingMultiple Myeloma160
FASTERNCT06974786P2recruitingMultiple Myeloma, Newly Diagnosed100
GMMG-DADANCT04656951P2active not recruitingMultiple Myeloma67
IFM 2024_06NCT06931704P2not yet recruitingMultiple Myeloma176
ASCENTNCT03289299P2active not recruitingSmoldering Multiple Myeloma87
Iber-KDdNCT05896228P2recruitingRefractory Multiple Myeloma30
PRISMNCT04775550P2active not recruitingHigh-risk Smoldering Multiple Myeloma61
aMMbitionNCT06577025P2active not recruitingMultiple Myeloma43
IFM2021-01NCT05572229P2recruitingMultiple Myeloma74
IFm2022-01NCT06353022P2active not recruitingMultiple Myeloma103
GEM-AnitoFIRSTNCT07045909P2recruitingDe Novo Multiple Myeloma30
REVIVENCT06100237P2recruitingMultiple Myeloma50
DARATALL-VHRNCT06253637P2active not recruitingT-Lymphocytic Leukemia, Acute31
HD10/DSMMXXNCT05695508P2recruitingMultiple Myeloma160
CARTITUDE-2NCT04133636P2active not recruitingMultiple Myeloma208PMID 36095849
GEM-TECTALNCT05849610P2active not recruitingHigh-Risk de Novo Multiple Myeloma30PMID 33151787
EUMELEIANCT06636552P2recruitingPrimary Plasma Cell Leukemia43
ITPNCT07234019P2recruitingImmune Thrombocytopenia160
TALTECNCT06505369P2recruitingMultiple Myeloma50
T-ALL-2024NCT06570915P2withdrawnALL, Adult0
ITPNCT07362238P2recruitingImmune Thrombocytopenia122
PCL-2NCT05054478P2not yet recruitingPlasma Cell Leukemia29
IXANCT03896737P2active not recruitingMultiple Myeloma401
ITPNCT07297563P2recruitingImmune Thrombocytopenia160
IFM 2018-04NCT03606577P2active not recruitingMultiple Myeloma50PMID 38394666
FIL_DALYANCT04915248P2recruitingPlasmablastic Lymphoma28
DPdNCT04124497P2active not recruitingMultiple Myeloma45
DARANIVOVAXNCT06015724P2recruitingPancreatic Ductal Adenocarcinoma54
DAMOCLESNCT06889948P2recruitingKidney Failure30
ITPNCT07362199P2recruitingImmune Thrombocytopenia20
EMN19NCT04166565P2active not recruitingMultiple Myeloma41
ADVANCENCT04268498P2active not recruitingMultiple Myeloma310
IBEXNCT06107738P2recruitingMultiple Myeloma60
MGRSNCT06083922P2recruitingMultiple Myeloma20
AQUARIUSNCT05250973P2active not recruitingAmyloidosis151
ITPNCT07063199P2recruitingImmune Thrombocytopenia30
ITPNCT06838962P2recruitingImmune Thrombocytopenia30
SELIBORDARANCT03589222P2active not recruitingRefractory Multiple Myeloma62
DARA_T_ALLNCT07021677P2recruitingT Acute Lymphoblastic Leukemia18PMID 25999452
DeRIVENCT03942224P2active not recruitingPlasma Cell Myeloma49
MUKninebNCT03188172P2unknownMultiple Myeloma95PMID 35900614
MRDNCT04140162P2active not recruitingMultiple Myeloma57PMID 34182226
TAURUSNCT06189833P2unknownMultiple Myeloma200
IDA53NCT03734198P2active not recruitingRelapsed or Refractory Chronic Lymphocytic Leukemia29
COMBATNCT05145296P2terminatedSensitisation5PMID 27362308
Dara-MGUSNCT06046287P2withdrawnPeripheral Neuropathy0
POM MM 014NCT01946477P2completedMultiple Myeloma186PMID 31588567
ALNCT04131309P2completedLight Chain (AL) Amyloidosis, Stage 3B40
DarPALNCT04895917P2terminatedAL Amyloidosis27
IFM2018-01NCT03669445P2unknownMultiple Myeloma45
CheckMate142NCT02060188P2completedMicrosatellite Unstable Colorectal Cancer385PMID 28734759
DARALLONCT04024384P2withdrawnMultiple Myeloma0
PREDATORNCT03697655P2unknownMultiple Myeloma274
IDARANCT03757221P2terminatedMultiple Myeloma55PMID 42097596
DARALUPNCT04810754P2unknownSystemic Lupus Erythematosus10PMID 40465397
DARZADNCT04070378P2completedAlzheimer Disease16PMID 42063312
RRMMNCT03439293P2completedMultiple Myeloma61PMID 38856176
SY-1425NCT02807558P2completedAcute Myeloid Leukemia155PMID 36477975
DART4MMNCT03992170P2unknownMyeloma Multiple50PMID 19861683
FUSIONMM-003NCT02807454P2terminatedMultiple Myeloma37
DARIANCT03746652P2unknownMultiple Myeloma50
KyDaRNCT04065789P2completedMyeloma Multiple41PMID 33619369
JNJ-56022473NCT03011034P2completedMyelodysplastic Syndromes34
ALLNCT03207542P2withdrawnMalignant Neoplasms Stated as Primary Lymphoid Haematopoietic0
GMMG-DANTENCT02977494P2completedMultiple Myeloma22
MK-3475NCT03221634P2withdrawnMultiple Myeloma0
DARENCT03450057P2completedRelapsed/Refractory Multiple Myeloma38PMID 37340832
AMYDARANCT02816476P2completedAmyloidosis40
IFM2014-04NCT02626481P2completedMultiple Myeloma64PMID 31218679
REBUILDNCT03475628P2unknownMultiple Myeloma57
NKTCLNCT02927925P2completedLymphoma32PMID 38233570
FUSION-MM-005NCT03000452P2completedMultiple Myeloma18

Terminated and withdrawn Daratumumab trials (53)

Studies that ended before completion. Reasons are filed in each trial's ClinicalTrials.gov entry.

All Daratumumab trials (347)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

NCT IDAcronymTitlePhaseStatusEnrollmentSponsorStarted
NCT06358638SUN-RAYSickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell AntibodyP2recruiting12Children's National Research InstituteApr 2024
NCT07095452A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for TransplantP2/P3recruiting660AbbVieJan 2026
NCT05257083CARTITUDE-6A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple MyelomaP3active not recruiting759Stichting European Myeloma NetworkOct 2023
NCT04071457DRAMMATICS1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy DurationP3active not recruiting1,100SWOG Cancer Research NetworkAug 2019
NCT07428369LINKER-MM8A Study of Linvo-VR vs DVRd in Transplant-Eligible Adult Participants With Newly Diagnosed Multiple Myeloma (NDMM)P2/P3not yet recruiting1,570Regeneron PharmaceuticalsJun 2026
NCT06187441HOVON174MMFeAsiBility of a Treatment Free Interval in Newly Diagnosed MM Patients Treated With Daratumumab-lenalidomide-dexamethasone (HOVON174MM)P3recruiting599Stichting Hemato-Oncologie voor Volwassenen NederlandMay 2024
NCT06932562A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for TransplantP3recruiting1,000European Myeloma Network B.V.Dec 2025
NCT06918002ElLenElranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in Transplant-eligible NDMM PatientsP3recruiting824Intergroupe Francophone du MyelomeJul 2025
NCT06892522AEA Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion Alone or in Combination With Oral, IV, Subcutaneous Daratumumab; Lenalidomide; Dexamethasone; CarfilzomibP1/P2recruiting440AbbVieJun 2025
NCT07247097ELDORADOELDORADO: Elranatamab Versus Daratumumab in Combination With RVd Lite for Newly Diagnosed Transplant Ineligible/Deferred Multiple MyelomaP2not yet recruiting160Massachusetts General HospitalApr 2026
NCT05907759Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman DiseaseP2recruiting28National Cancer Institute (NCI)Jul 2024
NCT07072585T-ALLTesting the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)P2/P3not yet recruiting1,708Children's Oncology GroupAug 2026
NCT05137054A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care TreatmentsP1recruiting317Regeneron PharmaceuticalsAug 2022
NCT07222761LINKER-MM5A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)P3recruiting915Regeneron PharmaceuticalsJan 2026
NCT07285239PrE1005Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple MyelomaP3not yet recruiting500PrECOG, LLC.Jul 2026
NCT07107529Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.P2recruiting150European Myeloma Network B.V.Dec 2025
NCT07110844Teclistamab-Daratumumab in AL AmyloidosisP2recruiting25Suzanne Lentzsch, MDNov 2025
NCT05552222MajesTEC-7A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple MyelomaP3recruiting1,590Janssen Research & Development, LLCOct 2022
NCT05623020MagnetisMM-6A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for TransplantP3recruiting1,116PfizerNov 2022
NCT05259839IVA Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused Etentamig (ABBV-383) in Combination With Anti-Cancer Regimens for the Treatment of Adult Participants With Relapsed/Refractory Multiple MyelomaP1active not recruiting283AbbVieOct 2022
NCT07393282LINKER-SMM2A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)P3recruiting270Regeneron PharmaceuticalsMay 2026
NCT06974786FASTERFrontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple MyelomaP2recruiting100SCRI Development Innovations, LLCAug 2025
NCT07555938CEVOLUTIONCevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple MyelomaP3recruiting380Hoffmann-La RocheJun 2026
NCT07605416Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM TrialP2not yet recruiting74National Cancer Institute (NCI)Jul 2026
NCT04933539Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple MyelomaP2active not recruiting14National Cancer Institute (NCI)Oct 2022
NCT07075510Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell DisordersP1/P2recruiting30University of Maryland, BaltimoreOct 2025
NCT06182774Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Multiple MyelomaP3recruiting570Canadian Cancer Trials GroupApr 2024
NCT04975997EXCALIBER-RRMMOpen-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)P3active not recruiting939CelgeneJun 2022
NCT06615479QUINTESSENTIAL-2A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)P3recruiting440Juno Therapeutics, Inc., a Bristol-Myers Squibb CompanyMar 2025
NCT04513639REMNANTThe Relapse from MRD Negativity As Indication for Treatment (REMNANT) StudyP2/P3recruiting176Oslo University HospitalAug 2020
NCT07029776MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple MyelomaP2not yet recruiting50University of ArkansasJul 2026
NCT07513129Venetoclax, Dexamethasone, Bortezomib, and Daratumumab For The Treatment Of Adolescent And Young Adults With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And T-cell Acute Lymphoblastic LymphomaP1recruiting18M.D. Anderson Cancer CenterJun 2026
NCT04656951GMMG-DADADaratumumab for First Line Treatment of Transplant-ineligible Myeloma Patients Followed by Daratumumab Re-treatment at First RelapseP2active not recruiting67University of CologneJun 2021
NCT06931704IFM 2024_06Comparison of Elranatamab and Lenalidomide Versus Daratumumab and Lenalidomide as Post-transplant Maintenance Therapy in Patients With Newly Diagnosed Myeloma (ElMMA)P2not yet recruiting176Nantes University HospitalMay 2025
NCT03289299ASCENTAggressive Smoldering Curative Approach Evaluating Novel Therapies and TransplantP2active not recruiting87International Myeloma FoundationMay 2018
NCT06413498iMMagine-3A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple MyelomaP3recruiting450Kite, A Gilead CompanyAug 2024
NCT03314181A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple MyelomaP2active not recruiting156AbbVieApr 2018
NCT05561387NDMMComparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable TreatmentP3recruiting510SWOG Cancer Research NetworkOct 2023
NCT06679101DREAMM-10A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)P3recruiting520GlaxoSmithKlineDec 2024
NCT06785415Elotuzumab, Daratumumab, Iberdomide, and Dexamethasone for the Treatment of Relapsed Multiple MyelomaP1/P2recruiting37Mayo ClinicMar 2025
NCT05896228Iber-KDdIberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple MyelomaP2recruiting30Benjamin T Diamond, MDFeb 2024
NCT03742297Treatment for Elderly Fit Newly Diagnosed Multiple Myeloma Patients Aged Between 65 and 80 YearsP3active not recruiting462PETHEMA FoundationOct 2018
NCT06953960MMA Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)P1/P2recruiting199AbbVieJul 2025
NCT06464991FUMANBA-03A Phase III Study of Eque-cel in Subjects With Len-refractory RRMM (FUMANBA-03)P3recruiting240Nanjing IASO Biotechnology Co., Ltd.Mar 2024
NCT04775550PRISMDARA RVD For High Risk SMMP2active not recruiting61Omar Nadeem, MDMar 2021
NCT06022939Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL AmyloidosisP3recruiting338SWOG Cancer Research NetworkJul 2024
NCT06577025aMMbitionA Study of Different Sequences of Cilta-cel, Talquetamab in Combination With Daratumumab and Teclistamab in Combination With Daratumumab Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in Participants With Standard-risk Newly Diagnosed Multiple MyelomaP2active not recruiting43Janssen Research & Development, LLCAug 2024
NCT05572229IFM2021-01Study of Teclistamab in Combination in Elderly Patients With Multiple MyelomaP2recruiting74University Hospital, LilleDec 2023
NCT06232707ALUMMINATEA Study to Evaluate Efficacy and Safety of Alnuctamab Compared to Standard of Care Regimens in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)P3withdrawn0CelgeneMay 2024
NCT04139304A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic LymphomaEarly P1recruiting15AIDS Malignancy ConsortiumMay 2021
NCT07391657DURGA-4A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)P3recruiting508AstraZenecaFeb 2026
NCT06353022IFm2022-01Minimal Residual Disease-based Strategy With T-Cell Redirector After Treatment With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (D-VRd) in Newly Diagnosed Multiple MyelomaP2active not recruiting103Nantes University HospitalJun 2024
NCT06622005SX-682 in Combination With Carfilzomib, Daratumumab-Hyaluronidase, and Dexamethasone in Patients With Relapsed or Refractory Multiple MyelomaP1recruiting15Roswell Park Cancer InstituteApr 2025
NCT07221032FT836 CAR T-cell Therapy in Combination With Daratumumab in Patients With Relapsed and/or Refractory Multiple MyelomaP1not yet recruiting12Medical College of WisconsinJul 2026
NCT07452198A Study of GR1803 Injection Versus Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Participants With Relapsed or Refractory Multiple MyelomaP3recruiting358Genrix (Shanghai) Biopharmaceutical Co., Ltd.Mar 2026
NCT07045909GEM-AnitoFIRSTEfficacy and Safety of Anitocabtagene Autoleucel in Participants With Newly Diagnosed Multiple Myeloma (GEM-AnitoFIRST)P2recruiting30PETHEMA FoundationJun 2025
NCT03829371STUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMAP4active not recruiting450University of Turin, ItalyJan 2019
NCT06100237REVIVETeclistamab in Combination With Daratumumab for High-Risk Smoldering Myeloma: A Clinical and Correlative Phase 2 Immuno-Oncology Study (the REVIVE Study)P2recruiting50Carl Ola Landgren, MD, PhDDec 2023
NCT06119685IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic CancersP1/P2recruiting128Indapta Therapeutics, INC.Oct 2023
NCT05438043A Study of DaratumumabP3recruiting500Janssen Research & Development, LLCDec 2022
NCT05527340Iberdomide-dexamethasone Alone or in Combination With Standard MM Treatment Regimens in Transplant Ineligible Newly Diagnosed Patients.P2active not recruiting140PETHEMA FoundationDec 2022
NCT03937635Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering MyelomaP3recruiting288ECOG-ACRIN Cancer Research GroupSep 2019
NCT04910568CAMMA 1A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple MyelomaP1active not recruiting126Genentech, Inc.Jul 2021
NCT03710603PerseusDaratumumab, VELCADE (Bortezomib), Lenalidomide and Dexamethasone Compared to VELCADE, Lenalidomide and Dexamethasone in Subjects With Previously Untreated Multiple MyelomaP3active not recruiting709Stichting European Myeloma NetworkDec 2018
NCT06253637DARATALL-VHRDaratumumab in VHR T-ALL Treated According to the ALL National Treatment ProgramP2active not recruiting31Gruppo Italiano Malattie EMatologiche dell'AdultoOct 2024
NCT05695508HD10/DSMMXXGMMG-HD10 / DSMM-XX / 64007957MMY2003, MajesTEC-5P2recruiting160University of Heidelberg Medical CenterDec 2022
NCT04133636CARTITUDE-2A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple MyelomaP2active not recruiting208Janssen Research & Development, LLCNov 2019
NCT03899155Pan Tumor Rollover StudyP2recruiting1,500Bristol-Myers SquibbAug 2019
NCT05849610GEM-TECTALTeclistamab-Daratumumab and Talquestamab-Daratumumab in Newly Diagnosed High-risk Multiple MyelomaP2active not recruiting30PETHEMA FoundationSep 2023
NCT06952478A Study to Compare Pharmacokinetics, Efficacy and Safety of Subcutaneous CT-P44 and Darzalex Faspro in Combination With Lenalidomide and Dexamethasone in Patients With Refractory or Relapsed Multiple MyelomaP3recruiting486CelltrionAug 2025
NCT06348147Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell TransplantationP2withdrawn0UNC Lineberger Comprehensive Cancer CenterJul 2026
NCT07485647Identifying Effective and Cost-Conscious Maintenance Daratumumab DosingP2not yet recruiting50Eden BiltiboMay 2026
NCT07110662NET-CD38New Therapeutic Target for Toxic Epidermal Necrolysis (TEN) Using Anti-CD38+ Monoclonal Antibodies.P1/P2not yet recruiting9Hospices Civils de LyonOct 2025
NCT04181827CARTITUDE-4A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple MyelomaP3active not recruiting419Janssen Research & Development, LLCJun 2020
NCT07341867Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null PhenotypeP1not yet recruiting90Andrew Hantel, MDJun 2026
NCT07335887Sonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With t(11;14) Primary AL AmyloidosisP2not yet recruiting39Peking University People's HospitalJan 2026
NCT06636552EUMELEIAAn Investigator-Initiated, Phase II, Multicenter, Open-Label, Single-Arm, Prospective Clinical Trial to Evaluate the Efficacy and Safety of Alternating Bortezomib-Based Regimens in Combination With DaratUMumab Followed by Maintenance With Daratumumab in the Frontline Setting of Primary Plasma CEll LP2recruiting43Hellenic Society of HematologyNov 2021
NCT07287228DARA-AA-001The Safety and Efficacy of Daratumumab in Patients With Refractory Aplastic AnemiaP1/P2not yet recruiting37Institute of Hematology & Blood Diseases Hospital, ChinaDec 2025
NCT05486481ALTITUDEVenetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocation (11;14) (ALTITUDE)P1/P2withdrawn0Alfred Chung, MDJan 2024
NCT05083169MajesTEC-3A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple MyelomaP3active not recruiting587Janssen Research & Development, LLCOct 2021
NCT06042725MC210808 Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven-Rd), Daratumumab and Dexamethasone (Ven-Dd), or Daratumumab-Lenalidomide-Dexamethasone (Ven-DRd) for the Treatment of Multiple MyelomaP1recruiting100Mayo ClinicMar 2024
NCT07234019ITPRituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)P2recruiting160Institute of Hematology & Blood Diseases Hospital, ChinaJan 2026
NCT06768489A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide or in Combination With Pomalidomide for Multiple MyelomaP1recruiting140Janssen Research & Development, LLCDec 2024
NCT06505369TALTECBispecific T-cell Redirectors as Part of First Line Treatment in Transplant Eligible Multiple Myeloma PatientsP2recruiting50North Estonia Medical CentreJun 2024
NCT04972942ALLO-T-DARTTargeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & LymphomaP1recruiting30New York Medical CollegeMay 2023
NCT05392946Iberdomide, Daratumumab, Bortezomib, and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma, IDEAL StudyP1/P2active not recruiting49Mayo ClinicAug 2022
NCT05497804Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH TrialP2active not recruiting17Mayo ClinicSep 2022
NCT06570915T-ALL-2024Daratumumab for T Cell ALL With MRD-positive After Standard ChemotherapyP2withdrawn0Institute of Hematology & Blood Diseases Hospital, ChinaDec 2025
NCT05434689COMMANDERCOMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomideP1/P2active not recruiting80University of Alabama at BirminghamJan 2023
NCT07018050Phase II Study of QLS32015 Combination Therapy in the Treatment of Multiple MyelomaP2recruiting160Qilu Pharmaceutical Co., Ltd.Sep 2025
NCT02773030A Study to Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Subjects With Multiple MyelomaP1/P2active not recruiting466CelgeneOct 2016
NCT06868667DREAMM 7Japan Expansion Cohort: Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple MyelomaP3active not recruiting24GlaxoSmithKlineJul 2021
NCT06868654DREAMM 7China Subpopulation: Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple MyelomaP3active not recruiting72GlaxoSmithKlineJul 2021
NCT04246047DREAMM 7Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple MyelomaP3active not recruiting494GlaxoSmithKlineMay 2020
NCT04176718Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MMP2active not recruiting44Andrew Yee, MDMay 2020
NCT05455320MonumenTAL-3A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to TreatmentP3active not recruiting864Janssen Research & Development, LLCOct 2022
NCT06287944225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic SyndromeP1recruiting15City of Hope Medical CenterJul 2025
NCT04827979ATTAINDaratumumab and Belatacept for DesensitizationP1/P2active not recruiting19National Institute of Allergy and Infectious Diseases (NIAID)Nov 2021
NCT07362238ITPDaratumumab Versus Rituximab in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)P2recruiting122Institute of Hematology & Blood Diseases Hospital, ChinaMar 2026
NCT05054478PCL-2Primary Plasma Cell Leukemia: a Prospective Phase 2 Study Incorporating Daratumumab to Chemotherapy and Stem Cell TransplantationP2not yet recruiting29Assistance Publique - Hôpitaux de ParisOct 2021
NCT06948084Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First RelapseP2not yet recruiting80National Cancer Institute (NCI)Aug 2026
NCT07082270Selvigaltin With Standard of Care Treatment for the Treatment of Relapsed/Refractory Multiple MyelomaP1withdrawn0Roswell Park Cancer InstituteApr 2026
NCT03896737IXADaratumumab-bortezomib-dexamethasone (Dara-VCd) vs Bortezomib-Thalidomide-Dexamethasone (VTd), Then Maintenance With Ixazomib (IXA) or IXA-DaraP2active not recruiting401Stichting European Myeloma NetworkApr 2019
NCT06827860Subcutaneous Talquetamab in Elderly Patients With Multiple Myeloma in Early RelapseP2recruiting23Larysa SanchezNov 2025
NCT04270175Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to DaratumumabP2active not recruiting15Weill Medical College of Cornell UniversityApr 2021
NCT06697483Risk Stratification and MRD-driven Maintenance for MM After ASCTN/Arecruiting100Peking University People's HospitalDec 2024
NCT06409702Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease DetectionP4recruiting59The First Affiliated Hospital of Soochow UniversityJun 2024
NCT04566328Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE TrialP3recruiting1,450ECOG-ACRIN Cancer Research GroupFeb 2021
NCT04756401Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple MyelomaP2active not recruiting52Academic and Community Cancer Research UnitedDec 2022
NCT04302324A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to DaratumumabP2active not recruiting11Weill Medical College of Cornell UniversityOct 2021
NCT07297563ITPAnti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)P2recruiting160Institute of Hematology & Blood Diseases Hospital, ChinaJan 2026
NCT06867991RADIASafety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune EncephalitisP3recruiting200The First People's Hospital of ChangzhouNov 2024
NCT03606577IFM 2018-04An Intensive Program With Quadruplet Induction and Consolidation Plus Tandem Autologous Stem Cell Transplantation in Newly Diagnosed High Risk Multiple Myeloma PatientsP2active not recruiting50Nantes University HospitalJul 2019
NCT06142396Pilot Study Dara-CyBorD in Newly Diagnosed Multiple Myeloma Patients With Renal FailureEarly P1recruiting30Augusta UniversityNov 2024
NCT05849740AHA2023An Exploratory Study of Cluster of Differentiation 38 (CD38) Monoclonal Antibody Combined Corticosteroid in Acquired Hemophilia AP4recruiting25Institute of Hematology & Blood Diseases Hospital, ChinaMay 2023
NCT04113018Study of Daratumumab Combined With Carfilzomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple MyelomaP2active not recruiting39Wake Forest University Health SciencesJan 2020
NCT030042872015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance TherapyP2active not recruiting50University of ArkansasJul 2017
NCT03763162Daratumumab, Bortezomib, and Dexamethasone Followed by Daratumumab, Ixazomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple MyelomaP2active not recruiting40M.D. Anderson Cancer CenterJan 2019
NCT06140966Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, Ultra High-risk, Newly Diagnosed Multiple MyelomaP2recruiting54Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOct 2023
NCT05050097MonumenTAL-2A Study of Talquetamab With Other Anticancer Therapies in Participants With Multiple MyelomaP1active not recruiting166Janssen Research & Development, LLCSep 2021
NCT04722146MajesTEC-2A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple MyelomaP1active not recruiting140Janssen Research & Development, LLCMar 2021
NCT07274462DARA-MVIDARA-MVI Study (Daratumumab for Microvascular Inflammation in Kidney Transplantation)P4active not recruiting20University Hospital, MartinNov 2025
NCT03556332A Study of Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Patients With Relapsed/Refractory Myeloma With Salvage Autologous Hematopoietic Cell TransplantationP2active not recruiting41Memorial Sloan Kettering Cancer CenterJul 2018
NCT04915248FIL_DALYAStudy to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients.P2recruiting28Fondazione Italiana Linfomi - ETSJul 2022
NCT04124497DPdA Trial for Relapsed and Relapsed/Refractory Multiple Myeloma PatientsP2active not recruiting45Fondazione EMN Italy OnlusJul 2019
NCT06015724DARANIVOVAXAnti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung CancerP2recruiting54Georgetown UniversityJan 2024
NCT06889948DAMOCLESThe Effect of Daratumumab in Patients with Monoclonal Gammopathy of Renal Significance (MGRS) in FinlandP2recruiting30Helsinki University Central HospitalJan 2024
NCT05289687Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALLP2recruiting20Eastern Cooperative Oncology GroupMay 2023
NCT04009109Study of Lenalidomide/Ixazomib/Dexamethasone/Daratumumab in Transplant-Ineligible Patients With Newly Diagnosed MMP2active not recruiting79Alliance Foundation Trials, LLC.Oct 2020
NCT05020236MAGNETISMM-5A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other TreatmentsP3recruiting944PfizerOct 2021
NCT03283917Daratumumab, Ixazomib, and Dexamethasone in AL AmyloidosisP1active not recruiting21M.D. Anderson Cancer CenterFeb 2018
NCT02343042STOMPSelinexor and Backbone Treatments of Multiple Myeloma PatientsP1/P2active not recruiting300Karyopharm Therapeutics IncOct 2015
NCT03651128KarMMa-3Efficacy and Safety Study of bb2121 Versus Standard Regimens in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)P3active not recruiting381CelgeneApr 2019
NCT04108195A Study of Subcutaneous Daratumumab Regimens in Combination With Bispecific T Cell Redirection Antibodies for the Treatment of Participants With Multiple MyelomaP1active not recruiting290Janssen Research & Development, LLCFeb 2020
NCT07362199ITPAnti-CD38 Monoclonal Antibody Combined With Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)P2recruiting20Institute of Hematology & Blood Diseases Hospital, ChinaMar 2026
NCT06398457Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific AntibodiesEarly P1recruiting8Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsSep 2024
NCT06192979Optimize First-line Treatment for AL Amyloidosis With t (11; 14)N/Arecruiting41Jin Lu, MDJan 2024
NCT05671757DARE-APSDaratumumab in Primary Antiphospholipid SyndromeP1/P2recruiting22National Institute of Allergy and Infectious Diseases (NIAID)May 2023
NCT04166565EMN19Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary DiseaseP2active not recruiting41Stichting European Myeloma NetworkOct 2019
NCT04068597Study to Evaluate CCS1477 (Inobrodib) in Haematological MalignanciesP1/P2recruiting250CellCentric Ltd.Aug 2019
NCT05363111Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multiple MyelomaP1recruiting15City of Hope Medical CenterNov 2022
NCT04661137A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple MyelomaP2suspended96Hackensack Meridian HealthMar 2021
NCT07085728Testing the Investigational Agent Combination of Daratumumab, Bortezomib, and Dexamethasone Compared to the Usual Treatment of Cyclophosphamide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients With Kidney FailureP2active not recruiting74Eastern Cooperative Oncology GroupAug 2025
NCT04268498ADVANCEA Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple MyelomaP2active not recruiting310University of MiamiFeb 2020
NCT04230031Phase II Study of Daratumumab Pre-Mobilization and Post-ASCT in Multiple MyelomaP2withdrawn0Wake Forest University Health SciencesJul 2021
NCT07081126DARTABMRDaratumumab for Late Antibody-Mediated RejectionN/Arecruiting20University Hospital, MartinJul 2025
NCT06107738IBEXIberdomide and Daratumumab As Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple MyelomaP2recruiting60Barbara Ann Karmanos Cancer InstituteDec 2023
NCT04922723PRIDERadiation/Temozolomide and Immunotherapy With Daratumumab to Improve Antitumor Efficacy in GlioblastomaP1/P2active not recruiting16West Virginia UniversityOct 2022
NCT05888870ITI Using SCT800 Alone or Combining Daratumumab in Hemophilia A Adolescents and Adults With High Titer InhibitorP4recruiting50Institute of Hematology & Blood Diseases Hospital, ChinaNov 2023
NCT05898646Daratumumab Maintenance Therapy for Improving Survival in Patients With Light Chain Amyloidosis, EMILIA TrialP2recruiting96Mayo ClinicJul 2023
NCT04925193Personalized Selinexor-based Therapy for Relapsed/Refractory Multiple MyelomaP2active not recruiting18University of Colorado, DenverNov 2021
NCT04973605BGB-11417A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple MyelomaP1/P2recruiting246BeOne MedicinesSep 2021
NCT03989414RRMMA Study to Determine the Recommended Dose and Regimen and to Evaluate the Safety and Preliminary Efficacy of CC-92480 in Combination With Standard Treatments in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) and Newly Diagnosed Multiple Myeloma (NDMM)P1/P2active not recruiting424CelgeneSep 2019
NCT07026604CCM-DS01Daratumumab for Familial Cerebral Cavernous Malformations: A Single-Arm Safety and Efficacy StudyEarly P1not yet recruiting10Beijing Tiantan HospitalJul 2025
NCT06083922MGRSA Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)P2recruiting20Memorial Sloan Kettering Cancer CenterOct 2023
NCT05581875A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Pomalidomide and Dexamethasone in Patients With Relapsed/ Refractory Multiple Myeloma Previously Treated With One Line Therapy Who Are Lenalidomide RefractoryP1/P2not yet recruiting48Hellenic Society of HematologyOct 2022
NCT05139225A Study of TTI-622 in Combination With Daratumumab Hyaluronidase-fihj in People With Multiple MyelomaP1active not recruiting7Memorial Sloan Kettering Cancer CenterOct 2021
NCT05250973AQUARIUSA Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) AmyloidosisP2active not recruiting151Janssen Research & Development, LLCMar 2022
NCT06629818Daratumumab Combined With Venetoclax and Dexamethasone for Newly Diagnosed Light-Chain Amyloidosis With Translocation (11;14)P2recruiting36Peking Union Medical College HospitalOct 2024
NCT03993912IFM2017_03Compare Lenalidomide and Subcutaneous Daratumumab vs Lenalidomide and Dexamethasone in Frail Subjects With Previously Untreated Multiple Myeloma Who Are Ineligible for High Dose TherapyP3active not recruiting294University Hospital, LilleOct 2019
NCT03236428Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple MyelomaP2active not recruiting42Dana-Farber Cancer InstituteNov 2017
NCT07015021DKPDThe Efficacy and Safety of the Combination Therapy of Daratumumab, Cabozantinib, Pomalidomide, and Dexamethasone (D-KPd) in the Treatment of High-risk First-time Relapsed or Primary Refractory MM PatientsN/Anot yet recruiting72The First Affiliated Hospital of Soochow UniversityJun 2025
NCT06169215Comparing the Combination of Selinexor-Daratumumab-Velcade-Dexamethasone (Dara-SVD) With the Usual Treatment (Dara-RVD) for High-Risk Newly Diagnosed Multiple MyelomaP2active not recruiting70National Cancer Institute (NCI)Jul 2024
NCT05451771Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) AmyloidosisP1/P2recruiting53Rajshekhar Chakraborty, MDOct 2022
NCT04868838Daratumumab to Treat Active Lupus NephritisP2active not recruiting12Mayo ClinicApr 2021
NCT03290950A Study of Daratumumab in Patients With Newly Diagnosed Multiple MyelomaP2active not recruiting69Memorial Sloan Kettering Cancer CenterSep 2017
NCT07063199ITPAnti-CD38 Antibody Treating Elderly Patients With Primary Immune Thrombocytopenia (ITP)P2recruiting30Institute of Hematology & Blood Diseases Hospital, ChinaAug 2025
NCT06838962ITPAnti-CD38 Antibody Treating Children With Primary Immune Thrombocytopenia (ITP)P2recruiting30Institute of Hematology & Blood Diseases Hospital, ChinaAug 2024
NCT05654506Daratumumab for Treatment of Proliferative Glomerulonephritis With Monoclonal Immune DepositsP2recruiting40Mayo ClinicAug 2023
NCT05300451Daratumumab in HLA Desensitization Prior to TransplantationP2enrolling by invitation10Barry A. BoilsonMar 2022
NCT04497961A Study of Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or LenalidomideP2active not recruiting95Memorial Sloan Kettering Cancer CenterAug 2020
NCT03589222SELIBORDARASELIBORDARA: Selinexor, Bortezomib and Daratumumab in Multiple MyelomaP2active not recruiting62PETHEMA FoundationJul 2018
NCT07021677DARA_T_ALLUse of a New Medicine "Daratumumab" to Treat Left-over Cancer in a Blood Cancer Called "T Acute Lymphoblastic Leukemia"P2recruiting18Tata Memorial CentreAug 2023
NCT04635189Steroid Sparing Treatment With in Newly Diagnosed Transplant Ineligible Patients With Multiple MyelomaP2active not recruiting28University of RochesterJul 2021
NCT03836014CONFIRMStudy Comparing Continuous Versus Fixed Duration Therapy With Daratumumab, Lenalidomide, and Dexamethasone for Relapsed Multiple MyelomaP3active not recruiting436Assistance Publique - Hôpitaux de ParisJul 2019
NCT03942224DeRIVEDaratumumab, Ixazomib, & Dexamethasone or Daratumumab, Bortezomib, & Dexamethasone in Patients With Newly Diagnosed Multiple MyelomaP2active not recruiting49Emory UniversityJul 2019
NCT03346135Daratumumab After Stem Cell Transplant in Treating Patients With Multiple MyelomaP2active not recruiting31City of Hope Medical CenterJul 2019
NCT03500445Daratumumab, Carfilzomib, Lenalidomide and Low Dose Dexamethasone (DKRd) in Newly Diagnosed, Multiple MyelomaP2active not recruiting75University of ChicagoFeb 2019
NCT06483139Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathyrecruiting450Brigham and Women's HospitalJun 2024
NCT04782687Study of Selinexor Plus DRd for Newly Diagnosed Multiple MyelomaP2active not recruiting73US Oncology ResearchSep 2021
NCT04052880Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly NDMMP2active not recruiting17Larysa SanchezOct 2019
NCT03188172MUKninebMUK Nine b: OPTIMUM Treatment ProtocolP2unknown95University of LeedsSep 2017
NCT03901963AURIGAA Study of Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Participants With Newly Diagnosed Multiple Myeloma Who Are Minimal Residual Disease Positive After Frontline Autologous Stem Cell TransplantP3active not recruiting200Janssen Research & Development, LLCApr 2019
NCT03447808Daratumumab and Ibrutinib in Treating Patients With Symptomatic Chronic Lymphocytic LeukemiaP1completed15Jennifer WoyachAug 2018
NCT04151667Daratumumab Based Response Adapted Therapy for Older Adults With Newly Diagnosed Multiple MyelomaP2active not recruiting33H. Lee Moffitt Cancer Center and Research InstituteNov 2019
NCT03301220A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple MyelomaP3completed390Janssen Research & Development, LLCNov 2017
NCT04140162MRDPhase 2 Study With Minimal Residual Disease (MRD) Driven Adaptive Strategy in Treatment for Newly Diagnosed Multiple Myeloma (MM) With Upfront Daratumumab-based TherapyP2active not recruiting57University of Michigan Rogel Cancer CenterOct 2020
NCT04667663CPD-DARACPD-DARA in Patients With Relapsed/Refractory Multiple Myeloma.P1active not recruiting16Cancer Trials IrelandDec 2021
NCT03652064A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial TherapyP3completed395Janssen Research & Development, LLCNov 2018
NCT05776940Probiotic Supplementation Reduces Gastrointestinal Symptoms During the Therapy and Improves Therapeutic Response in AL AmyloidosisP3unknown116Air Force Military Medical University, ChinaMar 2023
NCT05280275A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Transplant IneligibleP1/P2unknown36Hellenic Society of HematologyApr 2022
NCT04814615A Diagnostic Study of CD38-Targeted ImmunoPET of MyelomaP2unknown60Hoag Memorial Hospital PresbyterianMar 2021
NCT05408026PVD-DARAStudy of Combination POM, BTZ, Low-Dose DEX, and DARA (PVD-DARA) in Patients With RRMMP1/P2withdrawn0Alliance Foundation Trials, LLC.Oct 2022
NCT06549634Biomarkers of AKI in Patients Receiving Daratumumabcompleted20Brigham and Women's HospitalSep 2024
NCT06297681Combination of Daratumumab and BD Regimen and Dapagliflozin in the Treatment of M-protein Related Cardiac Diseaseunknown40Beijing Chao Yang HospitalMar 2024
NCT06189833TAURUSPhase 2 Study Applying MRD Techniques for Participants With Previously Untreated Multiple Myeloma Treated With D-VRd Prior To and After High-dose Therapy Followed by ASCT - TAURUSP2unknown200Stichting European Myeloma NetworkNov 2023
NCT05857982Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Relapsed/Refractory Multiple MyelomaP1/P2unknown20Second Affiliated Hospital of Soochow UniversityMay 2023
NCT05562882A Clinical Trial to Assess Safety and Efficacy of Daratumumab in the Treatment of Primary Immune ThrombocytopeniaP2unknown60Institute of Hematology & Blood Diseases Hospital, ChinaDec 2022
NCT05308654A Study to Assess the Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma Receiving Oral ABBV-453 TabletsP1active not recruiting34AbbVieMay 2022
NCT03734198IDA53Evaluation of the Safety and Efficacy of the Association of Ibrutinib and Daratumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia With p53 DysfunctionP2active not recruiting29French Innovative Leukemia OrganisationDec 2018
NCT05403138DAWNSafety and Efficacy of Daratumumab in Patients With Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum DisordersP2/P3active not recruiting135Tianjin Medical University General HospitalNov 2022
NCT01665794Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple MyelomaP1/P2completed25University of ChicagoAug 2012
NCT05807048Daratumumab in STK11 Mutated NSCLCP2completed8NYU Langone HealthJun 2023
NCT05218603MMEvaluation of Maintenance With Bortezomib Plus Daratumumab (V-Dara) After Induction With Bortezomib, Melphalan, Prednisone Plus Daratumumab (VMP-Dara) in Newly Diagnosed Multiple Myeloma (MM) Patients Non-eligible for autoSCTunknown100PETHEMA FoundationNov 2021
NCT05145296COMBATThe Safety/Efficacy Of Daratumumab With Belatacept In Highly HLA-Sensitized Patients Awaiting Kidney TransplantationP2terminated5University Hospital, GrenobleJan 2022
NCT03622775Daratumumab in Treating Participants With Relapsed Multiple Myeloma After Stem Cell TransplantP2terminated13M.D. Anderson Cancer CenterApr 2019
NCT05561049Efficacy and Safety of Daratumumab in Combination With Bortezomib, Thalidomide, and Dexamethasone Regimens in Newly Diagnosed Multiple Myelomaunknown120The First Affiliated Hospital of Soochow UniversityOct 2022
NCT06046287Dara-MGUSDaratumumab for Polyneuropathy Associated With MGUSP2withdrawn0Georgetown UniversitySep 2025
NCT04824794GEN3014 Trial in Relapsed or Refractory Hematologic MalignanciesP1/P2terminated130GenmabMar 2021
NCT06055075A Study Evaluating Safety, Tolerability, and Clinical Activity of Forimtamig-Based Treatment Combinations in Participants With Relapsed or Refractory Multiple MyelomaP1/P2completed19Hoffmann-La RocheDec 2023
NCT03590652Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone as Salvage Therapy in Relapsed/Refractory Multiple MyelomaP2terminated23University of California, San DiegoOct 2018
NCT01946477POM MM 014Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide-based Therapy in the First or Second Line SettingP2completed186CelgeneMay 2014
NCT01415882Ixazomib Citrate in Treating Patients With Relapsed Multiple Myeloma That Is Not Refractory to BortezomibP2completed165Mayo ClinicJan 2012
NCT03477539Daratumumab in Treating Transplant-Eligible Patients With Multiple MyelomaP2completed49Mayo ClinicApr 2018
NCT05675319AlloRelapseMMAllogeneic Stem Cell Transplantation vs. Conventional Therapy as Salvage Therapy for Relapsed / Progressive Patients With Multiple Myeloma After First-line TherapyP3terminated28Universitätsklinikum Hamburg-EppendorfMar 2023
NCT06455748Daratumumab/Daratumumab and Hyaluronidase-fihj in Combination With Pomalidomide and Dexamethasone for the Treatment of Patients With Newly Diagnosed AL Amyloidosis: a Prospective, Multicenter, Single-arm StudyN/Arecruiting20Yongyong MAMar 2024
NCT05704400Efficacy of Anti-CD20 Ab Associated With Anti-CD38 in the Childhood Multidrug Dependent and Resistant Nephrotic SyndromeP2unknown20Istituto Giannina GasliniMar 2023
NCT04288765Carfilzomib, Daratumumab, Lenalidomide and Dexamethasone as First Line Treatment in Multiple MyelomaP3withdrawn0Grupo Cooperativo de Hemopatías MalignasMar 2020
NCT04230304Daratumumab and Ibrutinib for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia, DIRECT StudyP2terminated8Mayo ClinicNov 2020
NCT05835726DILEMMADaratumumab-containing Induction Effects on Stem Cells Mobilization, colLection and Engraftment in Newly Diagnosed Multiple MyelomA Patients.completed188Fondazione Policlinico Universitario Agostino Gemelli IRCCSJan 2022
NCT04131309ALA Study of Daratumumab Monotherapy in Previously Untreated Patients With Stage 3B Light Chain (AL) AmyloidosisP2completed40Stichting European Myeloma NetworkSep 2019
NCT03473730Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney CancerEarly P1completed17M.D. Anderson Cancer CenterMay 2018
NCT04895917DarPALDaratumumab and Pomalidomide in Previously Treated Patients With AL AmyloidosisP2terminated27Fondazione IRCCS Policlinico San Matteo di PaviaJun 2021
NCT05088330A Study to Access of Daratumumab Combined With VRD in the Treatment of Patients With Standard-risk Newly Diagnosed MMN/Aunknown76The First Affiliated Hospital of Soochow UniversityDec 2021
NCT04703621The DART Study- Daratumumab Treatment in ITPP2unknown21Ostfold Hospital TrustJan 2021
NCT03732703MyDRUGMyeloma-Developing Regimens Using Genomics (MyDRUG)P1/P2completed103Multiple Myeloma Research ConsortiumApr 2019
NCT03669445IFM2018-01Study Association of Lenalidomide, Ixazomib, Dexamethasone and Daratumumab in Newly Diagnosed Standard Risk Multiple MyelomaP2unknown45University Hospital, ToulouseDec 2018
NCT05832216Efficacy of Daratumumab to Overcome Platelet Transfusion Refractoriness in Patients with Aplastic AnemiaP1completed10Institute of Hematology & Blood Diseases Hospital, ChinaApr 2023
NCT03180736EMN14Comparison of Pom and Dex in Subjects With RRMM Previously Treated With Len and a PI Dara/Pom/Dex vs Pom/DexP3completed304Stichting European Myeloma NetworkJun 2017
NCT02076009A Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple MyelomaP3completed569Janssen Research & Development, LLCJul 2014
NCT03201965ALA Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) AmyloidosisP3completed416Janssen Research & Development, LLCOct 2017
NCT01615029Daratumumab in Combination With Lenalidomide and Dexamethasone in Relapsed and Relapsed-refractory Multiple MyelomaP1/P2completed45Janssen Research & Development, LLCJun 2012
NCT02060188CheckMate142A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has SpreadP2completed385Bristol-Myers SquibbMar 2014
NCT05182073FT576 in Subjects With Multiple MyelomaP1completed31Fate TherapeuticsNov 2021
NCT04714372FT538 in Combination With Daratumumab in AML Acute Myeloid LeukemiaP1completed9Masonic Cancer Center, University of MinnesotaNov 2021
NCT02252172Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Participants With Previously Untreated Multiple MyelomaP3completed737Janssen Research & Development, LLCFeb 2015
NCT05004259DARA-AIHAThe Safety of Repurposing Daratumumab for Relapsed or Refractory Autoimmune Antibody Mediated Hemolytic AnemiaP1completed2Dartmouth-Hitchcock Medical CenterMar 2022
NCT05284591MYLENENon-interventional Study to Evaluate Patient and Healthcare Provider Satisfaction of Daratumumab Use in the Treatment of First-line Daratumumab, Lenalidomide, Dexamethasone (DRd) Multiple Myeloma Patients in Germany Depending on Application Route (sc or iv)completed96iOMEDICO AGJul 2022
NCT05913596The Safety and Efficacy of CD38 Monoclonal Antibody Monotherapy for CaAMR in Renal TransplantationN/Aunknown15First Affiliated Hospital of Zhejiang UniversityMay 2023
NCT02195479DVMPA Study of Combination of Daratumumab and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants With Previously Untreated Multiple MyelomaP3completed706Janssen Research & Development, LLCDec 2014
NCT04024384DARALLODaratumumab as Maintenance After Peripheral Blood Stem Cell Transplantation From HLA-identical or Haploidentical Family Donor in the Treatment of Refractory or Relapsed Multiple Myeloma: a Phase 2 TrialP2withdrawn0Assistance Publique - Hôpitaux de ParisJul 2019
NCT03697655PREDATORPre-emptive Daratumumab Therapy of Minimal Residual Disease Reappearance or Biochemical Relapse in Multiple MyelomaP2unknown274Polish Myeloma ConsortiumDec 2018
NCT05243342A Study to Evaluate the Safety and Pharmacokinetics of XMAB24306 in Combination With Daratumumab in Participants With Relapsed/Refractory Multiple MyelomaP1completed18Genentech, Inc.Apr 2022
NCT01592370An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple MyelomaP1/P2completed320Bristol-Myers SquibbAug 2012
NCT05556616iinnovate-2A Study of Modakafusp Alfa in Adult Participants With Multiple MyelomaP1terminated15Teva Branded Pharmaceutical Products R&D LLCJan 2023
NCT02316106A Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple MyelomaP2completed123Janssen Research & Development, LLCMay 2015
NCT05590377iinnovate-3A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple MyelomaP1/P2terminated15Teva Branded Pharmaceutical Products R&D LLCJan 2023
NCT05511428Home Based Daratumumab Administration for Patients With Multiple MyelomaP4completed20Thomas Jefferson UniversityNov 2022
NCT03695744Daratumumab in Combination With Bortezomib and Dexamethasone in Newly Diagnosed Transplant Ineligible Multiple MyelomaP2unknown27Singapore General HospitalOct 2019
NCT03757221IDARAIxazomib -Daratumumab Without Dexamethasone (IDara) in Elderly Relapse Refractory Multiple MyelomaP2terminated55University Hospital, CaenFeb 2019
NCT04892446Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple MyelomaP2terminated36Gilead SciencesNov 2021
NCT03412565A Study to Evaluate Subcutaneous Daratumumab in Combination With Standard Multiple Myeloma Treatment RegimensP2completed265Janssen Research & Development, LLCApr 2018
NCT04474938Daratumumab Combined With Bortezomib and Dexamethasone in Mayo 04 Stage III Light Chain AmyloidosisP2unknown40Peking Union Medical College HospitalMay 2021
NCT04892264Belantamab Mafodotin, Lenalidomide, and Daratumumab for the Treatment of Relapsed, Refractory, or Previously Untreated Multiple MyelomaP1terminated5Mayo ClinicJun 2021
NCT03217812VMPA Study of VELCADE (Bortezomib) Melphalan-Prednisone (VMP) Compared to Daratumumab in Combination With VMP (D-VMP), in Participants With Previously Untreated Multiple Myeloma Who Are Ineligible for High-Dose Therapy (Asia Pacific Region)P3completed220Janssen Research & Development, LLCNov 2017
NCT03234972A Study to Compare Daratumumab, Bortezomib, and Dexamethasone (DVd) vs Bortezomib and Dexamethasone (Vd) in Chinese Participants With Relapsed or Refractory Multiple MyelomaP3completed213Janssen Research & Development, LLCNov 2017
NCT03177460Daratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Localized or Locally Advanced Prostate CancerP1completed33M.D. Anderson Cancer CenterJun 2017
NCT04610320Daratumumab-SC for Highly Sensitized Patients Awaiting Heart TransplantationP1completed8Ronald WittelesJul 2021
NCT03184194Nivolumab Combined With Daratumumab With or Without Low-dose CyclophosphamideP2completed62Amsterdam UMC, location VUmcFeb 2018
NCT04352205Daratumumab-Based Therapy for the Treatment of Newly Diagnosed Multiple Myeloma With Kidney FailureP2terminated17Emory UniversityMay 2020
NCT01998971A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple MyelomaP1completed240Janssen Research & Development, LLCFeb 2014
NCT02136134Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants With Relapsed or Refractory Multiple MyelomaP3completed498Janssen Research & Development, LLCAug 2014
NCT04223661Frailty Score-guided Dosing of Lenalidomide, Dexamethasone and Daratumumab Induction TherapyP2withdrawn0Attaya SuvannasankhaDec 2021
NCT04810754DARALUPAn Open Label Study to Evaluate Daratumumab in Participants With Moderate to Severe Systemic Lupus ErythematosusP2unknown10Charite University, Berlin, GermanyJun 2021
NCT04700176A Study of Daratumumab With Pomalidomide, Dexamethasone, and All-Transretinoic Acid in Patients With Multiple MyelomaP2terminated1Hackensack Meridian HealthMay 2022
NCT04304144A Study to Evaluate the Safety and Tolerability of CAEL-101 in Patients With AL AmyloidosisP2completed25Alexion Pharmaceuticals, Inc.Mar 2020
NCT04776018RRMMA Study Of TAK-981 Given With Monoclonal Antibodies (mAbs) In Adults With Relapsed or Refractory Multiple Myeloma (RRMM)P1/P2terminated27TakedaApr 2021
NCT04396496Treatment of POEMS Syndrome With DaratumumabP2completed2University of ArkansasSep 2020
NCT04121260A Study of Subcutaneous Delivery of JNJ-54767414 in Chinese Participants With Multiple MyelomaP1completed21Janssen Research & Development, LLCDec 2019
NCT02541383CassiopeiaA Study to Evaluate Daratumumab in Transplant Eligible Participants With Previously Untreated Multiple MyelomaP3completed1,085Intergroupe Francophone du MyelomeSep 2015
NCT04070378DARZADStudy of Daratumumab in Patients With Mild to Moderate Alzheimer's DiseaseP2completed16Marc L Gordon, MDNov 2019
NCT04614636FT538 in Subjects With Advanced Hematologic MalignanciesP1terminated42Fate TherapeuticsOct 2020
NCT05641324OMNIA-2A Study of ANV419 Alone or in Combination With Approved Treatments in Patients With Multiple Myeloma (OMNIA-2)P1terminated4Anaveon AGFeb 2023
NCT05205252ARIAA Study of Tazemetostat in Combination With Various Treatments in Participants With Blood Cancer.P1/P2withdrawn0Epizyme, Inc.Dec 2021
NCT03439293RRMMA Study of Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)P2completed61TakedaMar 2018
NCT03311828Copper 64Cu-DOTA-Daratumumab Positron Emission Tomography in Diagnosing Patients With Relapsed Multiple MyelomaP1completed12City of Hope Medical CenterFeb 2018
NCT04204980DARDARDesensitization in Kidney Allograft Using DaratumumabP1/P2completed21Assistance Publique - Hôpitaux de ParisFeb 2020
NCT04407442Daratumumab, Azacitidine, and Dexamethasone for Treatment of Patients With Recurrent or Refractory Multiple Myeloma Previously Treated With DaratumumabP2terminated5University of California, San FranciscoNov 2020
NCT04136756NKTR-255 in Relapsed/Refractory Multiple Myeloma & Non-Hodgkin LymphomaP1completed30Nektar TherapeuticsOct 2019
NCT02519452A Study of Daratumumab With the Addition of Recombinant Human Hyaluronidase (rHuPH20) for the Treatment of Participants With Relapsed or Refractory Multiple MyelomaP1completed120Janssen Research & Development, LLCOct 2015
NCT04088903Study of Daratumumab for Decreasing Circulating Antibodies in Sensitized Patients Awaiting Heart TransplantationP1withdrawn0Ronald WittelesApr 2021
NCT04045028PKA Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Activity of Tiragolumab in Participants With Relapsed or Refractory Multiple Myeloma or With Relapsed or Refractory B-cell Non-Hodgkin LymphomaP1terminated41Genentech, Inc.Jul 2019
NCT03490344Short Course Daratumumab in Patients With Multiple MyelomaP2completed10Memorial Sloan Kettering Cancer CenterMay 2018
NCT02807558SY-1425A Biomarker-Directed Phase 2 Trial of Tamibarotene (SY-1425) in Participants With Acute Myeloid Leukemia or Myelodysplastic SyndromeP2completed155Syros PharmaceuticalsSep 2016
NCT03992170DART4MMStudy of Daratumumab in Multiple Myeloma (MM) Patients in >VGPR/MRD-positiveP2unknown50Azienda Ospedaliera Universitaria SeneseDec 2018
NCT03012880Ixazomib Citrate, Lenalidomide, Dexamethasone, and Daratumumab in Treating Patients With Newly Diagnosed Multiple MyelomaP2completed80Mayo ClinicApr 2017
NCT04251065Daratumumab Plus Gemcitabine, Dexamethasone, Cisplatin in pt R/R CD38+ PTCL-NOS, AITL and TFHP2terminated8Fondazione Italiana Linfomi - ETSSep 2020
NCT03067571Daratumumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeP2terminated7M.D. Anderson Cancer CenterOct 2017
NCT02488759CheckMate358An Investigational Immuno-therapy Study to Investigate the Safety and Effectiveness of Nivolumab, and Nivolumab Combination Therapy in Virus-associated TumorsP1/P2completed578Bristol-Myers SquibbOct 2015
NCT03432741Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast CancerP1terminated17Mayo ClinicMar 2018
NCT03384654A Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaP2completed47Janssen Research & Development, LLCMay 2018
NCT03768960A Study of DARZALEX (Daratumumab) In Indian Participants With Relapsed and Refractory Multiple Myeloma, Whose Prior Therapy Included a Proteasome Inhibitor and an Immunomodulatory AgentP4completed150Johnson & Johnson Private LimitedJun 2019
NCT03143036Daratumumab, Thalidomide and Dexamethasone in Relapse and/or Refractory MyelomaP2unknown100National University Hospital, SingaporeMay 2018
NCT04895410IVStudy to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Lemzoparlimab With or Without Oral/IV Dexamethasone and in Combination With Oral/IV/Subcutaneous Anti-Myeloma Regimens in Adult Participants With Multiple MyelomaP1terminated8AbbVieJan 2022
NCT04956302Panobinostat in Combination With Daratumumab, Bortezomib and Dexamethasone for the Treatment of Relapsed/Refractory Multiple MyelomaP1terminated1Abdullah KhanSep 2021
NCT03792620MAXDARADaratumumab Intensified Treatment to Eligible MM New Patients CTD-Dara Induction, Follow by Dara ConsolidationP3unknown20Grupo de Estudos Multicentricos em Onco-HematologiaNov 2018
NCT03158688CANDORStudy of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma.P3completed466AmgenJun 2017
NCT02874742Study Comparing Daratumumab, Lenalidomide, Bortezomib, and Dexamethasone (D-RVd) Versus Lenalidomide, Bortezomib, and Dexamethasone (RVd) in Subjects With Newly Diagnosed Multiple MyelomaP2completed224Janssen Research & Development, LLCAug 2016
NCT03837509SCINCB001158 Combined With Subcutaneous (SC) Daratumumab, Compared to Daratumumab SC, in Relapsed or Refractory Multiple MyelomaP1/P2terminated15Incyte CorporationSep 2019
NCT04280328Study of Ciforadenant in Combination With Daratumumab in Patients With Relapsed or Refractory Multiple MyelomaP1completed7Corvus Pharmaceuticals, Inc.Feb 2020
NCT03841565Daratumumab, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed Multiple MyelomaP2withdrawn0Academic and Community Cancer Research UnitedAug 2020
NCT04649060LIGHTHOUSEStudy of Melflufen (Melphalan Flufenamide) in Combination With Daratumumab in Relapsed-Refractory Multiple MyelomaP3terminated54Oncopeptides ABDec 2020
NCT03537599Daratumumab and Donor Lymphocyte Infusion in Treating Participants With Relapsed Acute Myeloid Leukemia After Stem Cell TransplantP1/P2terminated4Sumithira VasuJan 2020
NCT03481556ANCHORStudy of Melphalan Flufenamide (Melflufen) + Dex With Bortezomib or Daratumumab in Patients With RRMMP1/P2terminated56Oncopeptides ABApr 2018
NCT02807454FUSIONMM-003A Study to Determine the Safety and Efficacy for the Combination of Durvalumab and Daratumumab in Relapsed and Refractory Multiple MyelomaP2terminated37CelgeneJul 2016
NCT03746652DARIASafety and Efficacy of Daratumumab in Combination With Ixazomib and Dexamethasone in Patients With Relapsed or Refractory Multiple MyelomaP2unknown50Hellenic Society of HematologyDec 2018
NCT03187262A Study of Daratumumab in Patients With Relapsed or Refractory Waldenström MacroglobulinemiaP2completed13Dana-Farber Cancer InstituteNov 2017
NCT03697629A Study of an Accelerated Infusion Rate of Daratumumab in Patients With Relapsed and Refractory Multiple MyelomaP2completed40Canadian Myeloma Research GroupDec 2018
NCT04205240Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple MyelomaP2terminated1Srinivas DevarakondaDec 2020
NCT03357952A Study of JNJ-63723283, an Anti-programmed Death-1 Monoclonal Antibody, Administered in Combination With Daratumumab, Compared With Daratumumab Alone in Participants With Relapsed or Refractory Multiple MyelomaP2/P3completed10Janssen Research & Development, LLCNov 2017
NCT04065789KyDaRCarfilzomib in Combination With Daratumumab, Lenalidomide and Dexamethasone in Transplant-ineligible NDMM PatientsP2completed41Tel-Aviv Sourasky Medical CenterMay 2018
NCT03011034JNJ-56022473Study to Separately Evaluate the Activity of Talacotuzumab (JNJ-56022473) or Daratumumab in Transfusion-Dependent Participants With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) Who Are Relapsed or Refractory to Erythropoiesis-Stimulating Agent (ESA) TreatmentP2completed34Janssen Research & Development, LLCFeb 2017
NCT03207542ALLTrial Evaluating the Efficacy and Safety of Daratumumab in Subjects With Relapsed/Refractory B-cell or T-cell Precursor Acute Lymphoblastic Leukemia (ALL)P2withdrawn0M.D. Anderson Cancer CenterJul 2018
NCT02977494GMMG-DANTEDaratumumab in Combination With Bortezomib and Dexamethasone in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma and Severe Renal ImpairmentP2completed22Universitätsklinikum Hamburg-EppendorfJun 2016
NCT03221634MK-3475Efficacy and Safety Study of Pembrolizumab (MK-3475) in Combination With Daratumumab in Participants With Relapsed Refractory Multiple Myeloma (MK-3475-668/KEYNOTE-668)P2withdrawn0Merck Sharp & Dohme LLCAug 2017
NCT03450057DAREEfficacy of Daratumumab in Patients With Relapsed/Refractory Myeloma With Renal ImpairmentP2completed38Hellenic Society of HematologyFeb 2018
NCT02431208MMA Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM)P1completed85Hoffmann-La RocheJul 2015
NCT04467281A Study of PET/CT Scans With the Radioactive Tracer 89Zr-DFO-Daratumumab in People With MyelomaP2withdrawn0Memorial Sloan Kettering Cancer CenterJun 2020
NCT02955810CyBorD-DaraCyclophosphamide-Bortezomib-Dexamethasone (CyBorD) With Daratumumab (DARA)P1unknown18National University of Ireland, Galway, IrelandNov 2016
NCT02816476AMYDARADaratumumab Therapy for Patients With Refractory or Relapsed AL AmyloidosisP2completed40University Hospital, LimogesSep 2016
NCT03679624Daratumumab Plus Ibrutinib in Patients With Waldenstrӧm's MacroglobulinemiaP2terminated1Weill Medical College of Cornell UniversityJul 2020
NCT02951819A Study to Evaluate Dara-CyBorD in Previously Untreated and Relapsed Subjects With Multiple MyelomaP2completed101Janssen Scientific Affairs, LLCNov 2016
NCT02841033Daratumumab for the Treatment of Patients With AL AmyloidosisP1/P2completed22Boston Medical CenterMar 2017
NCT03098550A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have SpreadP1/P2completed105Bristol-Myers SquibbJun 2017
NCT03701321Daratumumab, Bortezomib, and Dexamethasone With or Without Venetoclax in Treating Patients With Relapsed or Refractory Multiple MyelomaP1/P2withdrawn0National Cancer Institute (NCI)Jan 2019
NCT03095118Daratumumab in Treatment of PGNMID and C3 GNP2completed12Fernando FervenzaSep 2017
NCT03665155First-in- Human Imaging of Multiple Myeloma Using 89Zr-DFO-daratumumab, a CD38-targeting Monoclonal AntibodyP1/P2completed11Memorial Sloan Kettering Cancer CenterSep 2018
NCT02918331A Study of JNJ-54767414 (Daratumumab) in Combination With Lenalidomide and Dexamethasone in Japanese Participants With Previously Untreated Multiple Myeloma Who Are Ineligible for High-dose Therapy and Autologous Stem Cell TransplantationP1completed7Janssen Pharmaceutical K.K.Sep 2016
NCT02626481IFM2014-04Study of Daratumumab in Combination With Dexamethasone in Resistant or Refractory Multiple MyelomaP2completed64University Hospital, LilleDec 2015
NCT03475628REBUILDEffects of Daratumumab Monotherapy on Bone Parameters in Patients With Relapsed and /or Refractory Multiple MyelomaP2unknown57Hellenic Society of HematologyFeb 2018
NCT04264884SCPre-Approval Access for Administration of Daratumumab Subcutaneously (SC) in Participants Who Are Unable to Receive Intravenous (IV) Daratumumabapproved for marketing0Janssen Research & Development, LLC
NCT02927925NKTCLA Study to Assess the Clinical Efficacy and Safety of Daratumumab in Participants With Relapsed or Refractory Natural Killer/T-Cell Lymphoma (NKTCL), Nasal TypeP2completed32Janssen Research & Development, LLCFeb 2017
NCT02852837Dose Escalation Study of JNJ-54767414 (Daratumumab) in Chinese Participants With Relapsed or Refractory Multiple Myeloma Who Failed at Least 2 Prior Lines of Systemic TherapyP1completed50Janssen Research & Development, LLCSep 2016
NCT03591744Daratumumab, Bortezomib, Dexamethasone, Pegylated Liposomal Doxorubicin Hydrochloride, and Lenalidomide in Treating Participants With Plasma Cell LeukemiaP1withdrawn0City of Hope Medical CenterOct 2018
NCT03023423DARZALEXA Study of Daratumumab in Combination With Atezolizumab Compared With Atezolizumab Alone in Participants With Previously Treated Advanced or Metastatic Non-Small Cell Lung CancerP1/P2completed100Janssen Research & Development, LLCDec 2016
NCT03320707A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-54767414 (Daratumumab) in Healthy ParticipantsP1completed66Janssen Research & Development, LLCOct 2017
NCT03068351BETStudy of Bromodomain and Extra-Terminal Protein (BET) Inhibitor RO6870810 as Mono- and Combination Therapy in Advanced Multiple MyelomaP1completed24Hoffmann-La RocheJun 2017
NCT03035357Neoadjuvant Listeria or Daratumumab in Prostate CancerP2withdrawn0M.D. Anderson Cancer CenterMar 2017
NCT02497378A Study of JNJ-54767414 (Daratumumab) in Combination With Bortezomib and Dexamethasone (D-Vd) in Japanese Participants With Relapsed or Refractory Multiple MyelomaP1completed8Janssen Pharmaceutical K.K.Jul 2015
NCT03000452FUSION-MM-005A Study to Determine the Efficacy of the Combination of Daratumumab (DARA) Plus Durvalumab (DURVA) (D2) in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)P2completed18CelgeneMar 2017
NCT02944565Daratumumab in Treating Patients With Multiple MyelomaP2completed28Ohio State University Comprehensive Cancer CenterFeb 2017
NCT02413489An Efficacy and Safety Proof of Concept Study of Daratumumab in Relapsed/Refractory Mantle Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular LymphomaP2terminated36Janssen Research & Development, LLCSep 2015
NCT01985126An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiDP2completed124Janssen Research & Development, LLCSep 2013
NCT00574288Daratumumab (HuMax®-CD38) Safety Study in Multiple MyelomaP2completed104Janssen Research & Development, LLCMar 2008
NCT02419118DARA"Monoclonal Antibodies for Treatment of Multiple Myeloma. Emphasis on the CD38 Antibody Daratumumab "P2/P3completed4Vejle HospitalJan 2015
NCT02116569A Study of Daratumumab in Japanese Participants With Relapsed or Refractory Multiple MyelomaP1completed9Janssen Pharmaceutical K.K.Apr 2014
NCT02477891Early Access Treatment With Daratumumab for (Relapsed or Refractory) Multiple Myelomaapproved for marketing0Janssen Research & Development, LLC

Daratumumab clinical trials: frequently asked questions

How many Daratumumab clinical trials are there?
347 Daratumumab clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 86 are actively recruiting participants. 85 are marked completed.
Are Daratumumab clinical trials recruiting in 2026?
Yes — 86 Daratumumab trials are actively recruiting in 2026, with 1512 U.S. sites across 50 states. See the recruiting trials and the per-state site list further down this page.
What conditions is Daratumumab being studied for?
Daratumumab is being studied for Multiple Myeloma, Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Multiple Myeloma, AL Amyloidosis and 246 more. The trials are grouped by indication on this page.
What phase is Daratumumab in?
Daratumumab clinical trials span 7 Phase 4, 57 Phase 3, 161 Phase 2, 52 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
Who sponsors Daratumumab clinical trials?
The lead sponsor across the most Daratumumab trials is Janssen Research & Development, LLC, with 170 additional lead sponsors listed in the data. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Daratumumabas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed .

Related pages on Hipa.ai: